var title_f41_1_42000="Fluticasone: Patient drug information";
var content_f41_1_42000=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fluticasone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/5/28756?source=see_link\">",
"       Fluticasone (nasal): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/33/12822?source=see_link\">",
"       Fluticasone (oral inhalation): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/54/15204?source=see_link\">",
"       Fluticasone (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12492 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42000=[""].join("\n");
var outline_f41_1_42000=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/5/28756?source=related_link\">",
"      Fluticasone (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/33/12822?source=related_link\">",
"      Fluticasone (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/54/15204?source=related_link\">",
"      Fluticasone (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42001="Patient information: Fungal nail infections (The Basics)";
var content_f41_1_42001=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16898\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/33/7699\">",
"         Fungal nail infections",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Fungal nail infections (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/fungal-nail-infections-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H20278040\">",
"      <span class=\"h1\">",
"       What is a fungal nail infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A fungal nail infection is an infection of the nail that makes it get thick or turn white, yellow, or brown. It is caused by a type of germ called a &ldquo;fungus.&rdquo;",
"     </p>",
"     <p>",
"      Fungal infections happen in the toenails more often than the fingernails. They usually start on the big toe, and can affect 1 or more nails. People who have a toenail infection might also have a condition known as &ldquo;athlete&rsquo;s foot&rdquo; (a fungal infection of the foot). That&rsquo;s because certain types of fungi (plural of fungus) can cause both of these problems.",
"     </p>",
"     <p>",
"      Fungi like to grow in warm and wet places. People who swim or whose feet sweat a lot might have a higher chance of getting a fungal nail infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278055\">",
"      <span class=\"h1\">",
"       What are the symptoms of a fungal nail infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A fungal infection can cause a nail to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Turn white, yellow or brown (",
"        <a class=\"graphic graphic_picture graphicRef66584 \" href=\"mobipreview.htm?7/33/7699\">",
"         picture 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Get thick, change shape, or lift up",
"       </li>",
"       <li>",
"        Break off easily",
"       </li>",
"       <li>",
"        Hurt",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Fungal nail infections don&rsquo;t usually lead to serious long-term problems. But in some people they can. In people who have diabetes or whose bodies have trouble fighting infections, the infection can spread to other parts of the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278070\">",
"      <span class=\"h1\">",
"       Is there a test for a fungal nail infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Usually, your doctor or nurse can tell if you have a fungal nail infection by talking with you and doing an exam. But to make sure, he or she might take a small sample of the nail and look at it under a microscope. Your doctor might also send the sample to a lab where another doctor can see which germs are causing the infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278085\">",
"      <span class=\"h1\">",
"       Can I treat my fungal nail infection on my own?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can buy over-the-counter creams or products, but they usually don&rsquo;t work.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278100\">",
"      <span class=\"h1\">",
"       How are fungal nail infections treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends, in part, on how severe the infection is, and how much it bothers you. If your infection is mild or doesn&rsquo;t bother you very much, you might choose not to treat it. An untreated nail infection probably won&rsquo;t go away, but it probably won&rsquo;t cause any long-term problems either.",
"     </p>",
"     <p>",
"      When people need or choose to have treatment, it usually involves &ldquo;antifungal&rdquo; medicines. These medicines are taken by mouth, and treatment usually lasts a few months. Some people who take these medicines need to have blood tests. That&rsquo;s because these medicines can affect the liver.",
"     </p>",
"     <p>",
"      If you don&rsquo;t want to or can&rsquo;t take antifungal medicines, your doctor will talk with you about other treatment options. These might include using an antifungal nail polish or having surgery to remove your nail.",
"     </p>",
"     <p>",
"      Before starting any of these treatments, you should know that:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        It can take many months for your nail to look normal again. &nbsp;",
"       </li>",
"       <li>",
"        There is a chance that the treatment won&rsquo;t work. The infection might not get better, or it might come back. If either of these things happen, your doctor can try another treatment or send you to a specialist.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278115\">",
"      <span class=\"h1\">",
"       Can fungal nail infections be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. To reduce your chance of getting one, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Keep your feet clean and dry.",
"       </li>",
"       <li>",
"        Avoid sharing nail tools, such as clippers and scissors.",
"       </li>",
"       <li>",
"        Wear flip-flops or other footwear in a gym shower or locker room.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278130\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you want to get pregnant, let your doctor or nurse know. He or she might recommend that you not take certain antifungal medicines during pregnancy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20278145\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/1/42001?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16898 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-CACC98E3A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42001=[""].join("\n");
var outline_f41_1_42001=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278040\">",
"      What is a fungal nail infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278055\">",
"      What are the symptoms of a fungal nail infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278070\">",
"      Is there a test for a fungal nail infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278085\">",
"      Can I treat my fungal nail infection on my own?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278100\">",
"      How are fungal nail infections treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278115\">",
"      Can fungal nail infections be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278130\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20278145\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16898\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/33/7699\">",
"      Fungal nail infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42002="Ectopic ureter female";
var content_f41_1_42002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 502px\">",
"   <div class=\"ttl\">",
"    Location of ectopic ureteral orifices in females",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 482px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Possible sites for ectopic ureters noted by arrows. The green dotted line demonstrates other potential sites for ectopic ureters in females.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42002=[""].join("\n");
var outline_f41_1_42002=null;
var title_f41_1_42003="Senna: Pediatric drug information";
var content_f41_1_42003=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Senna: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=see_link\">",
"    see \"Senna: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/51/28468?source=see_link\">",
"    see \"Senna: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F220473\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Black Draught&reg; [OTC];",
"     </li>",
"     <li>",
"      Evac-U-Gen&reg; [OTC];",
"     </li>",
"     <li>",
"      ex-lax&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      ex-lax&reg; [OTC];",
"     </li>",
"     <li>",
"      Fleet&reg; Pedia-Lax&trade; Quick Dissolve [OTC];",
"     </li>",
"     <li>",
"      Fletcher's&reg; [OTC];",
"     </li>",
"     <li>",
"      Geri-kot [OTC];",
"     </li>",
"     <li>",
"      Little Tummys&reg; Laxative [OTC];",
"     </li>",
"     <li>",
"      Perdiem&reg; Overnight Relief [OTC];",
"     </li>",
"     <li>",
"      Senexon&reg; [OTC];",
"     </li>",
"     <li>",
"      Senna-Lax [OTC];",
"     </li>",
"     <li>",
"      SennaGen [OTC];",
"     </li>",
"     <li>",
"      Senokot&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1049855\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Laxative, Stimulant",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1049849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=see_link\">",
"      see \"Senna: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Constipation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 1 month to 2 years: Syrup: 1.25-2.5 mL (2.2-4.4 mg sennosides) at bedtime, not to exceed 5 mL (8.8 mg sennosides)/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Syrup:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     2 to &lt;6 years: 2.5-3.75 mL (4.4-6.6 mg sennosides) at bedtime, not to exceed 3.75 mL (6.6 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     6-12 years: 5-7.5 mL (8.8-13.2 mg sennosides) at bedtime, not to exceed 7.5 mL (13.2 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     2 to &lt;6 years:",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     tablet (4.3 mg sennosides) at bedtime, not to exceed 1 tablet (8.6 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     6-12 years: 1 tablet (8.6 mg sennosides) at bedtime, not to exceed 2 tablets (17.2 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Syrup: 10-15 mL (17.6-26.4 mg sennosides) at bedtime, not to exceed 15 mL (26.4 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet: 2 tablets (17.2 mg sennosides) at bedtime, not to exceed 4 tablets (34.4 mg sennosides) twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bowel evacuation: Children &ge;12 years and Adults: 130 mg sennosides (X-Prep&reg; 75 mL) between 2:00 PM to 4:00 PM on the day prior to procedure",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F220464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Senexon&reg;: Sennosides 8.8 mg/5 mL (237 mL) [contains propylene glycol; chocolate flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral [concentrate]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fletcher's&reg;: Senna concentrate 33.3 mg/mL (75 mL) [ethanol free; contains sodium benzoate; rootbeer flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral [concentrate/drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Little Tummys&reg; Laxative: Sennosides 8.8 mg/mL (30 mL) [dye free, ethanol free; contains propylene glycol, soya lecithin; chocolate flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Strip, orally disintegrating, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Pedia-Lax&trade; Quick Dissolve: Sennosides 8.6 mg (12s) [grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral: Sennosides 8.8 mg/5 mL (237 mL, 240 mL [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: Sennosides 8.6 mg, Sennosides 15 mg, Sennosides 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ex-lax&reg;: Sennosides USP 15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ex-lax&reg; Maximum Strength: Sennosides USP 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Geri-kot: Sennosides 8.6 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Perdiem&reg; Overnight Relief: Sennosides USP 15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Senexon&reg;: Sennosides 8.6 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Senna-Lax: Sennosides 8.6 mg [contains calcium 50 mg/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SennaGen: Sennosides 8.6 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Senokot&reg;: Sennosides 8.6 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Black Draught&reg;: Sennosides 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Evac-U-Gen&reg;: Sennosides 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ex-lax&reg;: Sennosides USP 15 mg [chocolate flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F220454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1049859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with water; syrup can be taken with juice or milk or mixed with ice cream to mask taste.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1049858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Short-term treatment of constipation; evacuate the colon for bowel or rectal examinations",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F220487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Perdiem&reg; may be confused with Pyridium&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Senexon&reg; may be confused with Cenestin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Senokot&reg; may be confused with Depakote&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F220486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Gastrointestinal: Abdominal cramps, diarrhea, nausea, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1049863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to senna or any component; nausea and vomiting; undiagnosed abdominal pain, appendicitis, intestinal obstruction or perforation",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1049848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid prolonged use (&gt;1 week); chronic use may lead to dependency, fluid and electrolyte imbalance, vitamin and mineral deficiencies",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1049847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Concentrated liquid contains sodium benzoate which may cause allergic reactions in susceptible individuals; use products containing sodium benzoate with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14079765\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     An increased risk of congenital abnormalities was not observed following maternal use of senna during pregnancy (Acs, 2009). Short-term use of senna is generally considered safe during pregnancy (Mahadevan, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1049854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I &amp; O, frequency of bowel movements, serum electrolytes if severe diarrhea occurs",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1049846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Active metabolite (aglycone) acts as a local irritant on the colon, stimulates Auerbach's plexus to produce peristalsis",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1049861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Within 6-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Evacuation occurs in 30 minutes to 2 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1049862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In the feces (via bile) and in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1049853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/51/28468?source=see_link\">",
"      see \"Senna: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May discolor urine or feces; drink plenty of fluids",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Acs N, B&aacute;nhidy F, Puh&oacute; EH, et al, \"Senna Treatment in Pregnant Women and Congenital Abnormalities in Their Offspring - A Population-Based Case-Control Study,\"",
"      <i>",
"       Reprod Toxicol",
"      </i>",
"      , 2009, 28(1):100-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/1/42003/abstract-text/19491001/pubmed\" id=\"19491001\" target=\"_blank\">",
"        19491001",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mahadevan U and Kane S, \"American Gastroenterological Association Institute Medical Position Statement on the Use of Gastrointestinal Medications in Pregnancy,\"",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2006, 131(1):278-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/1/42003/abstract-text/16831610/pubmed\" id=\"16831610\" target=\"_blank\">",
"        16831610",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perkin JM, &ldquo;Constipation in Childhood: A Controlled Comparison Between Lactulose and Standardized Senna,&rdquo;",
"      <i>",
"       Curr Med Res Opin",
"      </i>",
"      , 1977, 4(8):540-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/1/42003/abstract-text/872608/pubmed\" id=\"872608\" target=\"_blank\">",
"        872608",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12786 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-684EC2BD62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42003=[""].join("\n");
var outline_f41_1_42003=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220473\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049855\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049849\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220464\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220454\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049859\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049858\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220487\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220486\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049863\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049848\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049847\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300035\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222897\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14079765\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049854\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049846\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049861\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049862\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049853\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12786\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12786|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=related_link\">",
"      Senna: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/51/28468?source=related_link\">",
"      Senna: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42004="Type I hiatal hernia UGI";
var content_f41_1_42004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type I hiatal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 350px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFeATYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDtUPHBGM/1qaAsZHBC7ABg55/KqkbsRg5ycY96twH92euSfT2qhGZ4tuDDo8gV8GQ4z6Ywc9a8i1GT5mAYn1JPWvTvHkrLYqq9Tn+leQ6zceRE2HKv2Pp+BHNDA5fXtQVGaJcPKD0PQcdOvWuUuXd3O7qO4HWr96xdiSWzuPJ5rNmHue+ABxUjITnJ4/8Ar0gJzyO1OzwM+wximjoPpQANyMZ4pn8R5zk9qe349OlNGd2T/k0AGDjr2pQOnoKBnAG407B4AoAQU5QTj0+lJ9KdGpIH14oAkUerZ9R+XvU4UrwO3Yf/AK/amwR8Drn161aCgyNgZHXnmgBIFwR6Dt/k16N4RMmYCflzJxgY/KuEsrZpHUAMc+vXpXqXhm1VZraMcL1OB3x9KaA9E0e5ZkRWbpwPzrpoITJA3zjB4/SucsbUQhcsMA54rqdMZBbYZjnIAyvtTEYd/ZmJztfJI+ma5PV5p0yHAKN3NekX0CSOOGX68VzmtaW0rFVQgHhmHbn6UAeNa5AZldCSCQec9Dg+9efX8RguHQ84/IcV65rmnNHI6MDke3Fed+I9PkSXcMnr29vpSYzlJATIeMc+lMGSATgelSSKTJgAjnjimt09Pp6UgIskHHUUv0o2nZ36duOaRunXn0xQAuM9D/WkBOBmlGeOnrikGTgc5+lAA3oelOBycdMnnPpSKPU8Zp4GCeT1zx3oAtQyMrBgeSeMHqa6fQ9VeOQRklwSBz25+tcsqYPHy9hxz9f1q9auRlgx7d/c/wCfrQB6xo94shVo2zx6/wD169G8LT7nUqfn9M9a8P8ADt8yOo3E/KNpx/n/ACK9W8I3+5fMU4GcN7U0I9QkJ8t+RjqPz4rJvZdqkE9v6VfMuYwcnkE4FYGpy4BJOVxnpTA5fxjeJBbR+axx5mBhC3Y9hRWV4uuC6IDgkP8ATtRQB3VrMGVeecZ5xWrAVKYJ6delcvplwpVCcbiR68810NvIPLOCefl/T/69AHK+P7pVzyCx4UHB9M15BrrgMVHOeQcjPWvSPiHck36wc/IM59ScH/CvONQB/ed2YYBycj9O9JjONuggJwAOT90jBrPnVQGLED8s1fvJAMlydxOdvf6msuUli33m68knmkAz8BTTx1x0px7Yo7UAMYAnnH40oAHApxpKADFFKRQPoaAA/wAPqacAoxn/APXTUznkHPsKsRp90ZJPHTPJxQBPbMg5IOB0z+FXbWSMBg6cnADZGBVFFIxxjr+HSrcalcgKQB3x3zQBuaN5AZFxg9SeK9C0KUR3ELAgYOB09K830xwhViu4dhjHau70Pc7xbVxyOAKaA9Kt7j93ghN27HRST7102lOJbU7gv3sZAHoK4/S43ZV4JAA9fwrtNDGyAk8lW6GmI07vJjjMgG9s9AOaz7pFViD82PWtmc+dbLJtYckHk89KzNRt5Gw7jcCo6dKAOJ8VW8TIWESl8dQB715T4ghjngLPC4AGeQAV49D/AIV7N4gjl+zg4buCMH0rzjVIQZiHUAgnI5xQwPG9UtRHckbflzxn6ms1uMjGfcmu38V2WJ1eNSDjHU5P4965N4SW5B4ANSMog/ID3xSHHfHU9SDUhj2r0PT8qZj35z09eaAG8AA5BPBpAQWxjHr0p3THHIpv8QxnGMd6AHKRjgA89qcgXPA/HikA4/HNCj5enTpQBYBVVXA4464qzCV6gA8g54H/AOqqIJBzhicjA9qswOARx0x0JHegDe01wlwCGwu0+mB9f8969F8M36QTKZPmhcbHBAOVPsa8z06YGZckqxXrznP+ePxrtdLcYDKAB3AB600B9AWsoNmu7BYZ9D3/AJVzWt3CqnPBxkflVjwzeb9Es5XYseckk9mIx/KsfxG7CJlOd69StMRx3iS6AALOAN+OCB2orP16XKDG4/P0VsdjRSGdbpV7H50YLdxXaW8y7Ihk8jJ6V5fZyYkTjJyMY712lqW2RHcOYwoPr8uKYjkvFc/n6tO7En5uT+X+fwrhdXuYlZ3kJITHAwc8/wCfzrrNZRvNYEfMeT+lefeJJi85jQ4VDg8feOaTGc9cyGRmJPJY9ulViV5yM8c9PSppAcHg5zzULAhm5JpAMAwB16DtQPxoGcD6Dt/n2pfpmgAoHXnOKMH0oHUnt3oAbn5Twc4/CnYyRhSaTqOhGeKUDoR09qAHKPmXGc9SO1TwDDDAyM+gqJQc9z1NWIVYg44/DrQBZwGQeShLYAyMfL059atWlq0p2rJNnjngd+46VHbKArZb68Z9K1LBkWX5gxXoR3PP1oAm0hGLFHjPmRnYxIHzcZyPqCD+Neh+Ff8AXQvtZgWwPl55HpXH6PbFZHMjlgzB1BTGMKB6+w/Wu88LKEvYs/N8/GPpTQHoOmxKEDNFLGD2MeP8966bTIF+zOSkgGc5I9hWFZxylMgnGAK6jTYnFmVDnBONvY8UxFmWSPylRBJxnOR3pl0EEIwDxjrj8qrsjlvvHOf896JyRxtzwOfpQBlapErxjIOMen1rg/Eumxkl0TDc9BXod5kxgn+WK5zWIA6E7CfagDxvXLIPkGMnB549642W1hMZw37z7u3p2r1bWbXbOwEeM54JP+NcVdaXG025U28dRk8+/NIZwdzCEXIQ4GeetUpExyBnB9ua6m+051kIRgRz+BH49e9YU0LJ2GCeMZ9eKQFDGce/HSkIBOPbn3qZ0LDPUZ5/KoRkHv8AlQAuTj7vWkyCD2pwB70nIBxkmgAIBIB6A05GHoc9en9KTnng4zxSYIznI78jHegC7Z3IjkXGTlcY9DXcaBdK8YOWJPJOOleeA7SDnkjvW3ol4bSch9xjfGfb3/lQB7z4Tvx/YU0TBv3cmRx1Df8A1wah8Q3qShCu7mIZAHpkf0rK8MTt5E0J5LgFceoJPr/nFJqT74VYnPB/GqEcl4kuFSJASwJb6djRWf4wbEUeMcuD82fQ9KKQzqbWTEinrz6V1enXTO0ADABsD6YH/wBauHspw0irknABz278V02mSgBnDHcvA56Z/wAmgRleKLgpNdTdMcjHY8V5hfs8krSyEhmJI+mT7fSvRvFqq0Z3Mdr5ZsHsMf1rza9ZSWLHgcDkcc0hmbJgDGO/THtVduSc9MYqR23ZIOeSB7VGTncSDx70AIRlvrjHvQc4464/SjjaeeT70nyng5x65oAUjHI9D0pADzj6jnGPWlONuc8+5pwAJIzznnJoAAOhAOe+fSlPGDk01sDdxnPpT1PGDnFACr8pHHfkYqxD9wHAPbgVCigkDnqR1qzAoLckjtnNAGjYJ5gIwSRzx+Fa9hZ4kAckEj9c/SoNFgWRWYDJPGc+w/z+NdRaQRiMgYA/lQAtlAFUDHOOvpxXW+GIWkvYVTJ+bJAHbHNc9bw4ODkn1r0HwRaKjJJtbd5hGAe23/69MR2ul25WAMQdqfiTz0FdHYDzINw2qMDOO3H0qjZIGSJdhOWy3PWtrTLU7i0kbCFMs7Z+7hfTv9KYDbWylmz5KHC92H/1sU+70NwrO80aqignAb19l56V00USRrsjXao6AGnAHcDlgMDGKQWOJ1HQ7i3QZHmBuBsGex9s1hXdhIh2zRtGSCcMu04/KvU25AHNQXlpb3abLmMOo6Z6jp0Pai4Hz74isRHIdoyG55HANcHf25jlBB69RX0J4y8KxtEZ7RWMY6oWyV68j2rxPWLBoJwGGcjOc/WmBwt7CyyN8m4OCK5jUbc7jzk9/l967vU7LMBKjBwTXMXkAZWwcP7H3FSM5h4SMcH/ACM1VkiKtnkg9Rith0XIwW5x0PtVR0Qscg46E9qAM1lPPb/P0pFGQQepNXJ41HOG6+uapsArs2e+etADSD27+tP6jGOPpSDBYYPJ7UYGOTjn8aAHe4JHH5f41PE5Dt9M1XGSwIbtUqY5G7j6/SgD1DwTqDPbRPkiSJgGJ788H6dvwrd1BlVCEbKkbh7deK838JX5trxVLlVdwGOenJrvbp/3EgBzgbhz+dMDifGL4Cb8ABuPyPtRVbxjMd0YRip3E/eH+fSikBv6VcZCKM4PPU9zXWWMu23xn7zHP0xXn2iTh54wd3yn685NdtY4EKqoIHXA/pTAg8aMmYYznJRePToa8w1OTdcOoyMHoST3r0Dx3eDcztxK6hU+Uf7Oa82myH4BxnPp60mBX6jGDjrmo2zg8Y465qRjjoD1/Co2OBnHPSgBM8DqOPyoJAx14H1pSCQCPwHpSFT79OcDpQAvOeR6nrTlB4HFBA989Rx1oGSMYJ/CgBCcjJ7dgelPA9ASSffk/wCf5UgGM4B9TxUyjHUfgaAFRcN061ftY92Bg5/z/wDWqpACXXkjkg+oFatoQIwcbjkHgZ/z9KAN3RVZBtBOzAPf0GRW9EwI5IJrmraYFlP069B/nkVuQMSQ2MAj9aYG/aKrSRDPBI55447/AMq9S8L2+IbdduSeOM85ryzS925M/dz0x7V6t4RtoDe2dwQ3nR5QMWI4JBI25wT8o5IzTEegaXZsYtu0gthV6+vJ+nNdPbRLDCqKMADjnr71R0gF0Lup3cDpWkDx3x7fSkA7PJ4NJyMYz9aUnBx+lJxgcEj2FIYHoM03aAWxn5jnqT2HT06U7oOBTSBvLY5xg/SgBsvzEjkHt3ryb4oeHc4v7aJs9JFAPv8AN7V604zjg88dPrWVq0KzwMHTepHIOMUwPlmfIiZWHY8n1rnb2NTu2oScdO/UV0Wpxtb3U0MoO9GZCOOoJB/ka5y+kEZDFTjPPGeMigDCv7P5twV1U8dSe3pWM8LJIwYMCPrn/PSuhuLnzEXdkqD/AHfasi5ZfMwzHr1wOPakBnEY52nj6jvVKZSd5CkgnP1rTudhUBd3OcgjOBmqcirlx6nPagCgOCAT+VB46A/nTphgkY6txzTTgnp+nFACA/l/OpAwZ8jBx36+lRcLjA7dqAdpIUYzQBo2z7MfNj1PPHNejW90s2nQtzlUCnOfSvMYXAIJ4I6d/wCddTo96i20sBJ+YZU8dgeD70AZnixsMsbKflbkZ9utFV/EsyzOkoOWY4bKjsP8/lRQBpaC5EseQQOOh9672yfNsrevTBrzTSZGWZcHnd079ee1ehWDbYYxgjABI7jjJpgYnjuX99DGRggE9T7f0/rXFuMnke3X3966DxJMbi/mYnpg9P8AdGOlc3K2NwP3qQEJbqO/fNMHCkY6/pS9R3Wl5PbmgBOnQcUuCT07evSgDPUUuAB9BQAKDj7vtweKco65FJtbkAeuc/4U5QS3BGT2xQAuG4zyMDmpI0Jxxx3JNNVTj+uKkCnIzwSaAJowwdep+lXrQMR9PU8VRiU7k69T25rSsoywCjPHt7UAXIN4GNhwoBwDyeldJpsTMiofvdeTWTpdsJZM4wgwcYr0XwV4am1e6WO3XEa4MjnogJ+nXrge1MCLTLWX5QF9K9U8KwyRGEqDuyOR1HvW1pPw9sIYIy73Bfr94en+7XV6b4ftbGRZIjISOMMRzn8KYi3o8bpC3mZJYg8nnvWiCef89qjRQu0AHHTBp44HsakYpJ3dOfrSjoAAe3frTT396QfdznPbgUAByAT29ScUE44HTB4zQcZ5obqQe1AEb5Ixg8HOQcVQvWAiOQeB6/WrkjY6E/5zWDr16lvbSPI6Kqrkk9AOaYHzZ4wlzr2o44/0iXkf7xrjtWnZedrevXjrWpqcw3uzHPXp65rlLq4ZkCvkjkZH1+n60AU2nJTHO3uQevHNVJJGdiSefujn/P8AnFLLuyAMEnnp/n/JqqzEPnOOOB+VIBzscDrjtg1AzFs8dCcEmnMQ3UHn29/pUDjOfTJ6igBkhyvT+IcE9ajbkevbk/nTyPmIA6kDAFM5z3wec9f6UANYH5flHT1oY4Bx6U4nkA45H501hyfp2oAejHIPI5A4PvV+zuCHC4bOOOeeh/8Ar1m9DgD8Mf59qkgfDc9SOuP/AK1AFnUHY7eMD03UVHqDZKsvyq3Xsc/gKKALWntiaEHO0sucem6uytbzFpcSscYB59zxjrXBQEFl6Zz34rVWdBYuoK8kce4HtQAasW+0lnU7sc45yfzrHkOSeo/Htn61LdyKz9cnGTz1qtkZOePoaAF5xgfpQUznPQjpSLgAZ4BPpTxgDAHFAC4z2/z+dGzOSc9PfpRtBHr7d6cAMAD0wM0AKQSMYPQ05VycDOR6mlC5JO38TmnKuSCBnrigACkYzxxUqr359PpzTVXIzjnGasxRDqy4/wD10AEEeXBUdCRx3rUshiQBR14H5VVjQAjaAc96u20Z4JUDoRmgDotEiBYEg5Jyc/QV9JfCvSoYPD9rOkeJpgJJDnqcnHfsDivnPQQNqkDJ6819TfDtIh4asPJKsgiXkHv3/WmB18K4jUnPQDn6VPt54BBzUaAEDgD/APVUhx3APNDAMHdkf/XoUdBjH/6qMDOSBQMZ9u1ICOWNXZS28bemHZR2PIB56fqfWnY45z260pI74z/Om5GATjkYpgDcAYzz7e1MkPJ6nmmSMpHqRWTrOox2UbfModgQq9ycUATaleLaxNJI+AOpNeEfETxu2plrS0dltQfmYZBfqMcHlelJ8Udcaa8jgNwXVEBcA5w2Tx9QP5143qmoF24chc9QT70CHaneiRztbK4yPesGWV2GGLBsnPPfNMmk4PYYwRmqzsARwBx3PA5pDFyVIwWXAz+n51AWJPIP9acSGAwM4PFRkdwv49KAGt+ufX3qJlPOAeTzzUpQEgHAOewPrTXhCjJGefX+VAELjkAKevOaQ5wckkZ/GpGA5DYAyOtGExngc0AQkcjGTx60bTnHb8qcyDcD1NMJHXjaKAGlTt64HQ4H+f8AIo24Xknj/PrQ2OvBPSkbBGTge2fagCadiyryQMn1oqJuVIGRg0UASQkZAHtxx61baQC2C5PBz29KpRna3/16lmkJjICkAnPXoKAI3OWJ7UmRngfy560qEkjHrxzU8MLdSMLnIwaAGRxll46E9sVYEPy5GAMeoqzDA5T5R+OenFX4bKR25ABwcfN/nNAGYsQzyDjpjAzViG0ZxwucKTk4/Ot620eR8hwAoIHLckVt2Wl+WFCqM7cYB4oA5JbJ2GQgwQfTp/k1ctdHlkOWTapPXIPrXYxWCquNgxgj8KsJbMM/KPxpgcp/ZGF4VWGOtEunnaB5YAx0yK6w24C8AZ+tRfZTuPAIz60Acilidy/L178VZitGUZweTkjjp9K6ZbMnHT86abQg8L+tFgKulKIiMLjbj0r6J+Dt/DcaAtshPmWzEMDjjczMP5/pXgUEDKxwv1rtfA+uTaHqKSxlmjJAeLdgOM/z54oEfSSEFRgHJp5ODz0FZ2j3sV/YwXMI+WVFbbn7pxkj6+v0rQHPPvSGOGBzjn2pABjng/hRnpkECkbdkHPfn8ulACMP1FVppwBgHLYHAx61LMSQcHHFcN4ouNS0q4Fyz7rQRgFVPVy2Mnv6UwJfFPiJdOiHk3CiTPOMHsa8v1/xnI8jMhZpMnDMBWf4i1bznZFLPHncrbvrXD6nd4LHBJ9j60xEHiPVvNuC0uXZmLOcD8/61ys88Lg4jPbB4qxqEzzTEjKqOMZ+tVo7GS4P7tSw4HB9j3qRlFvLbjBxyBwOnFOWLfgIoPPHTNSTWc8PDQsvHemKGRgVU8HsenP+RQA+Kz3IMgFh6EHB4/xpk9s0b8qMEDnitOwnGR5gJHTOcdqty2xcebFhlAGcHn9aAOXaHDHggD6etQyKqhgckcjgjrW69riQhUAzx175z/QVlXkDqScdTyQaAKMoIGTnr6iq7YLfzJq64OSBwQegNQMp6457DPvQBXJ5znkDpxQwAyQCO3UU9lJwAOMdz2oZcMQc8Dsc0ARfKSfr25prHAAIJ/rUpBJyVIOfX3pjAgcj9aAGMSSQM0UPlf8A65ooAUdRyMe9L164IHGPbFJjp159KeqtyT3Of0oAlt4txGSp6/hWjbQeYeo2j2qvChGQCwI5/l71sada7m5DDj+vrQBb0zThIPm24zkgrW/a2Kxqc4yfT09Kj0eyaC2YPI8hdt53ZGOAMYJOBwTj3rYgi64HFMCS2tgQBwBV6G1yMcH3qe1h+UcHoM4zWpBb4wdvBHX+tAjPS0+bBA5FTx2RGcY6dCK2ILXnpyM1bS1xyBx2pgc29jtGOzDOf6URaazMO/4e/euqW0Gc4BBq4lsn9wjHYGgDlF0r5lBC+9XIdAExGMBTjtkV1MNomRiMjrjJqyI2O0H7o6UAci3hqILkS7fouQazLyxFlJgSAkcjjH513UkG4YB+v6VRubNJUKsM9vpQBW8L+Ir3T3CwTbAeqgAqeMd+9es6J4hF4qC6WOOQnG5fun/CvEG017eQPHnaCO9drpbyCNApbA689aAPW0kVlBVlOehFQ3FwIYndsbVBJJ9AK4q3vLiKJgskqjqcMR/WuC8Q+I9RLzQtcTmM/LjzmI5H1pWA9C1zxxbWTBY1WRiD/GOPyFcDrfjeTUITbOirDKArOx+4TxkjH+ffFcPe3EjkAknGcnOaz5N5XIf8M0ALfRPGzK3DjgjvmsC+haQkjaRg9Dg11xP22NVmYrKFAVyxPQH5Tz06VhXlq6XAWZWTjII5z+RoGZGmWEanzJ7ct2Csen6V0Nq8SR7EhCgdACK0tP0y5urMzaa7PLGQGhZhyDnlSTz24P50i6uIyIrqHyyOpUYJ+uaBGFfwq8bmRBtwRXGanbLDP+6dShOR/wDWrvrmRZYywzjnFcZrigz8q39089eeh5oGZkRI5IUnG339q2NKutjFJNu1iOnrWWkasFyWyMEfXH1qza7kkBy3GOtIDflto5I2PGGGQQKy5rNGZi4VhuPbnvxW1YtvG0/hUr2ytnqMGmByd9pCKhMbKOcbWrKksSudxX6Gu2vbYmDbGSMEVh3Nu6/K4BA/Mc/X/OKQHOPEMqAVGRx/+qmyW+B1U/T/ADzWvJbFiApYDaemfxplzaNFEQQchTk4PH+R/OgDBeM7iAwx9PeopF4wCOmQQauzI249Tj396rvHgc9h1PagCo+QPmIzRT5xg89fc/8A16KAGjBI9c1YgRQvO3iq6Y3dO/pVuHBUAgEH0/CgC5Zqpf5lGOh5xXS6bCu3cAOfX1zz+maw9OQGcbQMng/pXWabGu0AAH329f8APFAGpaRjaoAwO1attCMjgVVtAMDj8MVqW4Hfjj0piNK3gRlUMoPFalrGCQAAMDp61VtVyF4AxitazT58nsOKYFqGBR6cjPFXIYR/dxj2oiRSPbntV+FBgEDOTkcUAV/JXAwoHH51PHbqOwNWGiSRCjZAwPunafzFPRMIoJ3EcZIwTQBGkag5HHrSlR6DrU2MntSflQBWZRjBC5qu0YJztGc4q8wycYFKIyPT64oApxWSy87VHY1fSFI02qoGD+FSQ8Dacfl7VKRgMSo4wD3xQBR1RxDYzOGGVHX15ryLV5N1w/19a9V1wMbGQKvv+teV38am4fOF7/higDKaTB+nrUTybSvPGKmuFCuRkEYyMDiqsp3gY64pDEiusOc9uCM1esrqC43R3KAgg5OcenT3rnZZMyAIy7hjIz+lMa88q4O/iMd8e1AHY28yaXqBB23NuR8oBxuHODnHB9qnu7qwmVsxKzsAMv1Fcyb+G4iwHXd/WqZ1SOW32tw6nGaAKmq+dZuXglPlsT8uc/hj+tYM772LEE7uo9Of1q1cXhkTB+YAEZI+nPWqjY+XIySc8jvSAkttrMCMdeevH+eK1NNiVx823GRwc1mwrnaUXnv2PStLTyN4OD+Az6UAbtpEqlcAAelaDLkk44+lVLLnaP8AP51tGICMEbcYxjFMDKljHPyjrVOWCNuSin6jrWzOiBeCDyOKpTD5Tjv7UAYNxAkYBCKFxyADn86zbpVYllCkbTnkj07V0Nyo2k7QePTNY18uJDgBsfypAc7cxLklePz65x6VnSAEA8NjP49a2p1BVtq4A4/X/wDVWZOuR1wcf5PX2oAzZgoxniinXGCeg5PcUUANjOCM/Xr05q7CDxtU5x6+1U0GD1A6H9auxZBX7ox3P0oA29LQu6/KdueuevTt1/8A112Fgvy8LgA8DPvXJaSA9yoOwe5PSuytMD7oXrxTA04AdvI/GtGAZJ4/Cs2A5GBgd607buTtwPWgRu2WfcdO9bFsvf2rJsyTgEjtWzAOQCVPFMDTgUlc7cnHHNW4QSefX1qtB0BAAHbnNXIxycY9PSgCUAlclTnHY05iTwOtRsx7EYx0NLk54x1oAeG+YcfXmhc56HNMGcjOAfrU8Sbjj5Rzzx7UACKccj9anxgE849c+9CgKOi5/wD1U0k45IHT6CgCDcV7Y9OfarDEiLgcH3zVU/gRnOKkKM6Ar6+tAFe+AeJyeo75zXl+txbLiZ1PB7enAFeqz25EMhJByOc15Xr7NDdSfvUYt6DpQBzlwcHpyPeqVwcYCjHSrs0nmZGVzjOcdaqTW4lAJx0x07UhmHctskBQsHxzhuCeaoM8u59/QkhRk4C+nXr/APWrYubUKwAK4xnIGMn3FZrxZVtpTI4B7H8aQFdXbcCobPYZ+uKs/M2AkasWAy+7n3x79ag8nLdV/oTzUgVl8skoWxnp9aAKao6oTg/dIyDjGf8AIoAfd8oJx6HPOavfZwy9QoIz9aZLbMrLnb97rjjrQAyFSF4DZGOjHNalpEwIPzEcZ59qgtbdlVQ5TcD0xgCti2gHBXHUUwLlhEzuox1Pr2rXkVlBHIGT1qvYwFFLkj0xVh8kEEjqaBFWdvlOFPJ65qpMeT1HqKuzjK9hzVKZTjnb/hzQBSuBnHp1FZN6udxdM8Z/ya15QcD7prNvMqJOFB2nk0DOenIUsSuD2weTz1FZlyp3cr/DnOc44rTug25tpXOeh4rLmBzztyQeppAZt4DkYU/gaKW9Q8fcJzRQBHGCDweOn61dhGCOo/kTVFMD07fzq4hGwHAJOOM0AdDpQZJg2WLZxwM/1rrLViUHrXF2UsayZPQcdcYHH1rpdMcbTwMk5JBz3NAHQ27Er3rTt2OSRn2561j25GP/AK9aUByfoOxpiOlsy2ARnPFblkpP06DNYGngEjGMkV0loqqvGOnHNMDUjXHXOc/rVhcg45P1qqrALgYJ5708sOQMHn1oAn3EqSfw96co6Zzg1XQ8EsAPTBz2q3bx7gOnXrQA+JSSMce9WoweME/SlSA/Lxin+QwB49McUAMB6H3zTQh+bJ4zwMYqQR4PK8Zx1pjIodn4yQAffrgfqfzoArMSTnnH86mtATPsbJXg8fSmEKWI4P8A+qnxuEckDO3PA69O1ADrxsRynk7M1414kJe9k68V61qz7Y3UHhvfBxmvL9aii+2MCM5xzn2FAHLMrB+Sc9KeuVXrjtWjfJbZzCmCpIOSefQ/zqpFGpwvHGD1pDMe6UsxwSCOn61TeEl3bLdz684rUuYdrY4I+tV2RcnIGfrQBSNucksBnPQHr1o+zksvJK9xxV5UUE8A04xICApGPUnNAFSKNhtUliMY61YFsr8Mcg/eOeDU8UKlhnBwPWrkcS7R9wA5ON3PWgCmtphgACO1amnWW98YIA6n270QIvTGWJ656CtvyIo7eNY9qsVBJz34oERlAiqiDAHA9apTjjjr2qV5MHGcDPY1UllQvt3LuOTjdycdePxH50AI7E9c9arygHOetPcgDIPOfWoXcEHp+BoApzg9DnpWfeICjEjkg/yq/c7SMHvx1zWddSbI2wASOOW9s0DMO8jKB/vA/UYJz1/z6VkXIORw3TsOlaF7IGdsD2PPI69M/WsubBJ9NuOtIChfZPJJ69jRTb5BjjAJbk54ooAhR+M++OBVmJwEJXb9aqg47GpkfCjKkD60Aa1nIu8EY69xnPSuk0yYHBJ4OD9ef/r1x9vJhz8pIHvW1YXZjHVsccE0AdzbMNozWlBIOwArmrC5SaOFmBypJGD7EfyJrZgmzzg9KYHYaXMADnqcdRXQWs6lR6YribS72kcHjHeti11A8YDdO5piOshuMrkjaxzwcZHNWIyGf1weeOnWsK3uWl27P/1c12mheHNQvIElMaxROMq7t94f7o5/PFAENnby3EqrEjs55AAzXcaTocVsqPcYklBzgfdHPH1/lVnRtLj0yFgjNJI4G5jx0HQDt3rSJOcY7+tJsBqIiY2Iq9vlXH8qfhcg4Gc9cc0dxkY/GlGf4R+uKQyG4giuF2yojDsSOR9K43WrM2c5UZKtyG9a7YE9SMDPrXN+MJVEUagfNu9famhHLB+c8DPFOEgRCRxz6dBVUyfJ0Pp1qveviLHJbPODTAq6lqSiYq7A57Yz3rkNW2TXZKHLnBC4IPatHUZZWuG25BUE4z3rl7q6nEU5Vys7RsqOedrY4bH1wcUARPBIN2YWwFPJXpVKU5iA78c+lSzXkjOcu/Ocgt1FRIm/p6etICrcMmADw3p26etVpAoGCQRW9aaTeX8m20h3sMKTuCjnoOSPSq97pFzbXM8M8LpLEDvyOOOvPegZjrjfyCR9KniZS4BAz14HSpZbOaMoSh5xg565/TpTFgcI7BcovBOfWgCJSuTydvOBipkmHGOcc5xVcjHBz0qRB045z1z1oA0LSQblyOCa2JpBtAOMYHSsezX5guO9aTsTxtNAirOwzjj8qqOw59fpVyReD9fXpVfymfI2859aAK0jAe4z6VWlfA9T711Np4P1q9Vmt9PkIHXcyp6H+Iinn4f+IZc7NMYj/rvGP/ZqBnEzS8Ele3QcmsnUGDA8Dp0IzxXX6z4X1bTIjJeWLxoDgtvVwPrtJx+NcrqUTAH5flwc80AczcSDLdxn0rPlIJbH6VfuQ3mPxznB54zn1/GqEpO4HaeRSApXxBA4A564/Sikuy2AcZ565z29qKAIWz2xTwehKgZ759qbyThTUiIxUHOMdzQBJExDnO0nJzg1oQS/7oJOBVWCAs55JH16f/WrYsLLcckYw3JI9+/5UAaukuzInAIB/wA/jXRwFgv0qtptoIIABn8q1Io/UmmBPFuPAQHIrTtC+8fL2xVaMsFGwZbgYY4GPrz2rTtnw/GemDzQI9L+GXh9L7N9exRyW6Eqsb9Gfg5I9B6eterpheG2+2B/SuO+Gd3HLoPkr9+KViwz64wa7Ne4560AHYgnt+BpxGUIPTBGQcH8PekAIBwPw/z9aXoBkkfpSGAxkD5Sfr/n3o5wM7Tn9KMAPkdScfX2oUEkYJ69u9ADJJBHkuyhQMknsOOa898Taokt6VJ75/A9P0xXdalG81o6xqCTjhjgdq8y8R6Rcee0jSFncZ3A8Zz0/wDrU0IgmmHlliVKgZ6+1cpqGpM94sZ2bWcL7irE15OIDG7Ng8Z98dK5m9dzdDaehHNMDdup0VmQAEgjJJ4Of/riuNuWIdgcZrfnd5issWeQN3sQf/1ViXKbix5DdD78UAZsrEk9OKt2BySTgDgCmi0Zl3Fju5bB44p9kfKmiY4IRlbB6HBFID0Xw5aXckMUtrLGUWNZFQYATj+JR6+prJ8YarLDc3KrFDmT5FdiXwmBkFTx6811fh2K1sIQsLXCwTqZPPL53kg4JOM45rmvHej3FszyRaiGhclxDJuznAzg88n0OKYHGSTLNLNK0YG85OBgICc9PxqtcB/NRCFMZXduzg84xwBzxn8u9KMkNuDZLAZH8sU0u8kmXOXOByegpAJ5LYBynIzinrGfYn1q8sbiIyMp2FWUMDnnt6+tX9HshJJvZEmw4VVB/iyOTz6Z/GgZS062d3AC5x7e1XGgbIGBnP5V6PoWhiKNnSPc7DHI69+p/Ae9aNvpMBvBcT7DcQ4JVlAGOMY59TjP+NMR55pPhu61BwMeUmMlmU9PUCvQ/BngW2tnF3K6TuCVVZFxg+uD0rp7FrKzjadY8SvgsVXOM/jW7YbZIVkRdpJyw9KQDVsY0jRBHHjoccCpGt0UHCrjpgD3qyeMHnGRUc25UchSCpHp0796BmBqGlw3ELpJFE6yhtyMoIYEdD618/fFjwnHo92bi3SJLW5Y7YlXHlsAMj6Hr+dfSU0EhuvM34g8vATA+9nrnOa8v+NFxZpo0tu533D42ZHAIIyfr/jQI+WL1CGbKxg+2fXj3rJnXOcYB6/oa6HVYSszksQcnH51hzKQMckYxkfjSGZ93kgcgc9RxRS3YCjnIGfX2ooAhjUs316fnVuCMbeT831HpUUQ56A8+lX4V+YKRk5HbIoAfBEDOp7e5ro9LtwU3HkZGRkYHPT0/wD11QsbYNPhl46njOOn411NrEFQ4A/LrQBato1Ea4GMVdijyCMdvWoYEO0ccdM4q7HHkEfpTAnQHpjBIHep4uvXtnrSRpxnb+YqxGqjBxnigR1HhDWJ9IvEniKngqyscB1yMj+ua9v0nUYNRs1ubV9ytwQTyp9COxr5vDYwAcfhit+0vfsunbDHy7Z3n+6OPw5zTA9+DAkgEdAf5/4Vma9rEGnWrAtvnfISJWwT6njoO9eGy6ywQ53AY+6Tn+uKmh1I7whAOTzgUWA9J0nxJfXeqRRkmVHY5RFHA9uO39K7lAe/PNeReFL2ODWraSVTgF1JxknKkDFesxSBo0bqTgnjHakwHlQ4x1rnfEWnl4HkGDtwRz05xj/69dECOKbMFMLiQKVxzkDFAzwnV7QoeQAN5PFcvdwr9pfPqcDOK9G8RNHcXssqrsTg7MDjArgtaiLSMV5yf4eaYivYBWLBmURHBwW/KqN1GBK+GB64x0PGa1LPQLyeISCLap5BfC9/c1VvtLnt7gLM8SqMHIOaAM0KMLjcCQe9NsvLV13xGXp8gbGf0rRurWCNwRcIQuQeD16/4VRktI8r86sjAHgH/wCtSA7vw7dwPfwFYwSg2hWuARjaeigdPWtvxLocWtQyyCRnliBCBJVIQ45P09fpXFeHrWCC93szBlG9RjHRSc57dvauq06e0g06eONw0RDEllIYgj169ehpgeY69pb6VqDQPNDNkbg0TFgRk9T61SRMsGByR26dq2fENrHDqjLD5mGUMVkwSuc8ZHXp7elVrK1aWVQi/Me2KQFrRbI31xFE3CLjcR1Azg4/WvXfCmh2peTZCgjZwxAQDBzkAH/OKi8GeFXtLaMXKAxzKGLRoGKn+6efxzz/AIeiwWEdvCyRcKW3Yx09cUwMObZZlT9m2QqeWQ53t6etcjrGpJHeExRqyOQzdg34V3+pQFLUurTM/wDCqYHt68V5nrAE11lUCYGBjqeetAHaeGLqG9UF9saHkLuwRzXS2MKwq/lsvl5JVc/rXDeFraSMFnRymzB+XODnjNdbbRyHaRu2AHOUwGPt6UgNnaOOc8560YHXPPWoYJDgIVJKsBuPGasKQQDjHHTHvQMhmgSRCjhSGGCM+tc7qHhjTZGmkmgjmaQEEygNwe3PaunOCRwelQXW0RvjAIBbFAHyD8S/CY0XX7mCLZ5Lnz4VQ/dQsfl/DBA9gK8wu7QpnvxX1L8WdIlv7P7TFagywM3mFU+bbnB+vQH9a8A1m1AUkKuMY6Z+lAHB3qjA3dM+woq1rKBF4wPm/u+3tRSAigXcwIUk5AGe/Na9hCS2SDn88cCs+3Ulu2PXv1/+tW7axlYgQUJPJyM4GP8AI/CgDT01CZzhTsx/hj/P0regUY+6etZelJhclV5PXvWzCP8AdAzTAsQpgcDHrV+KPjO04xwarQj5ewq6hwGOBj2oEWUUA4I44707d8owD930/WolYEDBXHFODFyR8o4zTAngQsRkHJ9O1XNRUGKBGwQrCRQedpBOD9c0lhExJJ29CM+tal3biS2iIK7lIH05Jz+tAHNSTtja43EDg/nU+mwtPeJFubPVjk8im3MeGZSFyOOuTimW05t50bC4B5/OgD0/wVp8SatbEoNgfODXqW8KUXByx469uteO+GdYHnwvGU3odwG7+deu2cpmtoZCEG9Vb5TwcjNJgTAdgKbKqyKylTtbg4PanYPYgGhs4ONvtmgZ45r1nc6fLcQXAztIy+SQcgHrXH3F9NDMFAZl3Y+9j9e1eneOVmkMpLYOAWVRn5eAATXnv2Iz3UaYUFmHLdKYjY0wsbLeVkOeUUk84YjmsvXrFvJecrnP3RuIIGOSa7PR9PItXiDQvIM9shs85B7dqzdctXAeHbGCF25I5Bx1H45oA88nbzv3hQ4VeSOc4ABz6f8A16TT4PPddkZB45J4HvXVf2dA2nBnhUHeQvyjIIUZ46VSsx9l3fJCxXGAMY/LmgDZkgjtLWD5WlHlbnIBG5QpwCfrj/PTmNQvvKtn+zw7HuFeItuOEX5T8vv/AI11DSNcxQCRMhlY7QfbnH+fWua16DbEkcRjYRM+4r/tbcfy/WgDGxLczPJJku5yf8+ldl8PrRo9XjmaJ5NisQqLkk4OPyzmsfQbEyPwFZjgAfWvU/CugACKbz3XYvWNPlOVPRs896AOz0m3EdpFjIyg+XGAPpV1j6k+2DTIgyQIM5IX73rT8HByVwe1IZDcwtLGUQso7gdTxXm+u2SWWpeUC0gUKWzxk9T+Fel3TOkLOuzjt61xuraPdXFyJmdHeX5vUH8aEIv+HLgJayTlCqFSwG3gANjr+VRW/ihhdzC5WOOBXZSd43cdOP8AP9KzooL3RLd2YQH7QhIjYkkEEDkcdj61nq32u7cx2iGbcHUK3QdCMY55pgemKwPXBIPI6ikMIMscgaVSuflVsK2eORSrHsTYoUAYGFHH5VKvBIBXFSMQsc8Djp1phUBi207j3p/U/wAJ/pVc3MZvmtAJPOEXmk+U+zaTj7+Nucg/LnOOcYOaAKGrwh7dztyQP618neMLe3i1G8isxtgRiqjPTH9K+rPFIuzol41j5f2pYyU3dMg5/oa+UNXUjoQcj86YjzjxIm1UL7jl+o78UU/xcu2BMFSfM5+uDRSGVbIfMpyfvAf55/lW5bjOFbA9Rz6Dt+X51h2m3knOFxjBrZt8Kq4IA9m46UAdFYKAoPOTyf8AOa1Ic+/61l2G0IuCOOvNaMeP6daYF+E8ADpU7OSMH3xVDftTg8k06NuWJPOO5oEaccoQDvwD3qxCrGTnkEcdaz4OSOOeAav2Mm5+WCjbmmBp2krrKECgLyOQa6G1jNzD9nZsbjkFQTyO349KyIIEZlfGGb061sWKKpAxkA8dKAMW/wBOaFi3zEdsgj8azWt8jlj6Yr0OK0S9Xa4HmYwP9rjp9f8APXro2fgCS6iWSVYrfngSE7vyx/OgDzPR2e1vNwZivPHvXuHgbUFutLWNpWeZOqkH5FwMAHp/Wuck+HEqSboZrZs9dxIOfyqxY6XqegSb1JRGOCFbKnigD0BcnHJ5+tO69ifz4qppk4ubSNjndwpBPcf5zVnjsTx70hmZ4jG/RbxCCd0WM7Sa83sbZVlZcZmZwAuDkAc/lXq10I/sziXaFxzz7VyMNiLe/N1OCoMg2qR2weD+FCEWFikGmwssZAKksyDJXrn8evNYuq2z3EsjgSNvUAEIcnj9K6uVlkt0Fs+w54EfOOa5DWI7j7S+8gg88NkcrzjNMCtNYkabkblHz9VPPA/wrAj0Yo5K/NuwcFeQfzredpDGkZXG3LA+vSq0Sl1ztzjGR3NAEbWjC2CqPnA7A+lYkmkSvK293wQc7lJrsLfTZJU+bc2egzUk2jrbw7pDgnkJnkfXHSgDmtF0828+I8kqQc4I/r716r4dURWMcaMdgO4DB+XIz+XWuGiQIflHBrq/DN6SBaycnnYxwD/u8ChgdOAAmT2B7UHIABJ645qMMMcsOR3qF3igA3Pgu2QGbJJz2z/KpGSlhjHQH1HTj/P50xwVQOcDaAMDp6flVRLhWwyzReXuxhnBzx1P09KivNRt4lWRCJ9/3VVgOOOT/L8KYGn5CCdZWAMik4YKeB+JrPXT4E1A3ZkKyO5C8Y5PJ/lSRXDXE8dzFNJHEiMrW4CkSklSGJxnIAIABA+Y5zgYvvBHMoEirnO7I6igROWAIXd8xOMd6cOgzn8qghto4FVY1GB36n35qc9+n1pDA8gc9qU9Tk8884NNPIz04oOADkj8KAKmoSrDbSyOflRSxPPSvkTWOmO5XuPqa+iPizHqX9jM9vME08ALPEB8zEtwc+nTivnXVB1J9PX60xHn/i4kRLgkfvOeo7H3opvi4fuYyCxy+Rk+1FIZlxttUEbQTgdPetG3l2nsOO4GPxqkqlQuMkZGPfmrsCuccnB4yO3HegDptPuFIJ4BJzzg+lakbgjPGa56yLLLnI9uP/rf5xWxETznJpgaSv8AJjipYiMtjHQ5yKqxkhfbFSxl1BODg5HNAGmCiDdlQeOB60+GXLgqikY6YzVVQ8g+X72c8CtfSYlgV2BbeRjmgRuWIPkpjlucjI45rd06FnkVcbstxwO9YFqWUKTvAPBJ45/KvQPAkYm1e2LHIVmbIHoDTA7bQNIh061TeqPcEBmcgZU46D0/rWuMY4+ucUmSRnnJpQTtJz+lSMQckenvRgHPAII5FI2W4ywJ6Fc57/rS854yOewxQBWjhSMkxBVGc4/CpEkDk9AR68U/nr6Gmyrk7hnevT86YEVwisoDAY6j8qpTwFzGzmMhMj5sfdx1qzJcIYCJGKsB07/yrGubkSTZ3ZU8c9Rj3xQI1oEVYwAIz9FA79ao6laJcKxUITnqcDOBTrRjOgZG3KD0A96JUYMAWYrjk4oAzo7GNHOXjAxj5Vye1RRW9vCWUKrbhzlB+npW0CI4xgZLgjp2xWe7IVA/iA9KALduYxEg2qqgdgB2pl4YnTAjjZgM9B0qKMSPHtXqRkDHtTLjzEUk7gozjPc0Ac/dspnwiIoHYD60xH2spUgf0pkpP2ncehPXr3NIzYKluhPT8DTAtC5YKOTioZpS/wAzEHmmbgBnGB701m5Bz0PUCgCaG4luZILZpAF3YBYgBQfU+ldjo2n29tAXMkE7Eg7sA7T7HJrmdA05L67YSmQRhcnZ1Pt0Ndxbp5cSRgfKqhce3akwHqq54CjnOQPen8AdM470o5XGeKMnnI4zSGKcDGcdaOSd3AGOmOf50c+vf0oU55A6YoAGA6YB4pSAQ3Tnikzg888elKrcfz4oAgvba3vbZ7e6hjmhfG5JFDKecjg18w/EfQW0HVpLTO9QodGIAJU5xn/PavqYEtjqT1/WvIPjpol3dmDU4IpJIorfypSqk7QCzBj7cmmI+UfF68RnsHOBx6UVc8cRMltE3cyAfMOvymikMoRRHj7nBB+oz2q9bqcL9znvj2xUogLIhO88jJ2/59adKVt4lZuCB0x7cf5/yQC1D+6c/dYnoD+HNXYbncwzsHP3c+9YryPLyGAIHHFEF05J2uDkjnbyef8AGgDq4CHHYGrsS/KR7Vi2E7MgJPzfTrWzCTk7iMduOe1MC7aRledynpx1rbtoiXAULuIwR7e1Zdny65xkjrivQ/BHhx9ZuCNxjiSPJkKbgPQf57UxBo2hz6iwhtk3Ejknooz1PpXpHhbw5JpB8y5mjaYZAEecDPfJ/wAO9bOlWEWm2KWkBYxoTlmHLEnOTiralvU8UgEPTtTueoAzTTwOD+VKDkHr154oGKv8PTB5pAenCn8KTOcdPyoGTwGyMdCPakAD8BQM5PA49qOeR0z6jrRyxPPvnHvTAyNagzH5qBevPHfFYcUZkuFXAwc118kYmjMbdOOQO9Z508Wzq6NuUN6f0oEQQj7LB8mMY5FDK8yjOM9eKsbFPDLj/wDXUNxIIoSqkZOf4fagCtNcYkKoYyOM57fjUGUkTcAMgYz/AEpm45YYUkDuhqOGQg/w7SACcGgC3BIY2VTjnvmq+oJLIzkOmWU4B/KrOAED4Ax3GfT60hkWTIzk46gZ7UAckx+fDYyD0PPrSqfnU/LwD3/z6VJqUYS7baQQckkLgHrUaoWHHOB0xxTAaWOB93pQCSRwuP8A69PEbleO46Yq/o+nSXVwgdioznIXNAHS+FITHp3zxANI5O491wP/AK9bfO/t+dRW8fkRIkfCgADj0HenO21gdxB9PypDJ+/Ycf1pM4B4XPtUUcnmABT169u9PzkHB6nrigBzcEkYHSgZ6cc+9Ur+6eGW1TtLKEzjgD296uKTgHdxx/D15pAO9OnT8qNw+7lSR2HWk5yMdfeklj3qck7hnBA5FAD+uc4OeOlY/izTxqWgX1tkr5kLAFRznB/OoX1n+y2kh1mVI2HzQyqhAlXJz7BhjkZ78VetdQi1CAmIkjaCcqQMEcEZ6/hTEfFPxU02SxQQylAyz4znH8Jor0z9qTQo47ewvbMObqacLIoUncArYbrxjgf/AKqKQzyZIv8ARlw4PIPbjnrWXq7mM43L2AHAycc/z61uoE8pVIHTOSPeqOu2ySRoVMYbHRuOMGgDBSdhkM/X6e2en48VatkLvgMF5HAPXmmwQqspaQKdvQEd61bWKJmyqqDkYJGM89qALenqVTcCDzu/DFdHYOXUqQM4496x7OB3MfQAH5sjOff+VdFpsGyQH9MUwN/SLF5ZI8YwQMZr6A8E2UdloFuFULI673OOST0P5YryKwAG07ewIGK9l8OXS3GlwbV4SMIT1BIAoYi/e3K2tu8rEEgEhemao2GsR3cyxiPaxPUsMVpSRxyqQyo+QQcjtVI6ZaKQ0SCNs8Ed/wA6ALygjductnnBwNo9OKUcgcg00fc5IJHfHWnZUgH8f1oGKeoH50YHHI9aTA459ab2H3c/SgB46/LSADBJIxnjFICM9j3zS5BJDYAzxx1oAM8Z9f8ACggHAB4pDjHb/Iobg9VBz6UAQSKAccY7Vl3aK7MCwU9gcVqXDDBAI+pHvWWVQTEySJu9DigRIkEYQoc4Ocj0ql9j3EDJIPvzWi7RjLBgQVPaoo2iYAKwB47YxQA/yE8oA4IA7+uDUElum5sMAT3H0q2qjA6HIxmpjCuG6HigDkdVsv36kMOBzxT9O0l7iVV4AIJ5+ldQlhE7F5QCc8Y7davKqp8qIoAGOBQBk2+gWiRr5hZ2xyMgCtGCzgt2/dIF7ZB5qdSNn9SKD77T+HvQMP4QM4BOeeaijiRQFQduMnJ/WngqTxgn6Um5QQGK5PA9zQA1IRGzOMliT3461DNcxw7gxLNnj/8AVVl9vU4I7+9Y00CC6fB2M2SFbkehoESa0GzYFWUD7Uhzu56dOnP19q1o+VALKx9c1yWr3BmvrS3ztRG+bA6E8H9K6m2K+UpQgrgYyMHFAE2CcD2pxyAQMUwkLjpjvimGbLYVcE8HcDxQMqa7p0GpWbpMqsVBZSQDg/Q1U0eC7h0+H7RJE7eWA2wDjHpwK2lIyM9M/wBajupoobeSWSSNI0UszPgAAA8k+nvQB86ftYXbDSNHjhYK4uTlgQCMIeOh65/SiuV/aN1yLUtU/wBHmSW2inAjdeVJ8sBiD9QPyopAc1GpwMntg8e9MvbPz41YfeUcBuR0qdOQOMnPdasqpI4Gf1pgYtpp74yxZfmznr3HtW3Z2B25EZAyM8davw2TKS0gCgHBzir0ITeOBsU9CAc0AQ21mSBhDkc5I/z/AJFdBYacgYlzhlGCAcU2zHmLkKMdANta8ShN24AYHUjrTEalkpDqQDgYwcf/AFq9X8NSyy6XB5sYQJGsarg9FAG4/Ugn2/CuI8GW0DXkbTKHJZSFK5ya9JjAQEDoPahgTd+n9M0gPOOeD9KzLnWILWUxzJIHHHAH+NT2V6l3HviBwCQcjvSGWz0wemP0pSexxkelM3DnGMY5oyCBgYz/AI0APB5B+vag++etJnO3GOabngDp+H+fegBeCMHBXPpTs+h6fpTOAeBS565wef60AKDhfT/9VDn5gST1+tNyMc8E0p6gAc5oAa3zZ45Pesq5ikyzMDz3xWvuHYDGe1MYbkYMAR16e3agDHaN9m3LbeRj0/SmQxngYPGDx9a0pYCuOB36VLHbqAMgE8cAUCGQKzou44IxnP0q2oIB64A7fhTeg7Din7upIH6UDFydxyep9PrQMggYJxSHk85/KkXAUbVGMDoB6UAKfu+ox0HOaVjggAZOeRim8lOg79hSk9GxQAoOAMnv1poznk8f/qoGPbsKBy3ygYFACrwcg9/wJzUTIrkk9PrxU3f+tJn1AoAyzp3mauZ3ztUqR2zwAK1AcZ6jB/rSNjpxgnn3qtd38NoyCZvvnA5HTPWgC5n5h1PHFHU+hwarWN5FewiSHPUhlI5Vh2I/zkEEcEGrBxuJOMgdeKQDWcqpZSfwH/1q4Hx7rMw0e9ghzGXt3BB5yuw+3t0rvZCSXTA2+pwRyenWvM/iNbRLBekht/2SQqDjujD196Yj5g+JEpfT4SQTmcHGM/wtRUPxHyNPiBAH78dh/dNFAzoIxnH19K3dIsflWSRsHBIGKo6NYm4uUGVAzkjP/wBaukvYHjZEUrgAflj6UCKd3G8gwGIXOOnWltbURtljj8O2avCMBSXHygHgVEZY1GdmGPHApga1scKAjcdcYPP/ANetCMMVOGxng4/lXNQazb24H7uXGccAdfzpsvjawtt4khuiBn7qJ2Gf71AHqfhWZoLqKMchiBjb0PrXpkbHYMk8qMjFfM1t8UtHhEbeRqQLAEYhj46n+/7V3Hh34y6O1u32yHVHJAKlYI84wOD+8HrSA9D8T2Akie7WQ7lA3KRwR04/OsHTdQntZD5D9TyCMg/55rktd+L+k3ssVvbW2pCNmCkPHGMkuADw5r0BvD0lu2Xkjb5tvU9fypga2nSXNzGZZGCjpkA5P61pBWAwzdapyOLWBURQCoA4HXOakt5/NbGMEnrSAtHlR6+wx+FMZGVTtbofSnqMuR3XI6cdKjmVmCgHndjmgY0O+cH6dMVMGbqePwqGDIQsTwMY4+lSxksm/tnpQAoDbeuTjkgU45yOSeeBj2pApYAcc9/8/SlYYAPUA5NACDk9eD7e9ID8uSeB3IpSCGIz0/xpr/KGJ5A6/lQAYJ47AcDHSnLxznNIvBcLxyR260oU7Rg+1ADIwAixgsQgAyVPPHXJ61IM+vbpikAyMehA5pQM89setABk85JyOwGfWmSEgYyDxjGKeFLEYxz/APX9qhjAcMpzgYyfwJoAVHdUywJx6DrTgzMAGOBnP45/z+dOKbkI9jQI8KM9hn9RQAoznBbI6dOlA4Iycd+lI3ygkk446Uqj5yKADklcY75496XI2nDDrijGQp9ScfnQRgZ6Hd/n+dADZD1Jb7pz92uK12W5ur6XYGeOMAjapOM5/wAK7YpuX2Jx170hhXK/KAc9u3P0oA4TTddvbVgDsl+RYwXTlVXOACMZ+8eua7gCR9rRSxqCuM+UST0x3HHX1qIabaBxIbeJmAxkoO/NWiABgAACgCOZHZDlyTjjAxmvJfiZqsUFv5EMTJdPEV/eKciM7gSPftXrsqlI2Y9AN3X3r53+JGoNf65cyEHC/IAfQZoEeL/E6WJrCCISR+d5wbywfm24YZx1xmij4lWyGwhmEcfnecqb9o3bdrHGcZxRSGf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper GI series in a patient with a type I hiatal hernia. The gastric pouch is herniated upward, and gastric folds can be seen traversing the diaphragm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter J Kahrilas, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal upper GI series",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal air-contrast upper gastrointestinal study showing normal gastric folds and small intestinal anatomy, and no masses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul C Schroy III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42004=[""].join("\n");
var outline_f41_1_42004=null;
var title_f41_1_42005="Pseudostrabismus";
var content_f41_1_42005=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudostrabismus (pseudoesotropia)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Much more conjunctiva is visible on the temporal side of the cornea in this normal infant. The light reflex is centered in both eyes. B) The illusion of pseudoesotropia is even greater in side gaze.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2e. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy;2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42005=[""].join("\n");
var outline_f41_1_42005=null;
var title_f41_1_42006="Endoscopic palliation of esophageal cancer";
var content_f41_1_42006=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endoscopic palliation of esophageal cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42006/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/1/42006/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H107180395\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal cancer is often diagnosed at an advanced incurable stage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32250?source=see_link\">",
"     \"Epidemiology, pathobiology, and clinical manifestations of esophageal cancer\"",
"    </a>",
"    .) Although surgical palliation may be considered in patients without metastatic disease who are good operative risk, locally unresectable or medically poor risk patients may achieve excellent palliation of swallowing from nonoperative means. Palliation of dysphagia can often be achieved by radiation, with or without chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=see_link\">",
"     \"Management of locally advanced unresectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, improvement in swallowing may not occur for several weeks, and not all patients can tolerate these treatments. These individuals are plagued by symptoms of esophageal obstruction or fistulae, dysphagia, aspiration, poor nutrition, and weight loss.",
"   </p>",
"   <p>",
"    Symptomatic patients who are not candidates for chemoradiotherapy, or who have recurrent dysphagia following definitive chemoradiotherapy may benefit from palliative endoscopic maneuvers. While a variety of endoscopic methods have been described, esophageal stenting is probably most commonly used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/1\">",
"     1",
"    </a>",
"    ]. In a 2013 guideline, the American Society for Gastrointestinal Endoscopy recommended esophageal stenting as the preferred method for palliation of dysphagia and fistulas in patients with esophageal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/2\">",
"     2",
"    </a>",
"    ]. The degree of palliation with any of these methods is typically incomplete, underscoring that better approaches are still needed. As a general rule, palliative approaches for inoperable esophageal cancer should be based upon patient and tumor characteristics, goals of care, and patient and clinician preferences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will provide an overview of the endoscopic options available for the palliation of esophageal cancer. The use of expandable stents in treating esophageal obstruction is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link\">",
"     \"Expandable stents in the treatment of esophageal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180403\">",
"    <span class=\"h1\">",
"     ESOPHAGEAL DILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal dilatation with either through-the-scope balloon or wire-guided polyvinyl bougies can provide temporary relief of dysphagia until more definitive treatment can be accomplished. Most malignant strictures can be safely dilated to 16 or 17 mm in several sessions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/4\">",
"     4",
"    </a>",
"    ]. However, repeat dilatation is usually required every three to four weeks. Esophageal dilation is also associated with a small risk of perforation, especially if performed by blind Maloney dilation during radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/5-8\">",
"     5-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180411\">",
"    <span class=\"h1\">",
"     LASER THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laser therapy with Neodymium-yttrium-aluminum-garnet (Nd:YAG) has been the traditional form of palliative treatment for esophageal cancer. Treatment with the Nd:YAG laser typically requires several sessions. The goal is to fulgurate sufficient malignant tissue in order to restore luminal patency. Exophytic masses in the mid or distal esophagus are easily fulgurated, but masses at the esophagogastric junction or near the cricopharyngeus are difficult to access [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Treatments are performed every other day and are usually completed in three to four sessions (one week) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Luminal patency can be achieved in over 90 percent of cases with the Nd:YAG laser, and functional success occurs in 70 to 80 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/10\">",
"     10",
"    </a>",
"    ]. Relief may last for one to several months and treatments may have to be repeated.",
"    <strong>",
"    </strong>",
"    Perforation, the most serious complication, occurs in less than 5 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/9,11\">",
"     9,11",
"    </a>",
"    ]. Disadvantages of laser therapy include difficulty in management of long or tortuous segments, frequency of treatment sessions, and high cost.",
"   </p>",
"   <p>",
"    Newer studies suggest that photodynamic therapy may offer advantages. In addition, one randomized study compared metallic endoprostheses to laser therapy and found a significantly better improvement in dysphagia with stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/12\">",
"     12",
"    </a>",
"    ]. Another study involved 65 patients with inoperable esophageal and esophagogastric cancer who were randomly assigned to stenting or thermal ablation (principally with the Nd:YAG laser) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/11\">",
"     11",
"    </a>",
"    ]. Median survival was significantly longer in patients who underwent thermal therapy (125 versus 68 days). However, relief of dysphagia was disappointing in both groups. Furthermore, several patients in both groups had serious treatment-related complications. The thermal therapy group had a longer median hospital length of stay and incurred greater costs. Health-related quality of life was impaired in both groups, and deteriorated significantly in the stent group. Patients who received a stent more commonly reported pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180419\">",
"    <span class=\"h1\">",
"     ABSOLUTE ALCOHOL INJECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection of absolute alcohol into a tumor is a chemical method of ablating esophageal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The advantages of this technique are that it is the least expensive method, it uses equipment that is readily available, and the method of injecting alcohol is similar to that used during free-hand injection of esophageal varices.",
"   </p>",
"   <p>",
"    The disadvantages are that there is relatively little experience with this method and there are potential complications, including chest pain, mediastinitis, tracheoesophageal fistulas, and perforation, which is possibly due to the uncontrolled tracking of the sclerosant along tissue planes. Overall duration of palliation tends to be short and additional endoscopic sessions are often needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180427\">",
"    <span class=\"h1\">",
"     INTRATUMORAL INJECTION OF CISPLATIN/EPINEPHRINE GEL",
"    </span>",
"    &nbsp;&mdash;&nbsp;A newer approach to minimally invasive palliation of tumors of the upper aerodigestive tract is local injection of a chemotherapy-containing gel directly into the tumor. In pilot studies, an objective tumor response and improvement in dysphagia following multiple injections was observed in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The utility of this approach might be enhanced if used in conjunction with other therapeutic options, a strategy that requires further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180435\">",
"    <span class=\"h1\">",
"     ENDOSCOPIC MUCOSAL RESECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic treatment options are available for patients with early stage tumors and those who are too ill to undergo surgery or who refuse surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=see_link\">",
"     \"Management of superficial esophageal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=see_link\">",
"     \"Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endoscopic mucosal resection (EMR) or endoscopic mucosectomy can be curative in select patients and offers a histological specimen that can be evaluated for adequate resection margins. The technique has traditionally involved lifting the mucosa by submucosal injection of saline and endoscopic suction into an overtube in which a snare is fitted, with subsequent snare removal of the tumor, although it can also be performed without submucosal injection of saline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The value of the submucosal injection is not entirely clear since similar outcomes were described with and without it in a randomized controlled trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180443\">",
"    <span class=\"h2\">",
"     Inoperable patients with early stage disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another potential use of EMR is for patients with early stage disease who pose a high surgical risk, or those who refuse surgery. In a study of 16 patients with early stage esophageal cancer (cancer invading the muscularis mucosa or upper submucosa), EMR combined with chemoradiotherapy resulted in no local recurrences or metastasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4970?source=see_link\">",
"     \"Overview of endoscopic resection of gastrointestinal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180451\">",
"    <span class=\"h1\">",
"     PHOTODYNAMIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photodynamic therapy (PDT), a tissue ablative technique, uses a photosensitizing agent in combination with endoscopic low power laser exposure. Only one photosensitizing agent,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39157?source=see_link\">",
"     Porfimer",
"    </a>",
"    sodium (Photofrin, Lederle Parenterals, Carolina, PR), is currently available in the United States. Porfimer sodium is a hematoporphyrin derivative, which is approved for the palliation of esophageal cancer. PDT with porfimer sodium is thought to have a direct toxic effect on malignant cells via the production of singlet oxygen, which damages the microvasculature of the tumor and renders it ischemic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/22\">",
"     22",
"    </a>",
"    ]. It also is used for the treatment of high-grade dysplasia in the setting of Barrett's esophagus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link\">",
"     \"Management of Barrett's esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/27/26039?source=see_link\">",
"     \"Photodynamic therapy for ablation of Barrett's esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39157?source=see_link\">",
"     Porfimer",
"    </a>",
"    sodium accumulates in malignant tissue after intravenous injection, and the area is then exposed to an endoscopically placed low power laser diffuser with monochrome light (630 nm) which initiates a photochemical reaction that results in tumor necrosis. The malignant tissue can be repeatedly treated in order to provide optimal tissue ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180459\">",
"    <span class=\"h2\">",
"     Palliation of dysphagia in advanced disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial trials in esophageal cancer have demonstrated that PDT provides significant palliation from dysphagia in patients with advanced disease or locoregional failure after chemoradiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In a preliminary report of 10 patients with residual or locally recurrent disease following definitive chemoradiotherapy, 7 had a complete clinical response from PDT, 3 of whom remained progression-free at six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PDT is technically easier than Nd:YAG laser therapy and is better tolerated by patients. The expense of PDT is similar to traditional laser therapy due to the expense of the Photofrin and because it requires sophisticated equipment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a comparative trial of PDT and laser therapy, PDT was more effective for palliation and associated with fewer complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/22\">",
"       22",
"      </a>",
"      ]. PDT was particularly superior to laser therapy for proximal esophageal cancers, and was twice as effective at providing longer luminal patency in long malignant strictures (larger than 8 cm).",
"     </li>",
"     <li>",
"      In a prospective, randomized trial involving 236 patients, PDT and laser therapy had similar overall efficacy in terms of dysphagia relief, although there was a trend toward a better response with PDT for tumors located in the upper and middle third of the esophagus and for long tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/25\">",
"       25",
"      </a>",
"      ]. PDT was associated with fewer perforations than with the Nd:YAG laser (1 versus 7 percent), although treatment with PDT was limited by photosensitivity (sunburn in 19 percent.) Termination of sessions due to adverse events occurred in 3 percent with PDT versus 19 percent with laser therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common side effects with PDT in these studies were chest pain and worsening dysphagia. These complications gradually resolved over several weeks, except for a small percentage of patients with stricture development. Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39157?source=see_link\">",
"     Porfimer",
"    </a>",
"    sodium is cleared from a variety of tissues within 40 to 72 hours after injection, tumors, the skin, and some organs (ie, liver, spleen) retain the drug for a longer period. Skin photosensitivity may persist for four to six weeks after the treatment; sunscreens are ineffective since they do not block visible light.",
"   </p>",
"   <p>",
"    PDT is less commonly utilized for the palliation of malignant dysphagia with the widespread availability of newer self expanding metal stents for esophageal cancer. PDT can be used to treat tissue ingrowth or overgrowth in patients who have already undergone esophageal stenting. PDT has also been studied in combination with argon plasma coagulation. (See",
"    <a class=\"local\" href=\"#H107180475\">",
"     'Argon plasma coagulation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180467\">",
"    <span class=\"h2\">",
"     Inoperable patients with early stage disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another potential use of PDT is for patients with early stage disease who pose a high surgical risk, or those who refuse surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In the largest series of 123 such patients who were recommended for nonoperative treatment, the complete response rate at six months was 87 percent with PDT alone or as a component of multimodality therapy, and the five-year disease-specific survival rate was 74 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180475\">",
"    <span class=\"h1\">",
"     ARGON PLASMA COAGULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Argon plasma coagulation (APC) is a technique of monopolar, non-contact, high frequency electrocautery that uses ionized, electrically charged argon gas to cause tissue coagulation and tumor destruction. APC has been used to palliate tumors in a variety of gastrointestinal lumens. In a study of pulsed versus forced APC that included 51 patients with esophageal or esophagogastric junction cancer, an overall response was seen in 85 percent and dysphagia improved in 94 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/28\">",
"     28",
"    </a>",
"    ]. The most common complication was bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34695?source=see_link\">",
"     \"Argon plasma coagulation in the management of gastrointestinal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    APC has also been studied in combination with brachytherapy and photodynamic therapy (PDT). A randomized trial with 93 patients with malignant dysphagia assigned patients to treatment with APC plus brachytherapy, APC plus PDT, or APC alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients treated with APC alone had shorter median times to first dysphagia recurrence compared with those who also received brachytherapy or PDT (35 versus 88 and 59 days, respectively). There were no differences in overall survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H82628130\">",
"    <span class=\"h1\">",
"     CRYOSPRAY ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryospray ablation is another non-contact therapy that uses supercooling to cause cryonecrosis and has been used to palliate esophageal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/30\">",
"     30",
"    </a>",
"    ]. In a series of 79 patients with esophageal cancer, of which 53 had failed previous therapies, a complete intraluminal response was seen in 31 of 49 patients (63 percent) who completed therapy (30 patients were still receiving cryotherapy at the time of data collection). Although no serious adverse events were reported, benign strictures developed in 10 patients (13 percent), all of whom had undergone previous tumor therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180483\">",
"    <span class=\"h1\">",
"     ENDOSCOPIC STENTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with advanced stages of esophageal cancer or those who are poor surgical candidates can be offered stenting as a palliative treatment for dysphagia. Stenting can also be used for palliation of patients with postoperative tumor recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42006/abstract/32\">",
"     32",
"    </a>",
"    ]. This topic is discussed in detail elsewhere (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link\">",
"     \"Expandable stents in the treatment of esophageal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107181679\">",
"    <span class=\"h1\">",
"     BRACHYTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brachytherapy refers to the placement of a radioactive source within or in close proximity to a malignancy in order to provide local radiation therapy. This approach delivers the highest doses of radiation in close proximity to the tumor and thus offers a theoretical advantage over external beam radiation therapy. It can provide long-term palliation of dysphagia, although its role is not yet well defined. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=see_link\">",
"     \"Management of locally advanced unresectable esophageal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link\">",
"     \"Expandable stents in the treatment of esophageal obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link&amp;anchor=H9#H9\">",
"     \"Expandable stents in the treatment of esophageal obstruction\", section on 'SEMS versus brachytherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/17/9491?source=see_link\">",
"       \"Patient information: Esophageal cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107180499\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic interventions may be appropriate for palliation of dysphagia in patient with esophageal cancer in the following settings (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=see_link\">",
"     \"Management of locally advanced unresectable esophageal cancer\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients for whom definitive management with radiation or chemoradiotherapy is planned, but who have severe dysphagia at presentation, requiring intervention prior to therapy",
"     </li>",
"     <li>",
"      Failure to achieve adequate palliation of dysphagia with initial therapy",
"     </li>",
"     <li>",
"      Recurrent dysphagia due to locoregional failure",
"     </li>",
"     <li>",
"      Recurrent dysphagia due to benign strictures in patients who are successfully treated with radiation",
"     </li>",
"     <li>",
"      Patients are poor candidates for either chemotherapy or radiation therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are several endoscopic approaches to providing palliation from malignant dysphagia:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dilation",
"     </li>",
"     <li>",
"      Laser therapy",
"     </li>",
"     <li>",
"      Endoscopic injection therapies",
"     </li>",
"     <li>",
"      Endoscopic mucosal resection",
"     </li>",
"     <li>",
"      Photodynamic therapy",
"     </li>",
"     <li>",
"      Argon plasma coagulation",
"     </li>",
"     <li>",
"      Cryospray ablation",
"     </li>",
"     <li>",
"      Placement of prosthetic tubes (stenting)",
"     </li>",
"     <li>",
"      Brachytherapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stenting is preferable therapy for patients with a malignant stricture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fistula. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link\">",
"     \"Expandable stents in the treatment of esophageal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of a fistula, optimal therapy remains controversial. The choice of endoscopic palliative method should be based upon anatomical features, patient preferences, and available expertise.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/1\">",
"      Jacobson BC, Hirota W, Baron TH, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003; 57:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/2\">",
"      ASGE Standards of Practice Committee, Evans JA, Early DS, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2013; 77:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/3\">",
"      Shenfine J, McNamee P, Steen N, et al. A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 2009; 104:1674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/4\">",
"      Boyce HW Jr. Palliation of Dysphagia of Esophageal Cancer by Endoscopic Lumen Restoration Techniques. Cancer Control 1999; 6:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/5\">",
"      Heit HA, Johnson LF, Siegel SR, Boyce HW Jr. Palliative dilation for dysphagia in esophageal carcinoma. Ann Intern Med 1978; 89:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/6\">",
"      Cassidy DE, Nord HJ, Boyce HW. Management of malignant esophageal strictures: Role of esophageal dilation and peroral prosthesis. Am J Gastroenterol 1981; 75:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/7\">",
"      Lundell L, Leth R, Lind T, et al. Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction. Acta Chir Scand 1989; 155:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/8\">",
"      Hernandez LV, Jacobson JW, Harris MS, Hernandez LJ. Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures. Gastrointest Endosc 2000; 51:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/9\">",
"      Haddad NG, Fleischer DE. Endoscopic laser therapy for esophageal cancer. Gastrointest Endosc Clin N Am 1994; 4:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/10\">",
"      Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 1985; 145:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/11\">",
"      Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001; 54:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/12\">",
"      Adam A, Ellul J, Watkinson AF, et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 1997; 202:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/13\">",
"      Chung SC, Leong HT, Choi CY, et al. Palliation of malignant oesophageal obstruction by endoscopic alcohol injection. Endoscopy 1994; 26:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/14\">",
"      Moreira LS, Coelho RC, Sadala RU, Dani R. The use of ethanol injection under endoscopic control to palliate dysphagia caused by esophagogastric cancer. Endoscopy 1994; 26:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/15\">",
"      Monga SP, Wadleigh R, Sharma A, et al. Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer. Am J Clin Oncol 2000; 23:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/16\">",
"      Harbord M, Dawes RF, Barr H, et al. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointest Endosc 2002; 56:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/17\">",
"      Inoue H, Takeshita K, Hori H, et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993; 39:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/18\">",
"      Noda M, Kobayashi N, Kanemasa H, et al. Endoscopic mucosal resection using a partial transparent hood for lesions located tangentially to the endoscope. Gastrointest Endosc 2000; 51:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/19\">",
"      Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/20\">",
"      May A, Gossner L, Behrens A, et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003; 58:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/21\">",
"      Shimizu Y, Kato M, Yamamoto J, et al. EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma. Gastrointest Endosc 2004; 59:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/22\">",
"      Marcon NE. Photodynamic therapy and cancer of the esophagus. Semin Oncol 1994; 21:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/23\">",
"      McCaughan JS Jr, Ellison EC, Guy JT, et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg 1996; 62:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/24\">",
"      Muto M, Yano T, KAtada C, et al. Salvage photodynamic therapy for locoregional failure after definitive chemoradiotherapy for esophageal cancer (abstract). Proc Am Soc Clin Oncol 2004; 23:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/25\">",
"      Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995; 42:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/26\">",
"      Sibille A, Lambert R, Souquet JC, et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/27\">",
"      Corti L, Skarlatos J, Boso C, et al. Outcome of patients receiving photodynamic therapy for early esophageal cancer. Int J Radiat Oncol Biol Phys 2000; 47:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/28\">",
"      Eickhoff A, Jakobs R, Schilling D, et al. Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC. Endoscopy 2007; 39:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/29\">",
"      Rupinski M, Zagorowicz E, Regula J, et al. Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II). Am J Gastroenterol 2011; 106:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/30\">",
"      Cash BD, Johnston LR, Johnston MH. Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol 2007; 5:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/31\">",
"      Greenwald BD, Dumot JA, Abrams JA, et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc 2010; 71:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42006/abstract/32\">",
"      Siersema PD, Schrauwen SL, van Blankenstein M, et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 2001; 54:579.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2273 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-89ED0DCEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42006=[""].join("\n");
var outline_f41_1_42006=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H107180499\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180395\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180403\">",
"      ESOPHAGEAL DILATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180411\">",
"      LASER THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180419\">",
"      ABSOLUTE ALCOHOL INJECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180427\">",
"      INTRATUMORAL INJECTION OF CISPLATIN/EPINEPHRINE GEL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180435\">",
"      ENDOSCOPIC MUCOSAL RESECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107180443\">",
"      Inoperable patients with early stage disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180451\">",
"      PHOTODYNAMIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107180459\">",
"      Palliation of dysphagia in advanced disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107180467\">",
"      Inoperable patients with early stage disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180475\">",
"      ARGON PLASMA COAGULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H82628130\">",
"      CRYOSPRAY ABLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180483\">",
"      ENDOSCOPIC STENTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107181679\">",
"      BRACHYTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107180499\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34695?source=related_link\">",
"      Argon plasma coagulation in the management of gastrointestinal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=related_link\">",
"      Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32250?source=related_link\">",
"      Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=related_link\">",
"      Expandable stents in the treatment of esophageal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=related_link\">",
"      Management of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=related_link\">",
"      Management of locally advanced unresectable esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=related_link\">",
"      Management of superficial esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4970?source=related_link\">",
"      Overview of endoscopic resection of gastrointestinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/17/9491?source=related_link\">",
"      Patient information: Esophageal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/27/26039?source=related_link\">",
"      Photodynamic therapy for ablation of Barrett's esophagus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42007="Surgical management of Peyronie's disease";
var content_f41_1_42007=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of Peyronie's disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     William O Brant, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Anthony J Bella, MD, FRCSC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Tom F Lue, MD, ScD (Hon), FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42007/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/1/42007/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peyronie's disease, an acquired, localized fibrotic disorder of the tunica albuginea, can cause significant penile deformity and lead to sexual dysfunction and psychological trauma (",
"    <a class=\"graphic graphic_figure graphicRef76294 \" href=\"mobipreview.htm?21/50/22310\">",
"     figure 1",
"    </a>",
"    ). The nature and extent of Peyronie's plaque, and therefore severity or complexity of penile deformity, varies widely.",
"   </p>",
"   <p>",
"    Early medical intervention is the first line of therapy and is likely to be more effective when the disease is evolving. Once Peyronie's disease has reached a stable phase, surgery may be offered, but only for penile deformity that compromises sexual function.",
"   </p>",
"   <p>",
"    This topic will review the indications for surgery in Peyronie's disease, approaches to surgical correction, and the complications of surgical management.",
"   </p>",
"   <p>",
"    The diagnosis and medical management of Peyronie's disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/55/17273?source=see_link\">",
"     \"Peyronie's disease: Diagnosis and medical management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SURGICAL INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical management is indicated for patients whose Peyronie's disease has persisted for more than 12 months and is associated with a penile deformity compromising sexual function. It is important to delay surgery until Peyronie's disease has been stable for at least three months because surgical results can be compromised by active disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgery is not indicated for plaque without curvature, or minimal degrees of curvature, though \"minimal degree\" is a subjective measurement. The main determinant is whether sexual intercourse without pain is possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/3\">",
"     3",
"    </a>",
"    ]. Curvature that does not preclude intercourse does not warrant surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/55/17273?source=see_link\">",
"     \"Peyronie's disease: Diagnosis and medical management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concurrent implantation of a penile prosthesis is indicated in men with Peyronie's disease and erectile dysfunction (ED) unresponsive to oral agents or intracavernous injection therapy. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Penile prosthesis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16664?source=see_link&amp;anchor=H2#H2\">",
"     \"Surgical treatment of erectile dysfunction\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough review of the patient's medical and surgical history and a physical examination are performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Medications that prolong bleeding, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , are generally discontinued 7 to 10 days prior to the procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=see_link&amp;anchor=H25#H25\">",
"     \"Perioperative medication management\", section on 'Medications affecting hemostasis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=see_link\">",
"     \"Management of anticoagulation before and after elective surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following elements of the preoperative evaluation are specific to penile reconstructive procedures:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Duplex evaluation of erectile capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preoperative penile duplex ultrasound combined with intracavernous injection of a vasoactive agent is performed if distal flaccidity is present, or erectile function is in question. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32533?source=see_link\">",
"     \"Evaluation of male sexual dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasound assesses the nature and location of the Peyronie's plaque and penile vascular anatomy, identifying any arterial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    venous components of erectile dysfunction, if present. This information is particularly useful if grafting is being considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Preoperative penile photographs/measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative penile photographs should be obtained of the erect penis to document penile length, nature (dorsal, ventral lateral), and degree of curvature for future reference and for medicolegal purposes. Photographs in multiple views can be taken by the patient at home, or in the office by inducing an artificial erection by injecting a vasodilating medication, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/0/40966?source=see_link\">",
"     alprostadil",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Choice of surgical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important factor determining surgical success is selection of the appropriate surgical procedure for a given patient. No one procedure is suitable for all cases of Peyronie's disease. Surgical options include tunical shortening (eg, plication), tunical lengthening (eg, grafting) or implantation of penile prostheses.",
"   </p>",
"   <p>",
"    Important factors to consider in determining the best surgical approach include the length of the penis, configuration (eg, hourglass, curved) and severity of the deformity, erectile capacity, and patient expectations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Most curvature deformities are dorsal, although Peyronie's presentations are widely varied. A complete urologic examination is performed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For a penis with a simple curvature &lt;60&ordm;, adequate length, and intact erectile function, a tunical shortening procedure (ie, tunica wedge resection, plication) technique is appropriate. This procedure will not correct an hourglass deformity or hinge effect. When performed on appropriately selected men, simplified tunical shortening (ie, pure plication) offers satisfactory results and minimizes surgical morbidity. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Plication'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      For a very short penis, the presence of a severe curvature (&gt;60&ordm;), narrowing deformity (eg, hourglass, severe indentation), and good erectile function, tunical lengthening with plaque incision and graft placement may restore penile length,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      girth. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Grafting'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      For curvature associated with significant ED, a penile prosthesis can be placed and additional corrective procedures (plication or grafting) are performed if the prosthesis does not provide adequate straightening. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Penile prosthesis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Patient counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough preoperative discussion is essential and should review preparation, complications and realistic long-term outcomes associated with the planned surgery. Patients are informed of the risks of temporary or permanent penile hypoesthesia or anesthesia, future plaque formation, recurrent curvature, and risk of de novo or worsened ED. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If erectile function is compromised preoperatively, the risk of further dysfunction is increased. Patients with a history of cardiovascular disease (ie, coronary artery disease [CAD] or peripheral artery disease [PAD]), diabetes, or smoking also have an increased long-term risk for ED, independent of the surgery performed for Peyronie's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42696?source=see_link&amp;anchor=H2095608#H2095608\">",
"     \"Overview of male sexual dysfunction\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42696?source=see_link&amp;anchor=H189242040#H189242040\">",
"     \"Overview of male sexual dysfunction\", section on 'Association with cardiovascular disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38341?source=see_link\">",
"     \"Erectile dysfunction in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with ED or significant risk factors for future ED should be counseled regarding the placement of a penile prosthesis at the time of surgery. A prosthesis may also be placed at a later date as the need arises. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Penile prosthesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patient expectations about postoperative penile length should also be addressed. Penile shortening often accompanies Peyronie's disease and is dependent on direction and degree of curvature, and original penile length [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/6\">",
"     6",
"    </a>",
"    ]. Patients, however, may have unrealistic recollections of their erect penile length prior to the onset of Peyronie's disease, and premorbid penile measurements are rarely available. The patient is informed that plication surgery may result in a straight erection but is not likely to restore any length, and in fact will likely reduce length. With tunical lengthening procedures (ie, grafting), only about",
"    <span class=\"nowrap\">",
"     1/2",
"    </span>",
"    to 1 inch of additional length can be expected. It is important to document and review the preoperative stretched penile length with the patient.",
"   </p>",
"   <p>",
"    Uncircumcised patients are informed that certain incisions may necessitate circumcision to prevent the postoperative complication of foreskin necrosis, which can be difficult to manage. The aesthetic and sensory ramifications of circumcision should be explained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41705?source=see_link\">",
"     \"Neonatal circumcision: Risks and benefits\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SURGICAL ANATOMY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Tunica albuginea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tunica albuginea is a tough layer of fibrous connective tissue surrounding the bilateral corpora cavernosa of the penis (",
"    <a class=\"graphic graphic_figure graphicRef61965 \" href=\"mobipreview.htm?10/5/10324\">",
"     figure 2",
"    </a>",
"    ). The tunica is typically the target in Peyronie's disease surgery, with either plication of the side opposite the plaque, or",
"    <span class=\"nowrap\">",
"     incision/grafting",
"    </span>",
"    the same side as the plaque.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neurovascular bundle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurovascular bundle runs along the dorsal aspect of the penis in a groove between the corpora cavernosa (",
"    <a class=\"graphic graphic_figure graphicRef61965 \" href=\"mobipreview.htm?10/5/10324\">",
"     figure 2",
"    </a>",
"    ). The neurovascular bundle consists of the dorsal penile vein, and paired dorsal arteries and nerves. Preserving the neurovascular bundle is critical since injury may lead to glans hypoesthesia or even necrosis. The neurovascular bundle is often intimately adherent to the underlying Peyronie's plaque; releasing these structures is often the hardest component of reconstructive surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reconstructive procedures for Peyronie's disease are typically performed as an ambulatory procedure, or with overnight observation either in an ambulatory or inpatient setting. Plication procedures can be performed with local anesthesia and monitored sedation; general or regional anesthesia may be more appropriate for more complicated procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=see_link\">",
"     \"Overview of anesthesia and anesthetic choices\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the incision, a single dose of first generation cephalosporin is given. The patient is positioned supine and the operative area depilated with a clipper. Bladder drainage is generally not required unless a penile prosthesis will be placed. If the saphenous vein will be used as a graft, the non-dominant lower extremity is slightly flexed and abducted and prepped separately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/47/40697?source=see_link\">",
"     \"Placement and management of urinary bladder catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following sterile preparation, an artificial erection is induced by injecting normal saline with 60 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/2/37923?source=see_link\">",
"     papaverine",
"    </a>",
"    into the corpus cavernosum; this aids in preprocedure planning and intraoperative assessment of surgical results. The site of greatest curvature and plaque is marked and the incision made in the skin, and the penis degloved to access the tunica albuginea; the choice of incision (circumferential below the glans, or longitudinal) depends upon the nature of the planned surgery.",
"   </p>",
"   <p>",
"    An uncircumcised patient who receives a circumferential incision often requires a concomitant circumcision; profound lymphedema or even foreskin necrosis have been reported with prepuce-preserving techniques. Patients must be informed of the aesthetic and sensation ramifications of this. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Patient counseling'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A longitudinal incision may be advantageous in managing a dorsal curvature. This approach is also associated with improved healing, and avoids lymphedema and the need for circumcision; however, visible scarring will result unless the incision is placed along the penile raphe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complementary techniques employed in the surgical management of Peyronie's disease include plication, grafting, or placement of a penile prosthesis. Tailored approaches are often required to manage the variety of plaque-induced penile deformities associated with Peyronie's plaques.",
"   </p>",
"   <p>",
"    Each of the techniques can be performed with or without plaque incision, which facilitates tunica mobility. An H-shaped incision in the exterior surface of the plaque is often all that is needed. Plaque excision involves complete removal of the plaque and is associated with higher rates of ED, graft contracture and late recurrence of curvature; however, plaque excision may be required if the plaque is heavily calcified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Plication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Straightening the penis with plication is accomplished by shortening the convex side of the penis (ie, opposite the plaque). All plication procedures result in loss of penile length as the tunica albuginea is shortened on the longer side to match the shorter side [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/6\">",
"     6",
"    </a>",
"    ]. Since the stretched penile length is determined by the shorter, less elastic side, the objective loss of penile length after plication if often less than what is perceived by the patient.",
"   </p>",
"   <p>",
"    Thus, plication should only be performed in men with adequate penile length and generally only if the curvature less than 60&ordm; (",
"    <a class=\"graphic graphic_figure graphicRef67079 \" href=\"mobipreview.htm?24/35/25141\">",
"     figure 3",
"    </a>",
"    ). If curvature is greater than 60&deg;, plication can still be performed provided penile length is adequate, and may be particularly useful if the patient is not willing to accept the risk of de novo loss of erectile rigidity associated with grafting.",
"   </p>",
"   <p>",
"    Soft, braided, permanent, or delayed absorbable sutures are used because they are the least noticeable under the skin.",
"   </p>",
"   <p>",
"    Plication is performed with or without plaque incision. When the tunica albuginea is plicated without incision (ie, pure plication), normal anatomy is minimally disrupted. Since dorsal curvature is the most prevalent, plication of the ventral surface avoids the need to dissect the dorsal neurovascular bundle.",
"   </p>",
"   <p>",
"    The most common plication techniques are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nesbit procedure - One or more ellipses of the tunica albuginea are excised from the convex side (ie, tunica wedge resection) and the tunica plicated at the most prominent portion of the curvature [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Yachia procedure - Longitudinal incisions in the tunica albuginea on the convex side are closed horizontally (eg, Heineke-Mikulicz) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lue procedure - The Lue procedure, also known as the \"16 dot\" minimal tension approach, is a pure plication procedure consisting of two or three pairs of plications on the convex side [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Paired, mattress sutures are placed in the tunica albuginea and tension adjusted to straighten the curvature prior to completing the ties.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Grafting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with Peyronie's disease who have a short penis, extensive plaque, severe (&gt;60&ordm;), or complex deformities will require a grafting procedure. Grafting the concave side of the penis serves to lengthen that side and, therefore, straighten the penis (",
"    <a class=\"graphic graphic_figure graphicRef54241 \" href=\"mobipreview.htm?31/9/31891\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Dissection of the neurovascular bundle",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    corpus spongiosum may be required depending upon the location of the deformity; injury to the dorsal neural complex with loss of glans sensation may result.",
"   </p>",
"   <p>",
"    Opening the tunica albuginea often worsens erectile function. Patients must be aware of this risk, and should be counseled regarding the option of penile prosthesis implantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Complications'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H7\">",
"     'Patient counseling'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Graft materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following management of the plaque, a graft is placed. The choice of graft material depends upon several factors, including type of deformity, efficacy, and availability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/13\">",
"     13",
"    </a>",
"    ]. Grafting materials include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autologous tissue (eg, saphenous vein, fascia lata, rectus fascia, tunica vaginalis, dermis, buccal mucosa). Vein patch is the most commonly used autograft material and is harvested from the distal saphenous vein; if a larger graft is needed, the proximal saphenous vein can be used. Saphenous vein is spared in patients with significant cardiovascular disease (ie, CAD, PAD); these patients may need the saphenous vein for future bypass grafting.",
"     </li>",
"     <li>",
"      Allograft or xenograft materials (eg, cadaveric or bovine pericardium, engineered dermal graft, porcine small intestinal submucosa [SIS]) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/14-16\">",
"       14-16",
"      </a>",
"      ]. These acellular matrices allow regenerative in-growth of native tissues. The main advantage of allograft tissues is elimination of the need for tissue harvesting.",
"     </li>",
"     <li>",
"      Synthetic grafts (eg, PTFE). The use of synthetic materials is discouraged due to increased incidence of infection and postoperative inflammation leading to perigraft fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,3,16\">",
"       1,3,16",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Penile prosthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of choice for patients with Peyronie's disease and significant ED is placement of a penile prosthetic implant with or without manual modeling and with or without penile reconstruction.",
"   </p>",
"   <p>",
"    Patient satisfaction is higher with inflatable penile prostheses than malleable devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,17\">",
"     1,17",
"    </a>",
"    ]. Either a two-piece (",
"    <a class=\"graphic graphic_picture graphicRef79647 \" href=\"mobipreview.htm?32/33/33298\">",
"     picture 1",
"    </a>",
"    ) or three-piece (",
"    <a class=\"graphic graphic_picture graphicRef71063 \" href=\"mobipreview.htm?37/21/38239\">",
"     picture 2",
"    </a>",
"    ) prosthetic is used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16664?source=see_link&amp;anchor=H12#H12\">",
"     \"Surgical treatment of erectile dysfunction\", section on 'Inflatable'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The correction of penile curvature can be accomplished solely by implantation of the penile prosthesis in patients with mild to moderate curvature. Manual modeling over the prosthesis may be required to correct more significant deformities (eg, &gt;30&ordm; curvature) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/18\">",
"     18",
"    </a>",
"    ]. Penile reconstruction (plaque",
"    <span class=\"nowrap\">",
"     incision/grafting)",
"    </span>",
"    can be performed before or after implant placement in patients with severe or complex deformities, or calcified Peyronie's plaque [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manual modeling is a process by which the tunica plaque is fractured over the inflated prosthetic cylinder at the time of implantation. The penis is forcibly bent in a direction opposite the curvature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/18\">",
"     18",
"    </a>",
"    ]. Bending pressure is maintained on the penis for 90 seconds. When successful, the modeling procedure causes splitting and rupturing of the fibrotic plaques. The penile implant is left partially inflated for six weeks to prevent contraction of the tunica defect which could lead to recurrent curvature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Dressing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the reconstructive procedure, a petrolatum gauze is placed on the incision and covered loosely with a gauze pad. A snug, self-adhesive wrap (eg, Coban&trade;) is placed around the penis from distal to proximal and then squeezed gently to make it snug but not constrictive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the nature and length of the procedure and degree of postoperative pain, overnight observation may be indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous or oral pain medications are given, as needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=see_link\">",
"     \"Management of postoperative pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An ice pack is applied intermittently to the penis for the first 24 hours to lessen pain and swelling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Dressing",
"    </span>",
"    &nbsp;&mdash;&nbsp;On the first postoperative day, patients are taught how to change their dressing, and are instructed to perform daily dressing changes for 5 to 10 days. The patient may shower, but should keep the dressing dry, which can be accomplished by applying a condom. Water immersion is avoided for five weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Patient instructions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are instructed to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Resume activities as tolerated. If the patient has received a prosthesis, heavy lifting is avoided for four weeks.",
"     </li>",
"     <li>",
"      Return to work in a few days depending upon speed of recovery.",
"     </li>",
"     <li>",
"      Watch for signs of infection (ie, fever, redness, excess swelling, discharge, increasing pain), particularly if a prosthesis has been placed.",
"     </li>",
"     <li>",
"      Arrange to be seen by the surgeon if infection develops, or if there are any other concerns.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sexual activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is instructed not to engage in sexual intercourse or masturbation for four to eight weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     FOLLOW UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow up in the office varies depending upon the nature of the procedure and the patient's recovery. Following the placement of a prosthesis, the patient is scheduled to return to the clinic in approximately six weeks to learn how to use the device.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications associated with correction of Peyronie's disease deformities are dependent upon the technique used for reconstruction. General complications include surgical site infection, penile hematoma, penile narrowing or indentation, phimosis, sensory abnormalities and erectile dysfunction.",
"   </p>",
"   <p>",
"    Erectile dysfunction, like sensory abnormalities, is more likely to occur in procedures that require dissection and mobilization of the neurovascular bundle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Erectile dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erectile dysfunction (ED) is reported to occur in up to 20 percent of patients postoperatively. In retrospective reviews, pure plication (ie, Lue procedure) has been associated with the least risk of erectile dysfunction compared with standard plication (ie, Nesbit, Yachia) and grafting procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/8,11,16\">",
"     8,11,16",
"    </a>",
"    ]. Patients with preexisting ED are more likely to experience worsened sexual function, though ED can develop de novo. Up to 45 percent of patients with preexisting ED will suffer a further decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Long term, additional deterioration in both erectile and orgasmic function has been observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients with preexisting ED should be counseled appropriately. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Patient counseling'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Graft complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of grafting materials is associated with additional complications that include: persistent pain which may be due to neurological injury, graft bulging (ie, herniation), graft infection, or graft contracture leading to penile shortening or recurrent curvature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/14,22\">",
"     14,22",
"    </a>",
"    ]. Surgical site infection can also occur at the site of autogenous tissue harvest.",
"   </p>",
"   <p>",
"    If the patient notices a bulging of the graft, which can occur two to three months postoperatively, a duplex ultrasound is performed. If a hematoma is identified, an aspiration procedure is performed. If no hematoma is identified, observation is continued. Reoperation may be required if the bulge is chronic and clinically significant (ie, causing difficulty with or precluding sexual intercourse).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Penile implant complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications associated with penile implants are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16664?source=see_link&amp;anchor=H21#H21\">",
"     \"Surgical treatment of erectile dysfunction\", section on 'Penile implants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;With an appropriately-chosen technique taking into consideration patient-specific characteristics, reconstruction for Peyronie's disease achieves satisfactory results in the majority of men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,13,20,22\">",
"     1,13,20,22",
"    </a>",
"    ]. Long-term satisfaction with return to sexual activity was high for both patient (86 percent) and partner (77 percent) in a retrospective evaluation of 61 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/23\">",
"     23",
"    </a>",
"    ]. Curvature is corrected in most patients; however, minor residual and recurrent curvature is reported for all the techniques described.",
"   </p>",
"   <p>",
"    Plication (Yachia, Nesbit, Lue) achieves penile straightening in 67 to 100 percent of patients with a low risk for postoperative sexual dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,9,11,24,25\">",
"     1,9,11,24,25",
"    </a>",
"    ]. The primary concern for these patients is the degree of penile shortening. While some degree of penile shortening occurs in all patients, few have difficulty with penetration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/8\">",
"     8",
"    </a>",
"    ]. Residual curvature rates vary from 7 to 21 percent, and may be due to suture absorption, slippage, or breakage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Plication'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients who undergo grafting procedures, patient satisfaction and curvature correction rates are the highest (&gt;90 percent) with autogenous vein grafting (",
"    <a class=\"graphic graphic_table graphicRef70730 \" href=\"mobipreview.htm?17/8/17548\">",
"     table 1",
"    </a>",
"    ) compared with other grafting materials in retrospective reviews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,14,20,22,23,26,27\">",
"     1,14,20,22,23,26,27",
"    </a>",
"    ]. Recurrent curvature occurs in 12 to 16 percent of patients following vein graft procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/20,23\">",
"     20,23",
"    </a>",
"    ]. Other grafting materials (ie, dermis, pericardium, SIS) have been evaluated, but clinical outcomes are inconsistent and not superior to autogenous vein grafts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,23,26\">",
"     1,23,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of penile implants in the treatment of Peyronie's disease produces satisfactory correction of curvature with adequate erectile function in greater than 85 percent of patients in most large series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1,17,28\">",
"     1,17,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16664?source=see_link&amp;anchor=H9#H9\">",
"     \"Surgical treatment of erectile dysfunction\", section on 'Penile prostheses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peyronie's disease is an acquired, localized fibrotic disorder of the tunica albuginea, which can cause significant penile deformity and lead to sexual dysfunction and psychological trauma. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical management is indicated for patients whose Peyronie's disease has persisted for more than 12 months and is associated with a penile deformity compromising sexual function. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Surgical indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The length of the penis, nature (eg, hourglass, curved) and severity of the deformity, erectile capacity, and patient expectations are important factors to consider when determining the surgical approach. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Choice of surgical approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical techniques used for penile reconstruction in Peyronie's disease include plication, grafting, or placement of a penile prosthesis. Plication shortens the convex side of the penis, whereas grafting techniques lengthen the concave side. Penile implants are used in patients with pre-existing erectile dysfunction. Plaque incision is often combined with these techniques to improve the mobility of the plaque. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Erectile dysfunction (ED) occurs in up 20 percent of patients following surgical reconstruction for Peyronie's disease, and can occur without a prior history of ED; however, ED is more likely to complicate procedures requiring dissection of the neurovascular bundle, or in patients with preexisting ED. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a dorsal curvature less than 60&deg;, we suggest ventral plication as the initial surgical approach (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although generally used for curvatures less 60&deg;, plication can be used for greater degrees of curvature, provided there is sufficient penile length, and it may be particularly useful if the patient is not willing to accept the risk of de novo loss of erectile rigidity associated with grafting. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with curvatures greater than 60&deg;, we suggest plaque excision and grafting (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In those patients with preexisting ED, we suggest implantation of a penile prosthetic in conjunction with penile reconstruction (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient counseling'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/1\">",
"      Kadioglu A, Akman T, Sanli O, et al. Surgical treatment of Peyronie's disease: a critical analysis. Eur Urol 2006; 50:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/2\">",
"      Dean RC, Lue TF. Peyronie's disease: advancements in recent surgical techniques. Curr Opin Urol 2004; 14:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/3\">",
"      Ralph DJ, Garaffa G, Garc&iacute;a MA. Reconstructive surgery of the penis. Curr Opin Urol 2006; 16:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/4\">",
"      Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie's disease. J Urol 1997; 158:2149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/5\">",
"      Kadioglu A, Tefekli A, Erol B, et al. A retrospective review of 307 men with Peyronie's disease. J Urol 2002; 168:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/6\">",
"      Greenfield JM, Lucas S, Levine LA. Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol 2006; 175:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/7\">",
"      Brant WO, Bella AJ, Garcia MM, et al. Surgical Atlas. Correction of Peyronie's disease: plaque incision and grafting. BJU Int 2006; 97:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/8\">",
"      Ralph DJ, al-Akraa M, Pryor JP. The Nesbit operation for Peyronie's disease: 16-year experience. J Urol 1995; 154:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/9\">",
"      Yachia D. Modified corporoplasty for the treatment of penile curvature. J Urol 1990; 143:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/10\">",
"      Brant WO, Bella AJ, Lue TF. 16-Dot procedure for penile curvature. J Sex Med 2007; 4:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/11\">",
"      Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 2002; 167:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/12\">",
"      Ralph DJ. The surgical treatment of Peyronie's disease. Eur Urol 2006; 50:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/13\">",
"      Kendirci M, Hellstrom WJ. Critical analysis of surgery for Peyronie's disease. Curr Opin Urol 2004; 14:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/14\">",
"      Breyer BN, Brant WO, Garcia MM, et al. Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol 2007; 177:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/15\">",
"      Knoll LD. Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease. Urology 2001; 57:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/16\">",
"      Kadioglu A, Sanli O, Akman T, et al. Graft materials in Peyronie's disease surgery: a comprehensive review. J Sex Med 2007; 4:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/17\">",
"      Montorsi F, Guazzoni G, Bergamaschi F, Rigatti P. Patient-partner satisfaction with semirigid penile prostheses for Peyronie's disease: a 5-year followup study. J Urol 1993; 150:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/18\">",
"      Wilson SK, Delk JR 2nd. A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 1994; 152:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/19\">",
"      Rahman NU, Carrion RE, Bochinski D, Lue TF. Combined penile plication surgery and insertion of penile prosthesis for severe penile curvature and erectile dysfunction. J Urol 2004; 171:2346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/20\">",
"      Montorsi, F, Salonia, S. Five year follow-up of plaque incision and vein grafting for Peyronie's disease. Eur Urol 2004; 3:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/21\">",
"      Montorsi F, Salonia A, Maga T, et al. Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 2000; 163:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/22\">",
"      El-Sakka AI, Rashwan HM, Lue TF. Venous patch graft for Peyronie's disease. Part II: outcome analysis. J Urol 1998; 160:2050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/23\">",
"      Usta MF, Bivalacqua TJ, Sanabria J, et al. Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. Urology 2003; 62:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/24\">",
"      Gholami SS, Gonzalez-Cadavid NF, Lin CS, et al. Peyronie's disease: a review. J Urol 2003; 169:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/25\">",
"      Licht MR, Lewis RW. Modified Nesbit procedure for the treatment of Peyronie's disease: a comparative outcome analysis. J Urol 1997; 158:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/26\">",
"      Levine LA, Estrada CR. Human cadaveric pericardial graft for the surgical correction of Peyronie's disease. J Urol 2003; 170:2359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/27\">",
"      Akkus E, Ozkara H, Alici B, et al. Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie's disease. Eur Urol 2001; 40:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42007/abstract/28\">",
"      Wilson SK, Cleves MA, Delk JR 2nd. Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 2001; 165:825.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8096 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-4BCC47CC64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42007=[""].join("\n");
var outline_f41_1_42007=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SURGICAL INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Duplex evaluation of erectile capacity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Preoperative penile photographs/measurements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Choice of surgical approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Patient counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SURGICAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Tunica albuginea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neurovascular bundle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Plication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Grafting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Graft materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Penile prosthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Dressing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Dressing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Patient instructions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sexual activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      FOLLOW UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Erectile dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Graft complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Penile implant complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8096\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8096|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/50/22310\" title=\"figure 1\">",
"      Peyronies disease deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/5/10324\" title=\"figure 2\">",
"      Peyronies disease plaque cross section",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/35/25141\" title=\"figure 3\">",
"      Plication technique for Peyronies disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/9/31891\" title=\"figure 4\">",
"      Grafting technique for Peyronies disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8096|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/33/33298\" title=\"picture 1\">",
"      Two piece penile prosthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/21/38239\" title=\"picture 2\">",
"      Three piece penile prosthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8096|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/8/17548\" title=\"table 1\">",
"      Outcomes of vein grafting for Peyronies disease reconstruction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38341?source=related_link\">",
"      Erectile dysfunction in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32533?source=related_link\">",
"      Evaluation of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=related_link\">",
"      Management of postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41705?source=related_link\">",
"      Neonatal circumcision: Risks and benefits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42696?source=related_link\">",
"      Overview of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/55/17273?source=related_link\">",
"      Peyronie's disease: Diagnosis and medical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/47/40697?source=related_link\">",
"      Placement and management of urinary bladder catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16664?source=related_link\">",
"      Surgical treatment of erectile dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42008="Epidemiology, microbiology, and pathogenesis of Shigella infection";
var content_f41_1_42008=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, microbiology, and pathogenesis of Shigella infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Marcia B Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42008/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/1/42008/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella species are a common cause of bacterial diarrhea worldwide, especially in developing countries. Shigella organisms can survive transit through the stomach since they are less susceptible to acid than other bacteria; for this reason, as few as 10 to 100 organisms can cause disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/1\">",
"     1",
"    </a>",
"    ]. Ingested bacteria pass into the small intestine where they multiply; large numbers of bacteria then pass into the colon, where they enter the colonic cells. Given its relatively low infectious dose, Shigella transmission can occur via contaminated food and water or via direct person-to-person spread. Humans are the only natural reservoir for disease.",
"   </p>",
"   <p>",
"    The epidemiology, microbiology and pathogenesis of Shigella infections will be reviewed here. The clinical manifestations, diagnosis, and treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38535?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Shigella infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39334?source=see_link\">",
"     \"Treatment and prevention of Shigella infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial dysentery due to Shigella species is a major cause of morbidity and mortality; 165 million cases occur annually worldwide, with 1 million associated deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Shigella transmission can occur through direct person-to-person spread or from contaminated food and water. The minimal infectious dose can be transmitted directly from contaminated fingers, since intermediate bacterial replication is not required to achieve the low infectious dose.",
"   </p>",
"   <p>",
"    In developed countries, most cases are transmitted by fecal-oral spread from people with symptomatic infection. Outbreaks in the United States occur predominantly in institutions such as day care centers or custodial institutions and less commonly by common source contamination of food or drinking water.",
"   </p>",
"   <p>",
"    In developing countries, both fecal-oral spread and contamination of common food and water supplies are important mechanisms of transmission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     United States",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, 450,000 cases are estimated to occur annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/4\">",
"     4",
"    </a>",
"    ]. In 2008 the average incidence of confirmed shigellosis in the United States was 6.59 cases per 100,000 population; shigellosis was third in frequency after Salmonella and Campylobacter infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In the United States shigellosis predominantly affects children; in 2008 the incidence among children aged &lt;4 years was 28",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    population and the incidence among children aged 4 to 11 was 25.67",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most cases of shigellosis in the United States are caused by S. sonnei (&gt;75 percent), with S. flexneri the next most frequent isolate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/7\">",
"     7",
"    </a>",
"    ]. S. dysenteriae 1 (the Shiga bacillus) was the most common isolate both in Europe and the United States in the early 1900s but is now rare. In the United States, S. dysenteriae 1 infection is generally limited to imported cases from Mexico and Central America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/8\">",
"     8",
"    </a>",
"    ] or from laboratory contamination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Transmission in institutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigellosis in the United States is most common in day care centers and areas with crowded living conditions such as urban centers or residential institutions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Day care center outbreaks can be particularly difficult to control; strict hand washing guidelines must be followed, and infected children must be excluded from the facility until they have recovered. Convalescing children should be cohorted in a separate room until stool cultures for Shigella are negative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. In addition, children who attend day care centers frequently introduce the infection to their families and serve as index cases in urban outbreaks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/14\">",
"     14",
"    </a>",
"    ]. The secondary attack rate for family members in the same household as the index case is 20 percent and is highest when the index case is between one and four years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Food borne transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foodborne outbreaks are well described. Cold salads such as potato or macaroni salads have been implicated in several common source outbreaks of shigellosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/16\">",
"     16",
"    </a>",
"    ]. In most cases, these foods were presumed to have been contaminated either by food preparers with recent illnesses or through substandard food preparation facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Fecal contamination can occur during cultivation; raw vegetables including lettuce and tomatoes traced to a common supplier have also been implicated in outbreaks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Sexual transmission in MSM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outbreaks of shigellosis have occurred among men who have sex with men (MSM) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In a population-based case-control study including 76 case patients and 146 controls, MSM, HIV infection, and direct oral-anal contact were each associated with an odds ratio for shigellosis of 7.5 to 8.2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Developing countries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inadequate sewage disposal is associated with high rates of Shigella transmission. A study conducted among children in the Peruvian Amazon noted an incidence of 0.34 episodes of Shigella diarrhea per year among children &lt;6 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/25\">",
"     25",
"    </a>",
"    ]. In a report from Bangladesh including 1756 children &lt;4 years of age in regions where a sentinel case of Shigella had been identified, 12 percent of children developed Shigella diarrhea within one month, and an additional 13 percent had culture-negative dysenteric illnesses (many of which were probably due to Shigella) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mode of transmission in high prevalence areas may be more complex than simple person-to-person fecal-oral transmission; in Bangladesh, a poor correlation was found between the Shigella serotype of the sentinel case and the serotype of the secondary cases identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/26\">",
"     26",
"    </a>",
"    ]. In contrast, a study in the U.S. observed that all familial secondary contacts of shigellosis index cases were infected with the same organism as the index case [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In developing countries, S. flexneri is the predominant species; S. sonnei is the second most prevalent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Among the cases caused by S. flexneri, serotype 2a predominates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Breast feeding appears to confer significant protection against shigellosis and should be encouraged as a preventive measure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440124002\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella are nonmotile, facultatively anaerobic, gram-negative rods. They are members of the family Enterobacteriaceae, genus Shigella. There are four species of Shigella: S. dysenteriae (serogroup A), S. flexneri (serogroup B), S. boydii (serogroup C), and S. sonnei (serogroup D). Groups A, B, and C cannot be distinguished biochemically; S. sonnei can be differentiated from the other serogroups by the expression of ornithine decarboxylase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440124009\">",
"    <span class=\"h2\">",
"     Stool culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella is cultured by techniques that are routine for the handling of stool in most clinical microbiology laboratories. Initial inoculation should be on more than one low selectivity medium, such as MacConkey or eosin",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    (EMB). Colonies that appear suspicious on low selectivity media are usually subcultured onto highly selective media such as SS (Salmonella-Shigella), XLD (xylose-lysine-deoxycholate), HE (hektoen enteric), or deoxycholate citrate agar (",
"    <a class=\"graphic graphic_picture graphicRef81081 \" href=\"mobipreview.htm?7/21/7504\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    All the above media contain lactose, as well as a color indicator. Shigella do not ferment lactose (it is a lactose non-fermenter). At 24 hours, lactose-negative colonies are picked and inoculated onto triple sugar iron agar or lysine iron agar slants (",
"    <a class=\"graphic graphic_picture graphicRef57505 \" href=\"mobipreview.htm?35/59/36797\">",
"     picture 2",
"    </a>",
"    ). Shigella colonies give an alkaline slant, acid at the bottom, and no gas or hydrogen sulfide production. In the setting of possible exposure to S. dysenteriae 1 (eg, travel to an endemic area such as Southeast Asia or the Indian subcontinent), the use of more than one selective medium is warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Suspicious colonies can be further tested for motility and certain biochemical characteristics. Shigella are non-flagellated and are therefore non-motile. In addition, Shigella are indole positive, urea and oxidase negative, and ferment glucose (",
"    <a class=\"graphic graphic_picture graphicRef60548 graphicRef52747 \" href=\"mobipreview.htm?30/60/31695\">",
"     picture 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Further classification can be pursued including identification of serogroup and serotype, although these are rarely important to clinical management, and these studies are not performed in most clinical laboratories (",
"    <a class=\"graphic graphic_picture graphicRef71759 \" href=\"mobipreview.htm?11/36/11854\">",
"     picture 4",
"    </a>",
"    ). Serotype is determined by the structure of the repeating oligosaccharide that constitutes the O-antigen of the lipopolysaccharide (LPS) layer of the bacterial envelope. In addition, a variety of DNA probes of plasmid-encoded virulence determinants and ELISA of virulence proteins are available for use in the detection of Shigella.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440124016\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymerase chain reaction (PCR) has been used to detect Shigella-specific DNA sequences in stool. Using primers to the invasion associated locus (ial or ipa), as few as 10 S. flexneri organisms can be detected by PCR (as compared with 10(6) organisms detected by routine culture) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/31\">",
"     31",
"    </a>",
"    ]. A modification of this procedure involving the immunomagnetic separation of Shigella from stool followed by PCR showed similar sensitivity in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/32\">",
"     32",
"    </a>",
"    ]. Given the cost and labor required, PCR assays are unlikely to become generally available in clinical laboratories but are useful tools for the investigation of Shigella transmission and epidemiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440124159\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inoculum required for the development of clinical disease is quite low. Clinical disease was observed in 39 percent of volunteer subjects who received an inoculum of 100 S. flexneri organisms or 200 S. dysenteriae 1 organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/34\">",
"     34",
"    </a>",
"    ]. The minimum infectious inoculum for Salmonella in normal subjects is at least two orders of magnitude higher than for Shigella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125800\">",
"    <span class=\"h2\">",
"     Colonic entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of Shigella involves invasion of colonic mucosal cells and induction of an intense inflammatory response, leading to the death of epithelial and immune cells and the formation of colonic mucosal ulcerations and abscesses. Shigella infection of mammalian cells involves entry of bacteria by induced macropinocytosis, escape from the macropinocytic vacuole, multiplication and spread within the cytoplasm, and direct passage into adjacent cells by way of finger-like protrusions of the cell membrane. Shigella is among the few pathogens capable of penetrating mammalian cells yet evading the phagocytic vacuole; other such organisms include enteroinvasive E. coli and Listeria monocytogenes. Shigella infection is generally limited to the intestinal mucosa; bacteremia due to Shigella is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the colonic mucosa, Shigella is able to enter both colonic enterocytes and specialized epithelial cells (M cells) that overlie mucosal lymphoid follicles. Entry via the M cells is thought to be an important route of entry in clinical infection as suggested by examination of rectal biopsies from humans infected with Shigella, in which lesions were frequently located over lymphoid follicles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125807\">",
"    <span class=\"h2\">",
"     Macropinocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colonic enterocytes do not normally take up microorganisms; in vitro, Shigella entry occurs by a process involving bacterium-induced macropinocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/39\">",
"     39",
"    </a>",
"    ]. Shigella enter enterocytes most efficiently via the cell's basolateral surfaces [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/40\">",
"     40",
"    </a>",
"    ] and can gain access to these surfaces either from the tissue underlying the M cell or directly from the intestinal lumen following disruption of enterocyte cell-cell junctions, induced by either the transmigration of polymorphonuclear leukocytes across the epithelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/41\">",
"     41",
"    </a>",
"    ] or by Shigella-induced redistribution of cell junction proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/42\">",
"     42",
"    </a>",
"    ]. Transmigration of polymorphonuclear leukocytes across the epithelium enhances Shigella invasion in vitro two- to sixfold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Shigella-induced macropinocytosis occurs through extensive rearrangements of the host cell cytoskeleton that cause formation of large extensions of the host cell membrane, in which the bacteria become engulfed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/39\">",
"     39",
"    </a>",
"    ]. Shigella induces this process by injecting bacterial proteins into the host cell that activate host cytoskeletal signaling pathways.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125846\">",
"    <span class=\"h2\">",
"     Cytoskeletal signaling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Shigella proteins that activate host cytoskeletal signaling pathways are secreted from the bacterium via a type III secretion apparatus. Both the proteins that are secreted and the proteins that constitute the secretion apparatus are encoded on a large virulence plasmid carried by all virulent strains of Shigella. Homologs of these proteins exist in several other enteric gram-negative pathogens, including Salmonella typhimurium, Y. pestis, and enteropathogenic E. coli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. The genes that encode the effector proteins and the secretion apparatus are expressed at 37&ordm;C (normal body temperature), but not at 30&ordm;C when the bacterium is outside the human host [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/45\">",
"     45",
"    </a>",
"    ], and are induced by oxygen at the surface of colonic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Soon after uptake by induced phagocytosis, the bacterium lyses the phagocytic vacuole, releasing it into the host cell cytosol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/47\">",
"     47",
"    </a>",
"    ]. Short filaments of host cell actin then organize into a tight bundle that forms a tail several microns in length behind the bacterial body (",
"    <a class=\"graphic graphic_picture graphicRef56214 \" href=\"mobipreview.htm?21/59/22449\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/48\">",
"     48",
"    </a>",
"    ]. The bacterium uses this tail for movement through the cytosol and for passage into protrusions of the cell membrane (",
"    <a class=\"graphic graphic_figure graphicRef68970 \" href=\"mobipreview.htm?41/45/42705\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef79774 \" href=\"mobipreview.htm?1/41/1680\">",
"     movie 1",
"    </a>",
"    ). The actin-based mechanisms usurped by Shigella are processes normally used by the eukaryotic cell for other purposes.",
"   </p>",
"   <p>",
"    The Shigella surface protein IcsA (VirG) mediates the process of bacterial actin-based motility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. IcsA is unusual in that it is located on a single pole of the bacillus, the pole at which the actin tail forms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/52\">",
"     52",
"    </a>",
"    ]. IcsA binds the cellular protein neural Wiskott-Aldrich syndrome protein (N-WASP), after which N-WASP is activated at the bacterial surface by the cellular protein Toca-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/53\">",
"     53",
"    </a>",
"    ]. Active N-WASP in turn binds and activates the cellular complex known as",
"    <span class=\"nowrap\">",
"     Arp2/3.",
"    </span>",
"    <span class=\"nowrap\">",
"     Arp2/3",
"    </span>",
"    induces both actin polymerization and cross-linking of actin filaments, thereby leading to tail formation (",
"    <a class=\"graphic graphic_picture graphicRef56214 \" href=\"mobipreview.htm?21/59/22449\">",
"     picture 5",
"    </a>",
"    ). As the bacterium moves forward, the tail itself remains stationary in the host cytoplasm, and disassembly of the tail occurs at its distal end [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125861\">",
"    <span class=\"h2\">",
"     Spread to adjacent cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella spreads into adjacent cells via bacterium-induced, membrane-bound protrusions from the surface of the host cell (",
"    <a class=\"graphic graphic_figure graphicRef68970 \" href=\"mobipreview.htm?41/45/42705\">",
"     figure 1",
"    </a>",
"    ) and (",
"    <a class=\"graphic graphic_movie graphicRef58781 \" href=\"mobipreview.htm?3/39/3696\">",
"     movie 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/55\">",
"     55",
"    </a>",
"    ]. Bacterium-containing protrusions can extend several bacterial lengths away from the cell surface, with the bacterium at the tip. The tips are engulfed and taken up by adjacent cells, thereby transferring the bacterium into the adjacent cell. The formation of these protrusions depends at least in part on cellular actin polymerization proteins called formins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/56\">",
"     56",
"    </a>",
"    ]. Thereafter, the bacterium lyses the membranes that surround it, freeing itself into the cytoplasm of the new cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This mechanism of cell-to-cell passage enables the bacteria to spread from host cell to host cell without being enclosed within a true macropinocytic vacuole or having contact with the contents of the intestinal lumen. By remaining within the cytoplasm, the microorganism evades the toxic consequences of phagolysosomal fusion as well as other elements of the host defense system.",
"   </p>",
"   <p>",
"    Eukaryotic cells are able to degrade abnormal cytosolic molecules and particles, including infecting bacteria, by a process known as autophagy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/58\">",
"     58",
"    </a>",
"    ]. Shigella proteins that are secreted into the host cell cytoplasm via the type III secretion apparatus inhibit autophagy, thereby enhancing the ability of Shigella to survive within the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125878\">",
"    <span class=\"h2\">",
"     Elaboration of toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella strains elaborate three distinct enterotoxins: the virulence plasmid-encoded ShET2 (produced by all four species) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/60\">",
"     60",
"    </a>",
"    ], chromosomally-encoded ShET1 (produced by S. flexneri 2a) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/61-63\">",
"     61-63",
"    </a>",
"    ], and Shiga toxin (Stx) (produced by S. dysenteriae 1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/64\">",
"     64",
"    </a>",
"    ]. Each of these enterotoxins induces intestinal secretion of solutes and water. The contribution of each of these toxins to the disease process is probably minor, since nontoxigenic strains cause significant disease.",
"   </p>",
"   <p>",
"    S. dysenteriae 1 can cause the hemolytic-uremic syndrome, mediated by Stx. Stx is genetically and structurally similar to the Stx1 and Stx2 toxins produced by certain E. coli strains, such as enterohemorrhagic E. coli O157:H7. In the United States, these Stx-producing E. coli are the major cause of postdiarrheal hemolytic-uremic syndrome. The prominent renal involvement suggests that Shiga toxins may have a predilection for the renal circulation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link&amp;anchor=H20#H20\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'Shiga toxin-producing E. coli'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125905\">",
"    <span class=\"h2\">",
"     Immune response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pocket formed within M cells and the underlying tissue is rich in macrophages, B and T lymphocytes, and dendritic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/65\">",
"     65",
"    </a>",
"    ]. Within the macrophages, Shigella are able to induce apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/66\">",
"     66",
"    </a>",
"    ] with the release of proinflammatory cytokines, including interleukin (IL)-1 (but not IL-6 or TNF-alpha) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rectal biopsies from patients with acute Shigella diarrhea demonstrate intense acute inflammatory infiltrates with neutrophils and plasma cells in almost all samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/38\">",
"     38",
"    </a>",
"    ]. Immunohistochemical studies demonstrate greater numbers of cells producing IL-1a, IL-1b, IL-1ra, IL-4, IL-6, IL-10, interferon gamma (IFNg), TNF-alpha, TNF-beta, and transforming growth factor beta compared with uninfected controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/68\">",
"     68",
"    </a>",
"    ]. The acute inflammatory response to Shigella invasion is clearly a major contributor to symptoms and the disease process.",
"   </p>",
"   <p>",
"    Shigella modulates the innate immune response by secreting bacterial proteins capable of altering immune signaling pathways in host cells. These effector proteins variably block induction of NFkB signaling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/69\">",
"     69",
"    </a>",
"    ], alter signaling via the MAPK kinase pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/69-72\">",
"     69-72",
"    </a>",
"    ], and alter transcription of immunomodulatory proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/73\">",
"     73",
"    </a>",
"    ]. In addition, Shigella inhibits both T cell migration and the development of antigen-specific T cell responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunity following natural infection appears to occur, as evidenced by the observation that disease due to endemic Shigella species occurs primarily in children, while disease due to epidemic species occurs in all age groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/76\">",
"     76",
"    </a>",
"    ]. Immune protection appears to be serotype-specific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/76-80\">",
"     76-80",
"    </a>",
"    ]. Serotype is determined by the O polysaccharide composition, and multiple serotypes have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42008/abstract/81\">",
"     81",
"    </a>",
"    ]. A significant component of naturally-acquired protection may be mediated by a specific response to the polysaccharide component of bacterial lipopolysaccharide. The significance of antibody responses to antigens other than lipopolysaccharide (eg, IpaBCD, IcsA, or ShETs) is not known.",
"   </p>",
"   <p>",
"    No safe and effective Shigella vaccine is commercially available, although several are in advanced stages of human trials. However, those that are most promising appear to generate immunity only to the serotype contained in the vaccine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H440125962\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial dysentery due to Shigella species is a major cause of morbidity and mortality; 165 million cases occur annually worldwide, with 1 million associated deaths. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Shigella organisms can survive transit through the stomach since they are less susceptible to acid than many other bacteria. For this reason, the inoculum required for the development of clinical disease is quite low; as few as 10 to 100 organisms can cause disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In developed countries, most cases of Shigella are transmitted by fecal-oral spread from people with symptomatic infection. In developing countries, both fecal-oral spread and contamination of common food and water supplies are important mechanisms of transmission. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Shigella are nonmotile, facultatively anaerobic, gram-negative rods. &nbsp;There are four species of Shigella: S. dysenteriae, S. flexneri, S. boydii and S. sonnei. In developing countries, S. flexneri is the predominant species; S. sonnei is the second most prevalent. Most cases of shigellosis in the United States are caused by S. sonnei; S. flexneri is the next most frequent isolate. S. dysenteriae 1 (the Shiga bacillus) was the most common isolate both in Europe and the United States in the early 1900s but is now rare. In the United States S. dysenteriae 1 infection is generally limited to imported cases from Mexico and Central America. (See",
"      <a class=\"local\" href=\"#H440124002\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of Shigella infection involves invasion of colonic mucosal cells and induction of an intense inflammatory response, leading to the death of epithelial and immune cells and the formation of colonic mucosal ulcerations and abscesses. Shigella-induced macropinocytosis occurs through extensive rearrangements of the host cell cytoskeleton that cause formation of large extensions of the host cell membrane, in which the bacteria become engulfed. Thereafter, the bacteria spreads from host cell to host cell without having contact with the contents of the intestinal lumen. (See",
"      <a class=\"local\" href=\"#H440125800\">",
"       'Colonic entry'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H440125807\">",
"       'Macropinocytosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H440125846\">",
"       'Cytoskeletal signaling'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H440125861\">",
"       'Spread to adjacent cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      S. dysenteriae 1 can cause the hemolytic-uremic syndrome, mediated by Shiga toxin (Stx). Stx is genetically and structurally similar to the Stx1 and Stx2 toxins produced by certain E. coli strains, such as enterohemorrhagic E. coli O157:H7. (See",
"      <a class=\"local\" href=\"#H440125878\">",
"       'Elaboration of toxins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Immunity following natural infection appears to occur, as evidenced by the observation that disease due to endemic Shigella species occurs primarily in children, while disease due to epidemic species occurs in all age groups. (See",
"      <a class=\"local\" href=\"#H440125905\">",
"       'Immune response'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/1\">",
"      Bennish ML. Potentially lethal complications of shigellosis. Rev Infect Dis 1991; 13 Suppl 4:S319.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. New vaccine development: Establishing priorities. Diseases of importance in developing countries. National Academy Press, Washington, DC 1986. p.329.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/3\">",
"      Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/4\">",
"      Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food--10 States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/6\">",
"      Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--10 States, United States, 2005. MMWR Morb Mortal Wkly Rep 2006; 55:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/7\">",
"      Hopkins RS, Jajosky RA, Hall PA, et al. Summary of notifiable diseases--United States, 2003. MMWR Morb Mortal Wkly Rep 2005; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/8\">",
"      Parsonnet J, Greene KD, Gerber AR, et al. Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Lancet 1989; 2:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/9\">",
"      Kolavic SA, Kimura A, Simons SL, et al. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA 1997; 278:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/10\">",
"      MOSLEY WH, ADAMS B, LYMAN ED. Epidemiologic and sociologic features of a large urban outbreak of shigellosis. JAMA 1962; 182:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/11\">",
"      Centers for Disease Control and Prevention (CDC). Day care-related outbreaks of rhamnose-negative Shigella sonnei--six states, June 2001-March 2003. MMWR Morb Mortal Wkly Rep 2004; 53:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/12\">",
"      Centers for Disease Control (CDC). Shigellosis in child day care centers--Lexington-Fayette County, Kentucky, 1991. MMWR Morb Mortal Wkly Rep 1992; 41:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/13\">",
"      Mohle-Boetani JC, Stapleton M, Finger R, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health 1995; 85:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/14\">",
"      Weissman JB, Schmerler A, Weiler P, et al. The role of preschool children and day-care centers in the spread of shigellosis in urban communities. J Pediatr 1974; 84:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/15\">",
"      Wilson R, Feldman RA, Davis J, LaVenture M. Family illness associated with Shigella infection: the interrelationship of age of the index patient and the age of household members in acquisition of illness. J Infect Dis 1981; 143:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/16\">",
"      Donadio JA, Gangarosa EJ. From the national communicable disease center. J Infect Dis 1969; 119:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/17\">",
"      Wheatley W, Veer JB Jr. A foodborne outbreak of shigellosis on an Indian reservation. Public Health Rep 1969; 84:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/18\">",
"      Greenberg JH, Schmidt EA, Bell FS Jr. A common source epidemic of shigellosis. Public Health Rep 1966; 81:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/19\">",
"      Martin DL, Gustafson TL, Pelosi JW, et al. Contaminated produce--a common source for two outbreaks of Shigella gastroenteritis. Am J Epidemiol 1986; 124:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/20\">",
"      Reller ME, Nelson JM, M&oslash;lbak K, et al. A large, multiple-restaurant outbreak of infection with Shigella flexneri serotype 2a traced to tomatoes. Clin Infect Dis 2006; 42:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/21\">",
"      Velaudapillai T, Niles GR, Nagaratnam W. Salmonellas, shigellas and enteropathogenic Escherichia coli in uncooked food. J Hyg (Lond) 1969; 67:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/22\">",
"      Centers for Disease Control and Prevention (CDC). Shigella sonnei outbreak among men who have sex with men--San Francisco, California, 2000-2001. MMWR Morb Mortal Wkly Rep 2001; 50:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/23\">",
"      Centers for Disease Control and Prevention (CDC). Shigella flexneri serotype 3 infections among men who have sex with men--Chicago, Illinois, 2003-2004. MMWR Morb Mortal Wkly Rep 2005; 54:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/24\">",
"      Arag&oacute;n TJ, Vugia DJ, Shallow S, et al. Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection. Clin Infect Dis 2007; 44:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/25\">",
"      Kosek M, Yori PP, Pan WK, et al. Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics 2008; 122:e541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/26\">",
"      Ahmed F, Clemens JD, Rao MR, et al. Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment. Am J Trop Med Hyg 1997; 56:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/27\">",
"      Ferreccio C, Prado V, Ojeda A, et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol 1991; 134:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/28\">",
"      Joe LK, Rukmono B, Oemijati S, et al. Diarrhoea among infants in a crowded area of Djakarta, Indonesia. A longitudinal study from birth to two years. Bull World Health Organ 1966; 34:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/29\">",
"      Ahmed F, Clemens JD, Rao MR, et al. Community-based evaluation of the effect of breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis in Bangladeshi children. Pediatrics 1992; 90:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/30\">",
"      Rahaman MM, Huq I, Dey CR. Superiority of MacConkey's agar over salmonella-shigella agar for isolation of Shigella dysenteriae type 1. J Infect Dis 1975; 131:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/31\">",
"      Frankel G, Riley L, Giron JA, et al. Detection of Shigella in feces using DNA amplification. J Infect Dis 1990; 161:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/32\">",
"      Islam D, Lindberg AA. Detection of Shigella dysenteriae type 1 and Shigella flexneri in feces by immunomagnetic isolation and polymerase chain reaction. J Clin Microbiol 1992; 30:2801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/33\">",
"      Gaudio PA, Sethabutr O, Echeverria P, Hoge CW. Utility of a polymerase chain reaction diagnostic system in a study of the epidemiology of shigellosis among dysentery patients, family contacts, and well controls living in a shigellosis-endemic area. J Infect Dis 1997; 176:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/34\">",
"      DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989; 159:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/35\">",
"      Blaser MJ, Newman LS. A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982; 4:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/36\">",
"      Morduchowicz G, Huminer D, Siegman-Igra Y, et al. Shigella bacteremia in adults. A report of five cases and review of the literature. Arch Intern Med 1987; 147:2034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/37\">",
"      Struelens MJ, Patte D, Kabir I, et al. Shigella septicemia: prevalence, presentation, risk factors, and outcome. J Infect Dis 1985; 152:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/38\">",
"      Mathan MM, Mathan VI. Morphology of rectal mucosa of patients with shigellosis. Rev Infect Dis 1991; 13 Suppl 4:S314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/39\">",
"      Clerc P, Sansonetti PJ. Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun 1987; 55:2681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/40\">",
"      Mounier J, Vasselon T, Hellio R, et al. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect Immun 1992; 60:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/41\">",
"      Perdomo JJ, Gounon P, Sansonetti PJ. Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest 1994; 93:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/42\">",
"      Sakaguchi T, K&ouml;hler H, Gu X, et al. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol 2002; 4:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/43\">",
"      Parsot C. Shigella type III secretion effectors: how, where, when, for what purposes? Curr Opin Microbiol 2009; 12:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/44\">",
"      Ogawa M, Handa Y, Ashida H, et al. The versatility of Shigella effectors. Nat Rev Microbiol 2008; 6:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/45\">",
"      Maurelli AT, Sansonetti PJ. Identification of a chromosomal gene controlling temperature-regulated expression of Shigella virulence. Proc Natl Acad Sci U S A 1988; 85:2820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/46\">",
"      Marteyn B, West NP, Browning DF, et al. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010; 465:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/47\">",
"      Sansonetti PJ, Ryter A, Clerc P, et al. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun 1986; 51:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/48\">",
"      Bernardini ML, Mounier J, d'Hauteville H, et al. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc Natl Acad Sci U S A 1989; 86:3867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/49\">",
"      Goldberg MB, Theriot JA. Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc Natl Acad Sci U S A 1995; 92:6572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/50\">",
"      Kocks C, Marchand JB, Gouin E, et al. The unrelated surface proteins ActA of Listeria monocytogenes and IcsA of Shigella flexneri are sufficient to confer actin-based motility on Listeria innocua and Escherichia coli respectively. Mol Microbiol 1995; 18:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/51\">",
"      Goldberg MB. Actin-based motility of intracellular microbial pathogens. Microbiol Mol Biol Rev 2001; 65:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/52\">",
"      Goldberg MB, B&acirc;rzu O, Parsot C, Sansonetti PJ. Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. J Bacteriol 1993; 175:2189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/53\">",
"      Leung Y, Ally S, Goldberg MB. Bacterial actin assembly requires toca-1 to relieve N-wasp autoinhibition. Cell Host Microbe 2008; 3:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/54\">",
"      Theriot JA, Mitchison TJ, Tilney LG, Portnoy DA. The rate of actin-based motility of intracellular Listeria monocytogenes equals the rate of actin polymerization. Nature 1992; 357:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/55\">",
"      Kadurugamuwa JL, Rohde M, Wehland J, Timmis KN. Intercellular spread of Shigella flexneri through a monolayer mediated by membranous protrusions and associated with reorganization of the cytoskeletal protein vinculin. Infect Immun 1991; 59:3463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/56\">",
"      Heindl JE, Saran I, Yi CR, et al. Requirement for formin-induced actin polymerization during spread of Shigella flexneri. Infect Immun 2010; 78:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/57\">",
"      Allaoui A, Mounier J, Pr&eacute;vost MC, et al. icsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread. Mol Microbiol 1992; 6:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/58\">",
"      Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2004; 2:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/59\">",
"      Ogawa M, Yoshimori T, Suzuki T, et al. Escape of intracellular Shigella from autophagy. Science 2005; 307:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/60\">",
"      Nataro JP, Seriwatana J, Fasano A, et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun 1995; 63:4721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/61\">",
"      Noriega FR, Liao FM, Formal SB, et al. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J Infect Dis 1995; 172:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/62\">",
"      Fasano A, Noriega FR, Maneval DR Jr, et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest 1995; 95:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/63\">",
"      Fasano A, Noriega FR, Liao FM, et al. Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 1997; 40:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/64\">",
"      Keusch GT, Donohue-Rolfe A, Jacewicz M. Shigella toxin(s): description and role in diarrhea and dysentery. Pharmacol Ther 1981; 15:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/65\">",
"      Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996; 86:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/66\">",
"      Zychlinsky A, Thirumalai K, Arondel J, et al. In vivo apoptosis in Shigella flexneri infections. Infect Immun 1996; 64:5357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/67\">",
"      Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M. Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest 1995; 96:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/68\">",
"      Raqib R, Lindberg AA, Wretlind B, et al. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 1995; 63:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/69\">",
"      Kim DW, Lenzen G, Page AL, et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 2005; 102:14046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/70\">",
"      Kramer RW, Slagowski NL, Eze NA, et al. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog 2007; 3:e21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/71\">",
"      Li H, Xu H, Zhou Y, et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007; 315:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/72\">",
"      Zurawski DV, Mitsuhata C, Mumy KL, et al. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect Immun 2006; 74:5964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/73\">",
"      Arbibe L, Kim DW, Batsche E, et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 2007; 8:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/74\">",
"      Jehl SP, Doling AM, Giddings KS, et al. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri. Infect Immun 2011; 79:2021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/75\">",
"      Konradt C, Frigimelica E, Nothelfer K, et al. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism. Cell Host Microbe 2011; 9:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/76\">",
"      Taylor DN, Bodhidatta L, Brown JE, et al. Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand. Am J Trop Med Hyg 1989; 40:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/77\">",
"      Huan PT, Taylor R, Lindberg AA, Verma NK. Immunogenicity of the Shigella flexneri serotype Y (SFL 124) vaccine strain expressing cloned glucosyl transferase gene of converting bacteriophage SfX. Microbiol Immunol 1995; 39:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/78\">",
"      Keren DF, Kern SE, Bauer DH, et al. Direct demonstration in intestinal secretions of an IgA memory response to orally administered Shigella flexneri antigens. J Immunol 1982; 128:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/79\">",
"      Mallett CP, Hale TL, Kaminski RW, et al. Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection. Infect Immun 1995; 63:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/80\">",
"      Rasolofo-Razanamparany V, Cassel-Beraud AM, Roux J, et al. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity. Infect Immun 2001; 69:5230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42008/abstract/81\">",
"      Talukder KA, Dutta DK, Safa A, et al. Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. J Clin Microbiol 2001; 39:3757.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2719 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-655E7897C0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42008=[""].join("\n");
var outline_f41_1_42008=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H440125962\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      United States",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Transmission in institutions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Food borne transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Sexual transmission in MSM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H440124002\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440124009\">",
"      Stool culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440124016\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H440124159\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125800\">",
"      Colonic entry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125807\">",
"      Macropinocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125846\">",
"      Cytoskeletal signaling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125861\">",
"      Spread to adjacent cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125878\">",
"      Elaboration of toxins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H440125905\">",
"      Immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H440125962\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2719\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2719|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/45/42705\" title=\"figure 1\">",
"      Shigella in epthelial cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2719|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/21/7504\" title=\"picture 1\">",
"      Selective media GI pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/59/36797\" title=\"picture 2\">",
"      Triple sugar iron agar slant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/5/5214\" title=\"picture 3A\">",
"      Motility medium Shigella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/36/14926\" title=\"picture 3B\">",
"      Urea slant Shigella v Proteus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/36/11854\" title=\"picture 4\">",
"      Salmonella Shigella agglut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/59/22449\" title=\"picture 5\">",
"      Shigella and actin EM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2719|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?1/41/1680\" title=\"movie 1\">",
"      Motility of Shigella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?3/39/3696\" title=\"movie 2\">",
"      Shigella protrusion from the cell",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38535?source=related_link\">",
"      Clinical manifestations and diagnosis of Shigella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39334?source=related_link\">",
"      Treatment and prevention of Shigella infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42009="Borderline personality disorder: Treatment and prognosis";
var content_f41_1_42009=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Borderline personality disorder: Treatment and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Kenneth R Silk, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Andrew Skodol, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42009/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/1/42009/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Borderline personality disorder (BPD) is characterized as instability of interpersonal relationships, self-image, and emotions, and by impulsivity. The name of the disorder was originally based upon a concept that this syndrome constituted the boundary or borderline between neurosis (a pattern of maladaptive traits and coping mechanisms) and psychosis (a condition of grossly impaired reality testing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with borderline personality disorder (BPD) often receive mental health treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In addition, the disorder is more widely studied than any other personality disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/4\">",
"     4",
"    </a>",
"    ]. Despite these efforts, patients with BPD continue to suffer considerable morbidity and mortality.",
"   </p>",
"   <p>",
"    The treatment and prognosis of BPD will be reviewed here. The epidemiology, clinical features, diagnosis, and differential diagnosis of BPD and other personality disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10553?source=see_link\">",
"     \"Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40824?source=see_link\">",
"     \"Personality disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL TREATMENT GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard treatment consists of psychotherapy as the primary treatment plus medications as adjunctive treatment. Reviews have concluded that although both psychotherapy and pharmacotherapy are useful in treating patients with borderline personality disorder (BPD), psychotherapy is more beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Psychoeducation is also helpful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Numerous treatments are available for patients with BPD, including different psychotherapies that have been developed or adapted specifically for BPD. In addition, clinicians can use various mood stabilizers and second generation antipsychotics to target particular symptoms of the disorder. It is not known whether there are different subtypes of the disorder that respond preferentially to the numerous treatment options.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Treatment setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment begins with a comprehensive evaluation that is used to decide where treatment should occur. This initial assessment should focus on the:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severity of signs and symptoms",
"     </li>",
"     <li>",
"      Presence of violent ideation directed at self or others",
"     </li>",
"     <li>",
"      Ability to control dangerous impulses",
"     </li>",
"     <li>",
"      Presence of comorbid disorders",
"     </li>",
"     <li>",
"      Recent psychosocial stressors",
"     </li>",
"     <li>",
"      Level of functioning at home and work",
"     </li>",
"     <li>",
"      Coping strategies and behaviors",
"     </li>",
"     <li>",
"      Personal strengths and weaknesses",
"     </li>",
"     <li>",
"      Goals for treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The treatment setting options include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Outpatient care",
"     </li>",
"     <li>",
"      Partial hospitalization",
"     </li>",
"     <li>",
"      Brief inpatient hospitalization",
"     </li>",
"     <li>",
"      Extended inpatient hospitalization",
"     </li>",
"     <li>",
"      Residential care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Different factors contribute to the need for hospitalization. These include an increase in frequency or severity of self-destructive behavior, as well as transient psychotic symptoms that often occur when melancholic major depression is present or the patient is under extreme stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In addition, exacerbation of a comorbid depressive, substance use, or eating disorder, or medical consequences of impulsive behavior may necessitate hospital admission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Principles of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient management is guided by several principles that are based upon clinical experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Develop and maintain a therapeutic alliance",
"     </li>",
"     <li>",
"      Interact with patients in an active and empathic manner",
"     </li>",
"     <li>",
"      Encourage patients to take responsibility for their actions and problems",
"     </li>",
"     <li>",
"      Maintain regular appointments that patients are expected to keep",
"     </li>",
"     <li>",
"      Establish clear boundaries with respect to the treatment relationship and patient behaviors",
"     </li>",
"     <li>",
"      Set limits when necessary to maintain these boundaries",
"     </li>",
"     <li>",
"      Monitor patients for safety and consider hospitalization if they are judged to be at serious risk",
"     </li>",
"     <li>",
"      Provide psychoeducation to patients (and families if appropriate)",
"     </li>",
"     <li>",
"      Monitor the patient's overall clinical status and revise the treatment plan as necessary",
"     </li>",
"     <li>",
"      Collaborate closely with all clinicians providing care to the patient",
"     </li>",
"     <li>",
"      Be aware of the potential for the patient to excessively idealize some people and devalue others",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment should focus upon BPD even if a comorbid Axis I disorder is present, because remission of both disorders often depends upon first successfully treating the BPD. As an example, a longitudinal study found that improvement of major depression was not followed by improvement of BPD, whereas improvement in BPD significantly increased the probability of major depression remitting (RR 0.75, 95% CI 0.65-0.87) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Treatment team",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with BPD can be so intensely demanding and difficult to treat that clinicians often \"burn out\" and terminate the treatment. One way to avoid burn out is to assemble a team of clinicians to treat these patients, rather than trying to do so individually",
"   </p>",
"   <p>",
"    The treatment team should include clinicians from different disciplines, and the composition of the team will vary depending upon the treatment setting. A psychiatrist usually directs the team and is responsible for medically managing the patient, including prescribing medications. A psychologist provides psychotherapy, a nurse and mental health worker implement and reinforce different aspects of the treatment plan and provide psychoeducation (usually in an inpatient setting), and a social worker communicates with the family and outside agencies. Many of these roles can be carried out by clinicians from different disciplines. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Treatment setting'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H6\">",
"     'Psychotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H16\">",
"     'Pharmacotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H23\">",
"     'Psychoeducation and patient information'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Different types of mental health clinicians have different views and perspectives on the nature of BPD, and how well it responds to treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/11\">",
"     11",
"    </a>",
"    ]. An unpublished abstract described a study of over 700 clinicians at eight different university psychiatry departments, which found psychiatrists were moderately positive about the benefits of medications and psychotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/12\">",
"     12",
"    </a>",
"    ]. Nurses (who often see patients only as inpatients during times of crises) were the most pessimistic regarding the benefits of either psychotherapy or medications and they were more likely to view these patients as consciously manipulative. Psychologists generally viewed psychotherapy as potentially helpful and thought medications were of little benefit. Social workers shared the psychologists' enthusiasm for psychotherapy and the psychiatrists' optimism about medications playing a useful role.",
"   </p>",
"   <p>",
"    Good communication is required when multiple clinicians treat the same patient with BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. Joint treatment by more than one clinician increases problems with \"splitting,\" in which the patient rigidly classifies others (including treating clinicians) as all good or bad. The patient may selectively pass on negative information about one clinician to another clinician in a manner that leads to conflict between the \"good\" and \"bad\" members of the treatment team. Thus, the patient's tendency for splitting can lead to a situation in which two clinicians find themselves on opposite sides of an issue. Consistent communication between clinicians should minimize this problem and enable them to provide coordinated, consistent, and effective care.",
"   </p>",
"   <p>",
"    Clinicians may react strongly to patients with BPD because of countertransference. Countertransference is the clinician's counter-reaction or emotional response to the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/11\">",
"     11",
"    </a>",
"    ]. Countertransference often occurs in response to the patient's transference, which is the process in which a patient unconsciously transfers feelings about an important person onto the clinician (eg, the patient's resentment of a parent may be redirected and experienced as resentment of the clinician).",
"   </p>",
"   <p>",
"    Countertransference during treatment of patients with BPD can interfere with clinical judgment. Clinicians may intensely dislike the patient and believe that she is deliberately behaving in a provocative and defiant manner, and forget that the patient is doing the best she can [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/14\">",
"     14",
"    </a>",
"    ]. Clinicians can manage their countertransference by discussing it with other members of the treatment team. The goal is for the clinician to become aware of these countertransference feelings and attitudes and use them as important data about the patient, and to avoid behaving toward the patient in punitive ways.",
"   </p>",
"   <p>",
"    Projective identification can also occur in clinicians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/15\">",
"     15",
"    </a>",
"    ]. Patients may unconsciously project or ascribe feelings onto the clinician, for example, an angry patient may be unaware of her anger and instead believe that the clinician is angry. The patient may then behave in such a way that the clinician becomes angry with the patient (ie, the clinician identifies with the patient's projection). Projective identification is thus a self-fulfilling prophecy. Again, clinicians can manage their projective identification by discussing it with other members of the treatment team.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H345914986\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to systematically monitor the course of illness. We recommend clinicians assess change in borderline psychopathology over time by periodically asking patients about each of the nine criteria that define the diagnosis of BPD in the American Psychiatric Association Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/16\">",
"     16",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef63127 \" href=\"mobipreview.htm?42/42/43691\">",
"     table 1",
"    </a>",
"    ). The Zanarini Rating Scale for Borderline Personality Disorder follows the same procedure of assessing each of the nine diagnostic criteria in order to track course of illness in research studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10553?source=see_link&amp;anchor=H16#H16\">",
"     \"Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PSYCHOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Psychotherapy principles and practices",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review identified several common factors among different psychotherapies that are effective for treating borderline personality disorder (BPD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/6\">",
"     6",
"    </a>",
"    ]. Each therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Provides an active and focused intervention",
"     </li>",
"     <li>",
"      Provides psychoeducation",
"     </li>",
"     <li>",
"      Targets affective instability by teaching or helping with emotion regulation",
"     </li>",
"     <li>",
"      Targets impulsivity by helping patients to observe feelings rather than acting on them",
"     </li>",
"     <li>",
"      Targets relationship difficulties by teaching or helping patients to be cognizant of the feelings of other people",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, each of the effective psychotherapies is based upon a manual that provides structure to the therapy and standardizes the procedures that are used. The manual helps clinicians properly implement the treatment and maintain consistency. This is especially important for patients with BPD, because they will test limits and appeal to clinicians to make exceptions.",
"   </p>",
"   <p>",
"    All effective psychotherapies are compatible with pharmacotherapy. Every study that has demonstrated the efficacy of a specific type of psychotherapy has included adjunctive pharmacotherapy in the treatment protocol.",
"   </p>",
"   <p>",
"    A systematic review of 28 randomized trials involving 1804 patients with borderline personality disorders found that multiple psychotherapies reduce symptoms of the disorder compared to control conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/18\">",
"     18",
"    </a>",
"    ]., The review and individual trials have reported positive results for cognitive-behavioral therapy, dialectical behavior therapy, mentalization-based therapy, schema-focused therapy, systems training for emotional predictability and problem solving, and transference-focused psychotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/18-25\">",
"     18-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The various effective psychotherapies are distinguished by their overarching approach. Some therapies were developed specifically to treat BPD and emphasize behavioral skills training [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Psychodynamic and psychoanalytic therapies focus upon relationships and the meaning of interactions with others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/22-24,26\">",
"     22-24,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients with BPD are amenable to psychotherapy. These patients often have poor insight into the connection between their behavior and their problems, but are acutely aware of chronic interpersonal difficulties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/14\">",
"     14",
"    </a>",
"    ]. This awareness, combined with their desire to form strong attachments, often enables these individuals to commit considerable time and energy to therapy. The therapeutic relationship, however, can be very stormy.",
"   </p>",
"   <p>",
"    A treatment guideline states that clinicians should provide psychotherapy for a minimum of three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/13,27\">",
"     13,27",
"    </a>",
"    ], but the treatment studies that have been conducted ranged in length from 20 weeks to 36 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/19-25,28\">",
"     19-25,28",
"    </a>",
"    ]. Our clinical experience is that many if not most patients require treatment for years.",
"   </p>",
"   <p>",
"    Some therapies specify a duration for treatment, but this does not mean that treatment ends at that point. The implication is that patients will continue with a modified form of the treatment or a different therapy, but there are no studies addressing this issue. Patients move in and out of therapy through their lives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/29\">",
"     29",
"    </a>",
"    ]. Beyond safety for the patient and others, there are no specific criteria as to when a patient is ready to end therapy. The patient and clinician should jointly decide to stop treatment by reviewing progress and whether the patient has the skills to manage herself without therapy. In addition, the clinician should explicitly state that he or she is available to resume treatment without having the patient feel that it is inevitable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Specific psychotherapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each of these psychotherapies emphasizes current functioning and relationships. In the absence of head-to-head trials demonstrating meaningful differences between modalities, the choice of psychotherapy depends upon availability and patient preference. As an example, the amount of patient contact required for psychotherapy ranges from weekly sessions over 20 weeks (systems training for emotional predictability and problem solving) to twice per week sessions for 36 months (mentalization-based therapy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Cognitive-behavioral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;This therapy attempts to change maladaptive cognitions about oneself and others, and to develop behavioral strategies for improving social and emotional functioning.",
"   </p>",
"   <p>",
"    The largest randomized trial of this therapy enrolled 106 BPD patients, and compared cognitive-behavioral therapy plus treatment as usual (primary care plus mental health care), versus treatment as usual alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/21\">",
"     21",
"    </a>",
"    ]. Treatment lasted for 12 months, during which a median of 31 sessions of cognitive-behavioral therapy was offered, each session lasting an hour. Patients were assessed 12 months after treatment ended. The mean number of suicidal acts over two years was significantly lower in the experimental group compared to controls (0.9 versus 1.7).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Dialectical behavior therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is a cognitive-behavioral therapy that targets suicidal and other dangerous behavior, as well as behavior that interferes with treatment. It consists of weekly individual psychotherapy and weekly group skills training provided for approximately one year.",
"   </p>",
"   <p>",
"    A meta-analysis of randomized trials of dialectical behavior therapy (DBT) in patients with borderline personality concluded that DBT was helpful for multiple outcomes including reductions in anger and suicidality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individual trials have yielded conflicting results for some outcomes; for example:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 101 women with BPD found significantly fewer patients attempted suicide in the group that received dialectical behavior therapy versus community treatment by experts (23 versus 46 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/19\">",
"       19",
"      </a>",
"      ]. In addition, patients who received dialectical behavior therapy were significantly less likely to utilize a hospital emergency department for any psychiatric reason (43 versus 58 percent), require psychiatric hospitalization (20 versus 49 percent), and to drop out of treatment (19 versus 43 percent).",
"     </li>",
"     <li>",
"      A study of 180 patients with BPD found both dialectical behavior therapy and the control treatment of general psychiatric management reduced suicidal behavior and the number of hospital days, with no significant difference between the two treatments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Mentalization-based therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is primarily a psychodynamic therapy that also incorporates many cognitive techniques. The patient is taught to observe her state of mind at each moment, and to generate alternative perspectives of her subjective experience of herself and others.",
"   </p>",
"   <p>",
"    A randomized trial with 41 BPD patients evaluated mentalization-based treatment consisting of individual and group therapy provided in a partial hospital setting for 18 months, followed by an additional 18 months of outpatient treatment twice a week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/22\">",
"     22",
"    </a>",
"    ]. Patients received either mentalization-based therapy or, as a control, general outpatient psychiatric care. Eight years after study intake, significantly fewer patients in the active treatment group attempted suicide (23 versus 74 percent) or met criteria for BPD (14 versus 87 percent).",
"   </p>",
"   <p>",
"    A subsequent trial with 134 BPD patients evaluated a less intense version of mentalization-based treatment consisting of weekly combined individual and group therapy provided on an outpatient basis for 18 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/24\">",
"     24",
"    </a>",
"    ]. Significantly fewer suicide attempts and hospitalizations occurred in the group that received mentalization-based treatment compared with the control group that received structured clinical management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Schema-focused therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is a combination of cognitive-behavioral therapy and psychodynamic therapy that aims to modify maladaptive schemas (mental structures that represent some aspect of the world such as oneself or others, which are used to organize knowledge of the surrounding world).",
"   </p>",
"   <p>",
"    A study randomized 88 BPD patients to either schema-focused therapy or transference-focused therapy, with each treatment provided twice a week for three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/20\">",
"     20",
"    </a>",
"    ]. Both treatment groups improved significantly from baseline on the primary outcome scale that measured the frequency and severity of BPD symptoms, and on secondary measures of general psychopathology and quality of life. Patients receiving schema-focused therapy were more than twice as likely to recover from BPD compared to those receiving transference-focused therapy (RR 2.18, 95% CI 1.02 - 4.66). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Transference-focused therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Systems training for emotional predictability and problem solving",
"    </span>",
"    &nbsp;&mdash;&nbsp;This group therapy combines psychoeducation, cognitive-behavioral techniques, and skills training in management of emotion and behavior. The program involves 20 weekly sessions, each lasting two hours. These sessions supplement a patient's ongoing treatment (e.g., individual therapy or medication). Family members or significant others are also involved in the program.",
"   </p>",
"   <p>",
"    A randomized trial with 124 BPD patients compared systems training for emotional predictability and problem solving (STEPPS) plus treatment as usual versus treatment as usual alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/25\">",
"     25",
"    </a>",
"    ]. Disturbed affect and cognition, impulsivity, and disturbed relationships improved significantly more by week 20 for the systems training group, with a large estimated clinical effect. These treatment gains persisted at the one-year follow-up evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Transference-focused therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;This psychodynamic therapy involves exploration, confrontation, and transference interpretations of emotionally charged issues that arise in the relationship between the patient and therapist. The aim is to correct the patient's tendency to perceive significant others in a distorted manner.",
"   </p>",
"   <p>",
"    A randomized trial with 90 BPD patients compared one year of treatment with transference-focused therapy (two individual sessions per week) versus dialectical behavior therapy (one individual and one group session per week) versus supportive therapy (one individual session per week) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/23\">",
"     23",
"    </a>",
"    ]. Both transference-focused therapy and dialectical behavior therapy led to significant improvement in suicidality, compared with baseline. The three treatments were not compared with each other.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sequencing or combining psychotherapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no studies that have examined whether there are patients who should switch psychotherapy, when in the course of the illness this should occur, or whether different therapies should be sequenced.",
"   </p>",
"   <p>",
"    Based upon our clinical experience, we suggest initial treatment with more structured therapies such as dialectical behavior therapy or cognitive-behavioral therapy, especially for patients with significant behavioral dyscontrol and problems with safety. After behavior and safety has stabilized, patients can be treated with less structured and more dynamically-oriented therapies, such as mentalization-based therapy or transference-focused therapy.",
"   </p>",
"   <p>",
"    Schema-focused therapy combines cognitive-behavioral therapy and psychodynamic therapy, which makes it feasible to move from a more cognitive behavioral to a more dynamic approach as the patient improves and to use this treatment over long periods of time. Systems training for emotional predictability and problem solving is primarily an adjunctive treatment to other psychotherapies and can be added at any time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PHARMACOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pharmacotherapy principles and practices",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of pharmacotherapy is to stabilize specific problematic symptoms of borderline personality disorder (BPD) and thus facilitate the use of psychotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/30\">",
"     30",
"    </a>",
"    ]. Results from many meta-analyses and systematic reviews of randomized trials support this practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5,31-35\">",
"     5,31-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pharmacotherapy is an adjunctive treatment for psychotherapy. The US Food and Drug Administration has not approved any medication for treatment of BPD, and systematic reviews have concluded that medications alone do not lead to remission of the disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/6,13\">",
"     6,13",
"    </a>",
"    ]. Practice guidelines are clear that pharmacotherapy is not a cure for BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5,27\">",
"     5,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with BPD will agree to treatment with medication. One study found 84 percent of patients had been treated with daily medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pharmacotherapy is well tolerated by patients with BPD. Meta-analyses of randomized trials examined the proportion of patients who withdrew early from their study and found no significant difference between patients who received active drug and those who received placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31,33\">",
"     31,33",
"    </a>",
"    ]. Nevertheless, patients should be monitored for side effects, such as weight gain.",
"   </p>",
"   <p>",
"    Mood stabilizers and antipsychotics are generally preferred over antidepressants. However, there is little if any evidence to guide treatment of BPD symptoms in the context of common comorbid Axis I disorders, such as major depression, posttraumatic stress disorder, and panic disorder. In fact, most pharmacotherapy studies excluded patients with comorbid major depression or substance use disorders, despite the high prevalence of these disorders in patients with BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. It is reasonable to consider an antidepressant for patients who have BPD plus major depression, posttraumatic stress disorder, or panic disorder because antidepressants are indicated for these Axis I disorders. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33239?source=see_link\">",
"     \"Pharmacotherapy for posttraumatic stress disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=see_link\">",
"     \"Pharmacotherapy for panic disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not clear how well pharmacotherapy studies in patients with BPD generalize to usual clinical practice. In addition to excluding patients with highly prevalent comorbid disorders, studies usually excluded patients with suicidality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One consideration in providing pharmacotherapy is the concern that patients will overdose on their medications. Antipsychotics and selective serotonin reuptake inhibitors are rarely fatal in overdoses. Clinicians can limit the amount of medication dispensed by the pharmacy to reduce the risk of patients overdosing, or have a family member maintain possession of the medication. However, patients who require extreme precautions may need to be hospitalized.",
"   </p>",
"   <p>",
"    Many patients with BPD have comorbid substance use disorders. Clinicians should try to avoid prescribing benzodiazepines and other",
"    <span class=\"nowrap\">",
"     sedative/hypnotic",
"    </span>",
"    drugs because of the potential for misuse and dependence, and the lack of evidence of beneficial effects.",
"   </p>",
"   <p>",
"    It is not clear how long pharmacotherapy should last. Studies that evaluated the use of medications for symptoms of BPD have lasted only 4 to 26 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-34\">",
"     31-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians should try to avoid simultaneously using multiple psychoactive medications because there is no evidence to support it. In addition, it may increase the likelihood of adverse side effects such as weight gain. Polypharmacy is nevertheless common. One study found that 46 percent of patients with BPD had a history of taking three or more psychotropic medications concurrently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prescribing physician should distinguish dysphoria from chronic emptiness and loneliness. The symptoms of emptiness and loneliness are not amenable to psychopharmacologic intervention, and persistent attempts to treat them with medications can lead to increasingly complex and ineffective medication regimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/35,37\">",
"     35,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Specific symptoms to treat with medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should consider treating the following symptoms of BPD with pharmacotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Affective dysregulation (labile, inappropriate anger, and dysphoria)",
"     </li>",
"     <li>",
"      Impulsivity and aggression towards self and others",
"     </li>",
"     <li>",
"      Cognitive-perceptual symptoms (dissociation, disturbed identity, paranoia)",
"     </li>",
"     <li>",
"      Interpersonal problems",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While it is also important to treat comorbid Axis I disorders with pharmacotherapy as appropriate, treatment should focus upon BPD, because remission of both disorders often depends upon first successfully treating the BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Specific pharmacotherapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mood stabilizers and antipsychotic medications may have larger beneficial effects on a broader range of symptoms compared with antidepressants (including selective serotonin reuptake inhibitors) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. This finding is based upon comparing estimates of clinical effects derived from placebo controlled trials rather than head-to-head studies of active treatments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Mood stabilizers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses of randomized controlled trials found mood stabilizers provided moderate to large clinical effects for treating affective dysregulation, including inappropriate anger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Mood stabilizers also had large beneficial effects in treating impulsivity and aggression, interpersonal problems, and global functioning. Medications that demonstrated significantly positive results compared to placebo included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/11/25785?source=see_link\">",
"       Valproate",
"      </a>",
"      (mean daily dose 850 mg, mean serum level 65",
"      <span class=\"nowrap\">",
"       mcg/mL)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/27/5561?source=see_link\">",
"       Topiramate",
"      </a>",
"      (mean daily dose 200 - 250 mg, daily dose range 25 - 250 mg)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"       Lamotrigine",
"      </a>",
"      (mean daily dose 200 mg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Antipsychotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses of randomized controlled trials found antipsychotics provided moderate to large clinical effects for treating affective dysregulation, including inappropriate anger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. In addition, antipsychotics had large beneficial effects in treating",
"    <span class=\"nowrap\">",
"     impulsivity/aggression",
"    </span>",
"    and interpersonal problems, moderate effects treating cognitive-perceptual symptoms, and small to moderate effects for global functioning. Medications that demonstrated significantly positive results compared to placebo included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"       Olanzapine",
"      </a>",
"      (mean daily dose 5 - 9 mg, daily dose range 5 - 20 mg)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/11/43193?source=see_link\">",
"       Aripiprazole",
"      </a>",
"      (mean daily dose 15 mg)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       Risperidone",
"      </a>",
"      (daily dose range 0.25 - 2 mg)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"       Haloperidol",
"      </a>",
"      (mean daily dose 5 mg, daily dose range 4 to 16 mg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses of randomized controlled trials found antidepressants provided small to moderate effects for treating affective dysregulation, including inappropriate anger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Medications that demonstrated significantly positive results compared to placebo included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/49/15130?source=see_link\">",
"       Fluoxetine",
"      </a>",
"      (daily dose range 20 - 60 mg)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       Amitriptyline",
"      </a>",
"      (mean daily dose 149 mg, daily dose range 100 - 175 mg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Meta-analyses have consistently found that antidepressants have negligible to small clinical effects for treating the symptoms of dysphoria in the absence of major depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PSYCHOEDUCATION AND PATIENT INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comprehensive treatment includes psychoeducation that explains different aspects of borderline personality disorder (BPD), including its signs and symptoms, possible causes, course of illness, and treatment options. The efficacy of psychoeducation was established by a randomized trial in which patients informed of their diagnosis of BPD were assigned either to a single psychoeducation workshop or a waiting list [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/7\">",
"     7",
"    </a>",
"    ]. There were significantly greater reductions of impulsivity and storminess of close relationships in the treatment group compared with controls during 12 weeks of assessments",
"   </p>",
"   <p>",
"    Educational material explaining the symptoms, course of illness, and treatment is available in a pamphlet entitled \"Borderline Personality Disorder\" - National Institutes of Health Publication No. 01-4928. This publication is useful for patients, families and significant others, and can be obtained through a toll-free number, 866-615-646, or online at the web site",
"    <a class=\"external\" href=\"file://wwwapps.nimh.nih.gov/health/publications/borderline-personality-disorder.shtml\">",
"     file://wwwapps.nimh.nih.gov/health/publications/borderline-personality-disorder.shtml",
"    </a>",
"    . &nbsp;",
"   </p>",
"   <p>",
"    More comprehensive information about the illness is provided in books available at online bookstores:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Borderline Personality Disorder Demystified, written by Robert O. Friedel, M.D., published by Marlowe and Company, 2004",
"     </li>",
"     <li>",
"      Get Me Out of Here: My Recovery from Borderline Personality Disorder, written by Rachel Reiland, published by Hazelden, 2004",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, there are books written specifically for families and significant others available at online bookstores. These are useful since patients tend to externalize and blame others for their problems.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stop Walking on Eggshells: Taking Your Life Back When Someone You Care About Has Borderline Personality Disorder, written by Paul T. Mason and Randi Kreger, published by New Harbinger Publications, Inc., 1998",
"     </li>",
"     <li>",
"      Understanding and Treating Borderline Personality Disorder: A Guide for Professionals and Families, edited by John G. Gunderson and Perry D. Hoffman, published by American Psychiatric Publishing, Inc., 2005",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are two national organizations whose mission is to educate members about BPD, including how to cope with the disorder. Other functions include increasing public awareness of the illness and advocating for more research and services. The organizations are administered and maintained by patients and family members, and have local chapters.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The National Education Alliance for Borderline Personality Disorder (",
"      <a class=\"external\" href=\"file://www.borderlinepersonalitydisorder.com/\">",
"       www.borderlinepersonalitydisorder.com",
"      </a>",
"      or 914-835-9011)",
"     </li>",
"     <li>",
"      Treatment and Research Advancements National Association for Personality Disorder (",
"      <a class=\"external\" href=\"file://www.tara4bpd.org/\">",
"       www.tara4bpd.org",
"      </a>",
"      or 212-966-6514)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The National Alliance on Mental Illness (",
"    <a class=\"external\" href=\"file://www.nami.org/\">",
"     www.nami.org",
"    </a>",
"    or 800-950-6264) is a similarly structured organization devoted to providing education, support, and advocacy for patients with mental illnesses. BPD is one of their priority mental disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND FUNCTIONING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for patients with borderline personality disorder (BPD) is changing with the application of various psychotherapies designed specifically to treat the disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. In addition, the course of illness may be more positive than what was previously thought [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Thus, attitudes regarding the chronicity of BPD and beliefs that these patients never improve need to be revised in light of data from follow-up studies that demonstrate some patients recover.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Syndromal remission",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of remission in BPD has been found to range from 50 to 90 percent, depending upon the length of follow-up.",
"   </p>",
"   <p>",
"    A review of longitudinal studies with a wide range of follow-up intervals calculated a weighted average and found remission occurred in 45 percent of patients with BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/43\">",
"     43",
"    </a>",
"    ]. Other prospective longitudinal studies found remission rates of 50 to 54 percent during two to four years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Higher remission rates have been found with longer follow-up. A longitudinal study prospectively enrolled 290 patients with BPD and interviewed them every two years for up to 16 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/41,42,46\">",
"     41,42,46",
"    </a>",
"    ]. Of the 275 patients with at least one follow-up interview, diagnostic remission (defined as no longer meeting full diagnostic criteria for BPD for at least two years) was achieved by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      35 percent within two years of study intake",
"     </li>",
"     <li>",
"      93 percent within ten years of study intake",
"     </li>",
"     <li>",
"      99 percent within 16 years of study intake",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The duration of remission was prolonged for many patients. Seventy-eight percent achieved a remission that lasted for at least eight years.",
"   </p>",
"   <p>",
"    This study found seven variables were associated with a significantly shorter time to remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age 25 or younger (OR 1.46)",
"     </li>",
"     <li>",
"      Good functioning at work or school in the two years prior to study intake (OR 1.61)",
"     </li>",
"     <li>",
"      No history of childhood sexual abuse (OR 1.43)",
"     </li>",
"     <li>",
"      No family history of substance abuse (OR 1.40)",
"     </li>",
"     <li>",
"      Absence of comorbid anxious cluster Axis II disorder (OR 1.49)",
"     </li>",
"     <li>",
"      Low neuroticism (OR 0.97)",
"     </li>",
"     <li>",
"      High agreeableness and affiliating tendencies (OR 1.04)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another longitudinal study found that 85 to 91 percent of patients with BPD had experienced remission at a ten year follow-up assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/47\">",
"     47",
"    </a>",
"    ]. The first rate was determined using a definition of remission that required 12 consecutive months with the patient meeting two or fewer diagnostic criteria for BPD; the second rate was determined using a definition requiring two consecutive months with minimal symptoms, with the most significant change occurring during the early years. At ten years, 12 percent of patients with BPD who had met the 12-month criteria for remission relapsed. Twenty one percent of patients meeting the two-month remission criteria relapsed.",
"   </p>",
"   <p>",
"    There is conflicting evidence on whether baseline severity of borderline psychopathology predicts remission. Severity of illness, quantified in one study by the score on a semistructured clinical interview, was not significantly associated with time to remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/41\">",
"     41",
"    </a>",
"    ]. In a second study, greater numbers of diagnostic criteria were significantly associated with poorer outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/48\">",
"     48",
"    </a>",
"    ]. The discrepancy may be explained at least in part by differing definitions of remission.",
"   </p>",
"   <p>",
"    The presence of comorbid Axis I psychopathology may not decrease the rate of remission in BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/10,41\">",
"     10,41",
"    </a>",
"    ]. As an example, one longitudinal study found the remission rate of BPD was not significantly different in patients with and without comorbid major depression (39 versus 53 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The durability of remission from BPD is not known. Longitudinal studies have not addressed the issue of recurrence, or whether there are any factors such as treatment that prolong remission.",
"   </p>",
"   <p>",
"    The high remission rates seen in these studies call into question the definition of BPD as a stable and enduring pattern of maladaptive traits. This has led some authorities to reconceptualize personality disorders as hybrids of stable personality traits and intermittently expressed symptomatic behaviors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective longitudinal study of 290 patients with borderline personality disorder, found that patients experienced improvement in mean scores of defensive functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/50\">",
"     50",
"    </a>",
"    ]. At entry into the study, patients with borderline personality disorder had a lower mean score on the Defense Style Questionnaire on one mature defense mechanism (suppression) and higher mean scores on one neurotic-level, four immature, and two",
"    <span class=\"nowrap\">",
"     image-distorting/borderline",
"    </span>",
"    defenses, compared to a control group of 72 patients with other personality disorders. Over the course of the study, borderline patients showed improvement on 13 of 19 defenses, including higher mean scores on one mature defense (anticipation) and lower mean scores on 12 neurotic-level, immature, or",
"    <span class=\"nowrap\">",
"     image-distorting/borderline",
"    </span>",
"    defenses, as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurotic defenses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Isolation",
"     </li>",
"     <li>",
"      Undoing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immature defenses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acting out",
"     </li>",
"     <li>",
"      Denial",
"     </li>",
"     <li>",
"      Emotional hypochondriasis",
"     </li>",
"     <li>",
"      Fantasy",
"     </li>",
"     <li>",
"      Passive aggression",
"     </li>",
"     <li>",
"      Projection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Image-distorting/borderline",
"      </span>",
"      defenses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Devaluation",
"     </li>",
"     <li>",
"      Omnipotence",
"     </li>",
"     <li>",
"      Projective identification",
"     </li>",
"     <li>",
"      Splitting",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107688961\">",
"    <span class=\"h2\">",
"     Recovery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sixty percent of patients in the cohort described above experienced recovery from BPD lasting for at least 2 years over a 16-year period, while 40 percent attained and maintained recovery for at least eight years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/46\">",
"     46",
"    </a>",
"    ]. Criteria constituting recovery included maintaining all of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Remission from symptoms",
"     </li>",
"     <li>",
"      At least one emotionally sustaining relationship with a close friend, life partner, or spouse",
"     </li>",
"     <li>",
"      Consistent and competent engagement in school or work (including work as a homemaker)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Psychosocial functioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the general diagnostic criteria for a personality disorder is impairment in social, occupational, or other important areas of functioning (",
"    <a class=\"graphic graphic_table graphicRef78113 \" href=\"mobipreview.htm?38/41/39579\">",
"     table 2",
"    </a>",
"    ). An observational study of patients with BPD found that at the time of enrollment, occupational and interpersonal functioning were each severely impaired in more than 50 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/51\">",
"     51",
"    </a>",
"    ]. Overall psychosocial functioning was severely impaired in significantly more patients with BPD compared to patients with major depression in the absence of personality disorder (47 versus 19 percent).",
"   </p>",
"   <p>",
"    Improvement in psychosocial functioning follows improvement in symptoms, but the short-term prognosis for psychosocial functioning is poor. A prospective longitudinal study found that over two years, patients with BPD showed no functional improvement overall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/52\">",
"     52",
"    </a>",
"    ]. However, some patients who experienced a decrease in personality psychopathology showed significant improvement in social adjustment, employment, and recreation.",
"   </p>",
"   <p>",
"    Another prospective longitudinal study of BPD assessed psychosocial functioning at baseline and every two years for up to six years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/53\">",
"     53",
"    </a>",
"    ]. Good overall psychosocial functioning was defined as at least one close, emotionally sustaining relationship that involved contact one or more times per week, plus good work or school performance for at least 50 percent of the study period. Results from the four assessments showed the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The proportion of patients who achieved good psychosocial functioning improved steadily and significantly from baseline to year six (26 to 33 to 48 to 56 percent)",
"     </li>",
"     <li>",
"      At year six, good psychosocial functioning occurred significantly more often in patients who remitted from BPD compared to those who did not (66 versus 27 percent)",
"     </li>",
"     <li>",
"      Younger age and higher socioeconomic status were also significantly associated with good overall psychosocial functioning.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Higher rates of improvement in psychosocial functioning can occur with additional time. Assessment 10 to 15 years after psychiatric hospitalization found that approximately 50 to 75 percent of middle class and upper middle class BPD patients achieved stable full-time employment, and 50 percent of women and 25 percent of men married or developed a long-term sexual relationship [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434954279\">",
"    <span class=\"h2\">",
"     Recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrence is common in patients who remit (no longer meet full diagnostic criteria for BPD for at least two years) and also attain good social and vocational functioning. In a study of 275 patients followed for up to 10 years, 50 percent eventually remitted and achieved good psychosocial functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/42\">",
"     42",
"    </a>",
"    ]. However, loss of recovery (recurrence of BPD, poor social functioning, or poor vocational functioning) subsequently occurred in 34 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     OTHER RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional resources for treating patients with BPD are available in the form of practice guidelines from the National Institute for Health and Clinical Excellence (2009, United Kingdom) and the American Psychiatric Association (2001) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5,13,27\">",
"     5,13,27",
"    </a>",
"    ]. The guidelines focus upon specific treatment strategies, and also address clinical features of the illness, assessment of patients, diagnosis, and course of illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/10/16546?source=see_link\">",
"       \"Patient information: Borderline personality disorder (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment should focus upon borderline personality disorder (BPD) even if a comorbid Axis I disorder is present, because remission of both disorders often depends upon first successfully treating the BPD. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Principles of treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend psychotherapy for all patients with BPD (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Treatment should continue for a minimum of 20 weeks. Several types of psychotherapy are efficacious in BPD:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Cognitive-behavioral therapy",
"     </li>",
"     <li>",
"      Dialectical behavioral therapy,",
"     </li>",
"     <li>",
"      Mentalization-based therapy",
"     </li>",
"     <li>",
"      Schema-focused therapy",
"     </li>",
"     <li>",
"      Systems training for emotional predictability and problem solving",
"     </li>",
"     <li>",
"      Transference-focused psychotherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the absence of head-to-head trials demonstrating meaningful differences, and variable availability of specific psychotherapies, the choice depends upon local expertise and patient preference. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Psychotherapy principles and practices'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Specific psychotherapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who experience symptoms of dysregulation (lability, inappropriate anger, and dysphoria), impulsivity and aggression, or cognitive-perceptual problems in combination with difficulty in interpersonal functioning despite receiving evidence-based psychotherapy, we suggest the addition of adjunctive pharmacotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Pharmacotherapy is aimed at reducing these symptoms, but is not a cure for BPD. Patients should be monitored for medication side effects, such as weight gain. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Specific symptoms to treat with medications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For most patients with BPD treated with pharmacotherapy, we suggest mood stabilizers or antipsychotics rather than antidepressants (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Mood stabilizers and antipsychotics appear to have larger clinical effects upon a broader range of symptoms. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Specific pharmacotherapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For BPD patients with affective dysregulation, impulsivity and aggression, and interpersonal problems, mood stabilizers such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      provide moderate to large clinical effects. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Specific pharmacotherapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For BPD patients with affective dysregulation, impulsivity and aggression, interpersonal problems, and cognitive-perceptual symptoms, antipsychotics such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/11/43193?source=see_link\">",
"       aripiprazole",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"       haloperidol",
"      </a>",
"      provide moderate to large clinical effects. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Specific pharmacotherapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For BPD patients with comorbid disorders that are known to respond to antidepressants, such as major depression, panic disorder, and posttraumatic stress disorder, it is reasonable to use an antidepressant. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=see_link\">",
"       \"Initial treatment of depression in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33239?source=see_link\">",
"       \"Pharmacotherapy for posttraumatic stress disorder\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=see_link\">",
"       \"Pharmacotherapy for panic disorder\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psychoeducation should also be provided as part of psychotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Pamphlets and books are available from numerous sources. Clinicians should also refer patients and families to support and advocacy groups. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Psychoeducation and patient information'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The course of illness is heterogeneous. The rate of remission is about 50 percent during two to four years of follow-up. While the rate of remission (defined as no longer meeting full diagnostic criteria for BPD) increases to nearly 90 percent within 10 years of follow-up, remission is most robust during the initial two years of follow-up. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Syndromal remission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic remission is significantly associated with eventual improvement in psychosocial functioning. Over 50 percent of patients achieve good overall psychosocial functioning during six years of follow-up. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Psychosocial functioning'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/1\">",
"      Stern, A. Psychoanalytic investigation of and therapy in the borderline group of neuroses. Psychoanal Q 1938; 7:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/2\">",
"      Bender DS, Skodol AE, Pagano ME, et al. Prospective assessment of treatment use by patients with personality disorders. Psychiatr Serv 2006; 57:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/3\">",
"      Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001; 158:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/4\">",
"      Blashfield RK, Intoccia V. Growth of the literature on the topic of personality disorders. Am J Psychiatry 2000; 157:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/5\">",
"      American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001; 158:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/6\">",
"      Paris J. The treatment of borderline personality disorder: implications of research on diagnosis, etiology, and outcome. Annu Rev Clin Psychol 2009; 5:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/7\">",
"      Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord 2008; 22:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/8\">",
"      Silk, KR, Eisner, W, Allport, C, et al. Focused time-limited inpatient treatment of borderline personality disorder. J Personal Disorders 1994; 8:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/9\">",
"      Silk, KR, Lohr, NE, Westen, D, Goodrich, S. Psychosis in borderline patients with depression. J Personal Disorders 1989; 3:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/10\">",
"      Gunderson JG, Morey LC, Stout RL, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry 2004; 65:1049.",
"     </a>",
"    </li>",
"    <li>",
"     Gunderson, JG. Borderline Personality Disorder. American Psychiatric Press, Washington DC 1984.",
"    </li>",
"    <li>",
"     Pfohl B, Gunderson J, Silk, K, et al. Staff attitudes towards Borderline Personality Disorder, (Scientific Research Report) American Psychiatric Association, Annual Meeting, Washington, DC 1999.",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Borderline Personality Disorder: Treatment and Management. 2009. file://www.nice.org.uk/CG78. Accessed 2/12/10.",
"    </li>",
"    <li>",
"     Linehan, MM. Cognitive behavioral treatment of borderline personality disorder. Guilford Press, New York 1993.",
"    </li>",
"    <li>",
"     Ogden, T. Projective Identification and Therapeutic Technique, Jason Aronson, New York,1982.",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), Fourth edition, Text revision, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/17\">",
"      Zanarini MC, Vujanovic AA, Parachini EA, et al. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord 2003; 17:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/18\">",
"      Stoffers JM, V&ouml;llm BA, R&uuml;cker G, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2012; 8:CD005652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/19\">",
"      Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006; 63:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/20\">",
"      Giesen-Bloo J, van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006; 63:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/21\">",
"      Davidson K, Norrie J, Tyrer P, et al. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord 2006; 20:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/22\">",
"      Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry 2008; 165:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/23\">",
"      Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry 2007; 164:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/24\">",
"      Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 2009; 166:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/25\">",
"      Blum N, St John D, Pfohl B, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry 2008; 165:468.",
"     </a>",
"    </li>",
"    <li>",
"     Bateman, A, Zanarini, MC. Personality disorders. In: Cambridge Textbook of Effective Treatments in Psychiatry, Tyrer, P, Silk, KR (Eds), Cambridge University Press, Cambridge 2008. p.659.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/27\">",
"      Kendall, T, Pilling, S, Tyrer, P, et al. Borderline and antisocial personality disorders: summary of NICE recommendations. BMJ 2009; 338:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/28\">",
"      McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry 2009; 166:1365.",
"     </a>",
"    </li>",
"    <li>",
"     Paris, J. Treatment of Borderline Personality Disorder: A Guide to Evidence-Based Practice, Guilford, New York, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/30\">",
"      Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatr Clin North Am 2000; 23:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/31\">",
"      Nos&egrave; M, Cipriani A, Biancosino B, et al. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 2006; 21:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/32\">",
"      Ingenhoven T, Lafay P, Rinne T, et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry 2010; 71:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/33\">",
"      Lieb K, V&ouml;llm B, R&uuml;cker G, et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010; 196:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/34\">",
"      Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord 2009; 23:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/35\">",
"      Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry 2007; 8:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/36\">",
"      Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry 2001; 42:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/37\">",
"      Westen, D, Moses, MJ, Silk, KR, et al. Quality of depressive experience in borderline personality disorder and major depression: when depression is not just depression. J Personal Disord 1992; 6:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/38\">",
"      Gabbard GO. Do all roads lead to Rome? New findings on borderline personality disorder. Am J Psychiatry 2007; 164:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/39\">",
"      Silk KR. Augmenting psychotherapy for borderline personality disorder: the STEPPS program. Am J Psychiatry 2008; 165:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/40\">",
"      Levy KN. Psychotherapies and lasting change. Am J Psychiatry 2008; 165:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/41\">",
"      Zanarini MC, Frankenburg FR, Hennen J, et al. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry 2006; 163:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/42\">",
"      Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry 2010; 167:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/43\">",
"      Skodol AE, Siever LJ, Livesley WJ, et al. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry 2002; 51:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/44\">",
"      Kleindienst N, Limberger MF, Schmahl C, et al. Do improvements after inpatient dialectial behavioral therapy persist in the long term? A naturalistic follow-up in patients with borderline personality disorder. J Nerv Ment Dis 2008; 196:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/45\">",
"      Skodol AE, Bender DS, Pagano ME, et al. Positive childhood experiences: resilience and recovery from personality disorder in early adulthood. J Clin Psychiatry 2007; 68:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/46\">",
"      Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 2012; 169:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/47\">",
"      Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry 2011; 68:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/48\">",
"      Gunderson JG, Daversa MT, Grilo CM, et al. Predictors of 2-year outcome for patients with borderline personality disorder. Am J Psychiatry 2006; 163:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/49\">",
"      Skodol AE, Gunderson JG, Shea MT, et al. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord 2005; 19:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/50\">",
"      Zanarini MC, Frankenburg FR, Fitzmaurice G. Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery. Am J Psychiatry 2013; 170:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/51\">",
"      Skodol AE, Gunderson JG, McGlashan TH, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry 2002; 159:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/52\">",
"      Skodol AE, Pagano ME, Bender DS, et al. Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 2005; 35:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42009/abstract/53\">",
"      Zanarini MC, Frankenburg FR, Hennen J, et al. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord 2005; 19:19.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6618 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-1B6D22AFDF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42009=[""].join("\n");
var outline_f41_1_42009=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL TREATMENT GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Treatment setting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Principles of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Treatment team",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H345914986\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Psychotherapy principles and practices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Specific psychotherapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Cognitive-behavioral therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Dialectical behavior therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Mentalization-based therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Schema-focused therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Systems training for emotional predictability and problem solving",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Transference-focused therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sequencing or combining psychotherapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PHARMACOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pharmacotherapy principles and practices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Specific symptoms to treat with medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Specific pharmacotherapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Mood stabilizers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Antipsychotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Antidepressants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PSYCHOEDUCATION AND PATIENT INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PROGNOSIS AND FUNCTIONING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Syndromal remission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107688961\">",
"      Recovery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Psychosocial functioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H434954279\">",
"      Recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      OTHER RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/6618\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/6618|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/42/43691\" title=\"table 1\">",
"      DSM-IV-TR BPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/41/39579\" title=\"table 2\">",
"      Criteria personality disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10553?source=related_link\">",
"      Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/10/16546?source=related_link\">",
"      Patient information: Borderline personality disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40824?source=related_link\">",
"      Personality disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=related_link\">",
"      Pharmacotherapy for panic disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33239?source=related_link\">",
"      Pharmacotherapy for posttraumatic stress disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42010="Initial prenatal assessment and patient education";
var content_f41_1_42010=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial prenatal assessment and patient education",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Urania Magriples, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/1/42010/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/1/42010/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major goal of prenatal care is to ensure the birth of a healthy baby with minimal risk for the mother. There are several components involved in achieving this objective:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Early, accurate estimation of gestational age",
"     </li>",
"     <li>",
"      Identification of the patient at risk for complications",
"     </li>",
"     <li>",
"      Ongoing evaluation of the health status of both mother and fetus",
"     </li>",
"     <li>",
"      Anticipation of problems and intervention, if possible, to prevent or minimize morbidity",
"     </li>",
"     <li>",
"      Patient education and communication",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ideally, prenatal care is initiated by 10 weeks of gestation. The percentage of pregnant women who initiate prenatal care in the first trimester is one of the standard clinical performance measures used to assess the quality of maternal health care. In the United States (2008), approximately 71 percent of pregnant women obtained prenatal care in the first trimester, but 7 percent received no care or initiated prenatal care in the third trimester [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal individual components of prenatal care have not been rigorously examined in randomized trials, but composite prenatal care programs have been studied. In 1995, a systematic review of observational studies and randomized trials concluded there was no conclusive evidence that routine prenatal care improved birth outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/2\">",
"     2",
"    </a>",
"    ]. Randomized trials comparing routine prenatal care with enhanced prenatal care (eg, extra office visits, health education, home visits, telephone contact, psychosocial support) for women with high risk pregnancies by various criteria found enhanced care did not significantly improve outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Moreover, a randomized trial that compared routine prenatal care with a model that reduced prenatal care visits for low risk women found a reduction in care did not adversely affect outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Large randomized trials are essential for determining the optimal components of prenatal care. Observational studies comparing pregnancy outcomes in women who receive and do not receive prenatal care are consistently confounded by socioeconomic and other factors that influence access to prenatal care and",
"    <span class=\"nowrap\">",
"     maternal/perinatal",
"    </span>",
"    outcome. In the developing world, if prenatal care is not readily available, then adequate delivery of other health care and social services often also are not readily available. This is important since complications resulting in serious morbidity or mortality are most likely to occur at delivery. In addition, prenatal care is not a single intervention; instead, it represents a series of assessments and interventions over time that is not uniformly applied by different practitioners. Although the \"quantity\" of prenatal care is relatively easy to measure (ie, timing and number of visits adjusted for gestational age at delivery), the \"quality\" of prenatal care and the effect of individual components on outcome are quite difficult to measure. Defining outcomes is also not straightforward, as pregnancy has several measurable maternal, fetal, and neonatal outcomes. Lastly, most studies do not possess the sample size necessary to detect statistically significant differences in the outcomes evaluated.",
"   </p>",
"   <p>",
"    The following discussion relates primarily to prenatal care in the United States. Many of these issues are common to pregnancies worldwide. However, some issues that are highly important in other parts of the world, such as tetanus and malaria prophylaxis, are not discussed here, but are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16921?source=see_link\">",
"     \"Overview of malaria in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/11/7353?source=see_link\">",
"     \"Tetanus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12840240\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists (ACOG) and others have published guidelines for prenatal care in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. National organizations in other countries have also published guidelines for routine prenatal care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Some of the major differences among guidelines are whether they take a risk-factor-based approach to screening for some disorders (eg, chlamydia, diabetes) versus universal screening, and the available resources in the country. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CARE PROVIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, midwives are the lead maternity care providers for 8 to 9 percent of women during pregnancy and childbirth, family physicians are the lead maternity care providers for 6 to 7 percent of women, and obstetrician-gynecologists care for most of the remainder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/12\">",
"     12",
"    </a>",
"    ]. The different types of prenatal care providers have been studied:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A systematic review evaluated three randomized trials of",
"      <span class=\"nowrap\">",
"       midwife/general",
"      </span>",
"      practitioner-managed care compared to",
"      <span class=\"nowrap\">",
"       obstetrician/gynecologist-led",
"      </span>",
"      shared care of low risk women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/13\">",
"       13",
"      </a>",
"      ]. The clinical efficacy of the two groups was similar; however, women favored midwife-led care and, in some countries, there was a cost reduction if antenatal care was provided by staff other than an",
"      <span class=\"nowrap\">",
"       obstetrician/gynecologist.",
"      </span>",
"     </li>",
"     <li>",
"      Another systematic review compared clinical trials of midwife-led",
"      <span class=\"nowrap\">",
"       antepartum/intrapartum",
"      </span>",
"      care with other models of care and also found several benefits to midwife-led care (eg, more natural childbirths); perinatal mortality was similar for both groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third systematic review of three trials performed in the United States concluded that although specialized antenatal clinics (eg, women at high risk of preterm birth) were an accepted part of care in many settings, there was no clear evidence that these clinics improved outcome (eg, reduced the number of preterm births) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/15\">",
"       15",
"      </a>",
"      ]. However, available data were insufficient to make definitive conclusions and well-designed studies are needed.",
"     </li>",
"     <li>",
"      In developing countries, a systematic review of randomized trials and controlled studies found that training and support of traditional birth attendants significantly reduced perinatal and neonatal deaths, and resulted in a non-significant trend in reduction of maternal mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GROUP PRENATAL CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group prenatal care is an alternative means of providing prenatal care in which participants with the same month of expected delivery receive the majority of their care in a group setting. The only private time between patient and clinician is during the initial prenatal assessment, when health concerns involving need for privacy arise, and during cervical assessment late in pregnancy. At each prenatal visit, participants measure their own weight and blood pressure and update their medical records. Individual prenatal assessments (eg, fundal height, fetal heart rate) are performed by a clinician within the group space. The majority of the visit, which may last two hours, involves facilitated group discussion, education, and skills building to address explicit learning objectives in prenatal care, childbirth preparation, and postpartum and parenting roles. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11030?source=see_link\">",
"     \"Group prenatal care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;One goal of prenatal care is identification of women at increased risk of medical complications, pregnancy complications, or fetal abnormalities. Early identification of these women gives the provider an opportunity to discuss these issues and their management with the patient and, in some cases, offer interventions to minimize the risk of an adverse outcome. Ideally, this process is initiated prior to pregnancy during a preconception consultation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=see_link\">",
"     \"Preconception evaluation and counseling\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;At or prior to the first prenatal visit, the patient should complete a questionnaire detailing her social, medical, obstetrical, and family history. This information can be used to start an obstetrical record that will record her prenatal, intrapartum, and postpartum course. Several paper and computerized obstetrical record forms are commercially available for this purpose. They help to ensure complete and systematic documentation of the pregnancy and often may be used for risk-assessment planning.",
"   </p>",
"   <p>",
"    The elements of the patient history include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Personal and demographic information (",
"      <a class=\"graphic graphic_table graphicRef62280 \" href=\"mobipreview.htm?11/56/12171\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Past obstetrical history (",
"      <a class=\"graphic graphic_table graphicRef50272 \" href=\"mobipreview.htm?37/27/38331\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Personal and family medical history (",
"      <a class=\"graphic graphic_table graphicRef72734 \" href=\"mobipreview.htm?33/30/34285\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Past surgical history",
"     </li>",
"     <li>",
"      Genetic history",
"      <span class=\"nowrap\">",
"       (www.marchofdimes.com/Your_family_health_historypreconceptionprenatal.pdf)",
"      </span>",
"     </li>",
"     <li>",
"      Menstrual and gynecological history (",
"      <a class=\"graphic graphic_table graphicRef51691 \" href=\"mobipreview.htm?2/39/2683\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Current pregnancy history (",
"      <a class=\"graphic graphic_table graphicRef59001 \" href=\"mobipreview.htm?3/50/3883\">",
"       table 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Psychosocial information",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The American College of Obstetricians and Gynecologists (ACOG) and the American Medical Association (AMA) guidelines on domestic violence recommend that physicians routinely assess all pregnant women for domestic violence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The clinician should be aware of markers and characteristics of abuse, such as bruising, improbable injury, depression, late prenatal care (presentation after the first trimester), missed prenatal visits, and appointments cancelled on short notice. Exposure to domestic violence is associated with an increased risk of low",
"    <span class=\"nowrap\">",
"     birthweight/preterm",
"    </span>",
"    birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/20\">",
"     20",
"    </a>",
"    ]. Counseling and intervention can reduce intimate partner violence and improve pregnancy outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/41/5784?source=see_link&amp;anchor=H86601695#H86601695\">",
"     \"Intimate partner violence: Epidemiology and health consequences\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6393?source=see_link\">",
"     \"Intimate partner violence: Diagnosis and screening\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/54/14183?source=see_link\">",
"     \"Intimate partner violence: Intervention and patient management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Psychosocial issues of potential concern that should be identified and discussed with the patient include: whether the pregnancy was planned or unintended, potential barriers to care (eg, communication, transportation, child care issues, economic constraints, work schedule), whether the patient has stable housing, and her mental health and level of stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/22\">",
"     22",
"    </a>",
"    ]. This is an opportunity to provide information and, if indicated, make suggestions for possible changes or referral.",
"   </p>",
"   <p>",
"    After obtaining a complete history, a \"problem list\" is generated. These lists are useful for preventing the inadvertent omission of necessary maternal or fetal monitoring and interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Estimated date of delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tentative estimated date of delivery (EDD) can be calculated from the menstrual history in women with 28-day cycles by adding seven days to the first day of the last menstrual period (LMP) and then subtracting three months (Naegele&rsquo;s rule). As an example, if the last menstrual period is February 20th, then the EDD will be November 27th. If the last menstrual period is May 28th, the EDD will be March 4th.",
"   </p>",
"   <p>",
"    Accurate dating is crucial for managing the pregnancy, especially with regard to timing interventions and monitoring fetal growth. Sonographic estimation of the EDD is mandatory when menses are irregular, the LMP is unknown or uncertain, or in patients conceiving while taking oral contraceptive pills. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=see_link\">",
"     \"Prenatal assessment of gestational age\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Routine use of this test appears to be useful in the general obstetrical population, as well (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Ultrasound examination'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline blood pressure, weight, and height should be recorded as part of the examination. Calculating body mass index (BMI) helps to identify at risk populations and enables counseling of the amount of appropriate weight gain in pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19304?source=see_link\">",
"     \"Weight gain and loss in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/11/29882?source=see_link\">",
"     \"The impact of obesity on fertility and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the baseline blood pressure is borderline high, the clinician should attempt to find records of prepregnancy blood pressures to document whether the patient has chronic hypertension. This information can be important in establishing the correct diagnosis if blood pressure increases in the second half of pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=see_link&amp;anchor=H15110283#H15110283\">",
"     \"Preeclampsia: Clinical features and diagnosis\", section on 'Preexisting hypertension versus mild preeclampsia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A complete physical examination should be performed, with special attention to uterine size and shape and evaluation of the adnexa. When the uterine size on physical examination differs from that predicted by menstrual dating, sonographic assessment is indicated. Some causes for a discrepancy between the actual uterine size and that expected by LMP include uterine fibroids, uterine malposition (eg, retroverted uterus), multiple gestation, and incorrect date of LMP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=see_link\">",
"     \"Prenatal assessment of gestational age\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sonography is also useful for evaluating suspected adnexal masses and uterine fibroids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=see_link\">",
"     \"Approach to the patient with an adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When cardiac activity is present, the fetal heart can usually be heard by 12 weeks of gestation using a Doppler instrument. Transvaginal ultrasound can identify fetal cardiac motion as early as 5.5 weeks (",
"    <a class=\"graphic graphic_table graphicRef83304 \" href=\"mobipreview.htm?4/2/4139\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Experienced examiners can detect a very contracted pelvis, but clinical pelvimetry is not sufficiently reliable to identify women likely to experience labor abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LABORATORY TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suspected pregnancy should be confirmed by laboratory evaluation, in the absence of diagnostic physical findings (confirmation of pregnancy by ultrasound examination or identification of fetal cardiac activity). The standard test is the detection of the beta-subunit of human chorionic gonadotropin (hCG) in blood or urine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/48/44808?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Routine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A standard panel of laboratory tests should be obtained on every pregnant woman at the first prenatal visit. This panel can be augmented by additional testing of women at risk for specific conditions (see",
"    <a class=\"local\" href=\"#H12\">",
"     'At-risk women'",
"    </a>",
"    below). Repetition of tests performed preconceptionally is unnecessary. In the United States, the standard panel typically consists of the following tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1272361\">",
"    <span class=\"h3\">",
"     Rhesus type and antibody screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test will detect antibodies potentially causing hemolytic disease of the newborn. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32982?source=see_link\">",
"     \"Overview of Rhesus (Rh) alloimmunization in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/21/5464?source=see_link\">",
"     \"Management of pregnancy complicated by Rhesus (Rh) alloimmunization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/27/3513?source=see_link\">",
"     \"Significance of minor red blood cell antibodies during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rh(D)-negative women without alloantibodies should receive anti(D)-immune globulin, as indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/44/40648?source=see_link\">",
"     \"Prevention of Rh(D) alloimmunization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1272450\">",
"    <span class=\"h3\">",
"     Hematocrit or hemoglobin and mean corpuscular volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hematocrit or hemoglobin level and mean corpuscular volume (MCV) detect anemia and provide screening for thalassemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/24\">",
"     24",
"    </a>",
"    ]. An MCV &lt;80 femtoliters (fL) in the absence of iron deficiency suggests thalassemia; further testing with hemoglobin electrophoresis is indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21703?source=see_link&amp;anchor=H4#H4\">",
"     \"Hematologic changes in pregnancy\", section on 'Anemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=see_link\">",
"     \"Prenatal testing for the hemoglobinopathies and thalassemias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1272458\">",
"    <span class=\"h3\">",
"     Cervical cytology cancer screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical cancer screening is performed in women who are age 21 years or older who are due for screening according to standard guidelines. Pregnancy is not an indication for a change in the frequency of cervical cancer screening, but management of an abnormal test is different for pregnant women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link\">",
"     \"Screening for cervical cancer: Rationale and recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=see_link&amp;anchor=H23#H23\">",
"     \"Cervical intraepithelial neoplasia: Management\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6826?source=see_link\">",
"     \"Cervical cancer in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1272465\">",
"    <span class=\"h3\">",
"     Rubella immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunity to rubella should be determined (eg, documented verification of infection by a health care provider, documented vaccination, or laboratory evidence of immunity). If nonimmune, the patient should be counseled to avoid exposure to individuals with rubella and receive postpartum immunization. Once documentation of immunity to rubella as a result of infection or immunization has been obtained, repeat testing is unnecessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6087?source=see_link\">",
"     \"Rubella in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276165\">",
"    <span class=\"h3\">",
"     Varicella immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunity to varicella should be determined (eg, a healthcare provider's diagnosis of varicella or verification of history of varicella disease, documented vaccination, or laboratory evidence of immunity). Women who do not have evidence of immunity to varicella should be counseled to avoid exposure to individuals with varicella, may be candidates for passive immunization during pregnancy if exposed to varicella, and are candidates for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    postpartum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33225?source=see_link\">",
"     \"Varicella-zoster virus infection in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109279416\">",
"    <span class=\"h3\">",
"     Urine protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urine screening for proteinuria, such as with a dipstick, is useful as a baseline for comparison if assessment of renal function is performed later in pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276173\">",
"    <span class=\"h3\">",
"     Urine culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine urine culture is recommended because pregnant women with untreated asymptomatic bacteriuria are at high risk of developing pyelonephritis and rapid tests for bacteriuria do not have adequate sensitivity and specificity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=see_link&amp;anchor=H4#H4\">",
"     \"Urinary tract infections and asymptomatic bacteriuria in pregnancy\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment is per standard guidelines, except some clinicians treat group B streptococcal (GBS) bacteriuria regardless of colony count and presence of GBS is an indication for GBS prophylaxis in labor and delivery to prevent early onset neonatal infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=see_link&amp;anchor=H5#H5\">",
"     \"Urinary tract infections and asymptomatic bacteriuria in pregnancy\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43062?source=see_link&amp;anchor=H4#H4\">",
"     \"Group B streptococcal infection in pregnant women\", section on 'Asymptomatic bacteriuria'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    For women with asymptomatic bacteriuria, we suggest retesting monthly until delivery, or giving suppressive therapy for the remainder of pregnancy if they have recurrent or persistent bacteriuria. There are no strong data to guide the frequency of retesting or the optimum approach. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=see_link&amp;anchor=H11#H11\">",
"     \"Urinary tract infections and asymptomatic bacteriuria in pregnancy\", section on 'Suppressive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276310\">",
"    <span class=\"h3\">",
"     Syphilis testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cost and morbidity associated with testing for syphilis are low and the benefits of detecting and treating the disease are high for both mother and child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=see_link\">",
"     \"Syphilis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276336\">",
"    <span class=\"h3\">",
"     Hepatitis B antigen testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis B antigen screening is recommended for all pregnant women to prevent perinatal transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. This includes women who have been vaccinated because prevaccination screening to exclude acute or chronic infection is not commonly performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/31/4602?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology, transmission, and prevention of hepatitis B virus infection\", section on 'Perinatal transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276364\">",
"    <span class=\"h3\">",
"     Chlamydia testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Centers for Disease Control (CDC) and the American College of Obstetricians and Gynecologists (ACOG) recommend chlamydia screening for all pregnant women at the first prenatal visit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/23,26\">",
"     23,26",
"    </a>",
"    ]. The US Preventive Services Task Force (USPSTF) recommends limiting screening to women who are &le;24 years of age and older women who are at increased risk (eg, new or more than one sexual partner, history of sexually transmitted diseases, drug use). The National Screening Committee in the United Kingdom also does not recommend routinely screening all pregnant women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/29\">",
"     29",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Nucleic acid amplification tests (NAAT) have high sensitivity and excellent specificity for detection of C trachomatis, and are superior to culture. During prenatal care, the preferred approach is to test a specimen obtained from a swab of the endocervix or vagina, although urine testing appears to be as sensitive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26,30-34\">",
"     26,30-34",
"    </a>",
"    ]. Some NAATs have been cleared by the United States Food and Drug Administration for use on liquid-based cytology specimens. Positive results should be treated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276464\">",
"    <span class=\"h3\">",
"     Human immunodeficiency virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACOG supports universal human immunodeficiency virus (HIV) testing of pregnant women early in each pregnancy using an 'opt-out' approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/35\">",
"     35",
"    </a>",
"    ]. Other national organizations have also taken this approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26,36,37\">",
"     26,36,37",
"    </a>",
"    ]. Advantages of universal testing include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An informed decision can be made about continuing the pregnancy",
"     </li>",
"     <li>",
"      Appropriate medical management of the woman herself can be initiated",
"     </li>",
"     <li>",
"      Counseling for prevention of transmission to or identification of infected partners",
"     </li>",
"     <li>",
"      Perinatal transmission can be substantially reduced with appropriate intervention (eg, antiretroviral therapy antepartum and intrapartum, cesarean delivery, avoidance of breastfeeding). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=see_link\">",
"       \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/44/25290?source=see_link\">",
"       \"Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefit of the 'opt-out' approach over the 'opt-in' approach was illustrated in a study that found an opt-in policy was associated with testing rates of only 50 to 60 percent in some Canadian provinces due to patient refusal and physician failure to offer the test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/38\">",
"     38",
"    </a>",
"    ]. On the other hand, those provinces that chose an opt-out approach achieved high rates of testing, 95 to 100 percent. Similar success with the opt-out approach has been described in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some areas, local law requires that patient notification, as well as a signed consent form indicating permission for HIV testing, be obtained. The medical record should document the patient's decision to accept or decline testing. Reasons for refusal should be explored and testing offered at another time.",
"   </p>",
"   <p>",
"    Risk factors for acquiring HIV and serologic testing are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     At-risk women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional laboratory tests commonly performed in at-risk individuals are listed below. The health care provider should interpret the test results for the patient and discuss options for further evaluation or management. If a disorder is diagnosed, then the natural history of the disorder, risk of disease in offspring, and the woman's reproductive options should be discussed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/40\">",
"     40",
"    </a>",
"    ]. An abnormal result suggesting the presence of a heritable disorder is often an indication for referral for genetic counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276972\">",
"    <span class=\"h3\">",
"     Thyroid function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic development may be adversely affected in children born to mothers with hypothyroidism, while maternal hyperthyroidism can lead to fetal and maternal complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=see_link\">",
"     \"Treatment and prognosis of congenital hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/51/16186?source=see_link\">",
"     \"Overview of thyroid disease in pregnancy\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Professional societies (eg, ACOG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/41\">",
"     41",
"    </a>",
"    ], the Endocrine Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/42\">",
"     42",
"    </a>",
"    ], the American Thyroid Association [ATA] [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/43\">",
"     43",
"    </a>",
"    ]) recommend testing pregnant women for thyroid dysfunction if they have any of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Symptoms of thyroid disease",
"     </li>",
"     <li>",
"      Personal or family history of thyroid disease",
"     </li>",
"     <li>",
"      Characteristics that place them at high risk for overt hypothyroidism (eg, type 1 diabetes, history of",
"      <span class=\"nowrap\">",
"       head/neck",
"      </span>",
"      radiation, goiter,",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"        amiodarone",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"        lithium",
"       </a>",
"      </span>",
"      use, iodine deficiency)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some data suggest that this approach may miss many women with hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. For this reason, some experts recommend universal screening for thyroid dysfunction in pregnant women or those attempting to become pregnant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/51/16186?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of thyroid disease in pregnancy\", section on 'Screening'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    However, the clinical implications of failing to diagnose women with subclinical hypothyroidism are unclear. In a randomized trial, antenatal screening (at a median gestational age of",
"    <span class=\"nowrap\">",
"     12",
"     <sup>",
"      3/7",
"     </sup>",
"    </span>",
"    weeks) and maternal treatment for hypothyroidism did not result in improved cognitive function in children at 3 years of age compared with controls in whom blood was drawn and stored for testing after delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/48\">",
"     48",
"    </a>",
"    ]. Limitations of this trial included the mild degree of hypothyroidism, the insensitivity of cognitive testing of 3-year-olds, and initiation of maternal treatment at median age of",
"    <span class=\"nowrap\">",
"     13",
"     <sup>",
"      3/7",
"     </sup>",
"    </span>",
"    weeks, which may be too late since the fetal thyroid has begun to synthesize hormone at 12 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H362934781\">",
"    <span class=\"h3\">",
"     Type 2 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women at increased risk of diabetes, a diagnosis of overt diabetes can be made at the initial prenatal visit if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fasting plasma glucose &ge;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L],",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      A1C &ge;6.5 percent using a standardized assay, or",
"     </li>",
"     <li>",
"      Random plasma glucose &ge;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [11.1",
"      <span class=\"nowrap\">",
"       mmol/]",
"      </span>",
"      that is subsequently confirmed by elevated fasting plasma glucose or A1C.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some clinicians routinely screen for diabetes with A1C at the first prenatal visit, and repeat screening at 24 to 28 weeks in women with A1C&lt;6.5 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9210?source=see_link\">",
"     \"Screening and diagnosis of diabetes mellitus during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Testing for infection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832578\">",
"    <span class=\"h4\">",
"     N. gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women at risk for gonorrhea or living in an area in which the prevalence of",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    is high should be screened. Risk factors include women &lt;25 years of age, previous gonorrhea infection, other sexually transmitted disease (STDs), new or multiple sex partners, inconsistent condom use, commercial sex work, and drug use. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ]. Testing and management of positive test results are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832586\">",
"    <span class=\"h4\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women from populations recommended for tuberculosis screening should be screened with a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    or interferon-gamma release assay (IGRA). The CDC 2010 guidelines indicate that an IGRA can be used in place of a skin test in all situations in which CDC recommends a skin test as an aid in diagnosing M. tuberculosis infection. An IGRA is preferred for patients with history of Bacillus Calmette-Guerin (BCG) vaccination, and for individuals from groups that historically have poor rates of return for skin test reading. At-risk populations (",
"    <a class=\"graphic graphic_table graphicRef74584 \" href=\"mobipreview.htm?35/55/36732\">",
"     table 7",
"    </a>",
"    ), procedure for and interpretation of testing, and management of women with positive test results are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/26/29096?source=see_link\">",
"     \"Tuberculosis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832594\">",
"    <span class=\"h4\">",
"     Toxoplasmosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most common means of acquisition of toxoplasmosis are via environmental exposure (contaminated cat litter boxes or soil) and ingestion of undercooked meat from infected animals. Whether all pregnant women should undergo serological screening for toxoplasmosis is controversial. It is a routine practice in some areas of relatively high prevalence, such as France. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=see_link\">",
"     \"Toxoplasmosis and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832602\">",
"    <span class=\"h4\">",
"     Hepatitis C antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women at high risk for hepatitis C infection should be screened for hepatitis C antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ]. Several organizations have provided guidelines that describe criteria for considering an individual high risk. Despite having reviewed similar data, the various guidelines do not all agree, except that pregnancy alone is not an indication for testing. A summary of recommendations from the major organizations can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=see_link&amp;anchor=H2#H2\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\", section on 'Who should be tested'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832610\">",
"    <span class=\"h4\">",
"     Bacterial vaginosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for bacterial vaginosis is not recommended as a routine component of prenatal care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ]. Whether asymptomatic women with a history of prior preterm birth should be screened and treated, if positive, to lower the risk of recurrent preterm birth is controversial. Symptomatic women should be evaluated and treated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H18#H18\">",
"     \"Bacterial vaginosis\", section on 'Pregnant women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832618\">",
"    <span class=\"h4\">",
"     Trichomonas vaginalis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for Trichomonas is not recommended as a routine component of prenatal care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ]. Symptomatic women should be evaluated and treated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link&amp;anchor=H16#H16\">",
"     \"Trichomonas vaginalis\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link&amp;anchor=H6#H6\">",
"     \"Trichomonas vaginalis\", section on 'Pregnant women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832626\">",
"    <span class=\"h4\">",
"     Herpes simplex virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine screening for herpes simplex virus (HSV) infection in asymptomatic women is generally not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"     26",
"    </a>",
"    ], but this is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/50\">",
"     50",
"    </a>",
"    ]. Type-specific screening may be reasonable in asymptomatic partners of symptomatic men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12839588\">",
"    <span class=\"h4\">",
"     CMV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine serological screening for cytomegalovirus (CMV) in asymptomatic women is not recommended. Testing pregnant women for CMV is indicated as part of the diagnostic evaluation of mononucleosis-like illnesses (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=see_link&amp;anchor=H5#H5\">",
"     \"Infectious mononucleosis in adults and adolescents\", section on 'Clinical manifestations'",
"    </a>",
"    ), when a fetal anomaly suggestive of congenital CMV infection is detected on prenatal ultrasound examination (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link&amp;anchor=H14#H14\">",
"     \"Cytomegalovirus infection in pregnancy\", section on 'Prenatal diagnosis'",
"    </a>",
"    ), or if the woman requests the test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link&amp;anchor=H13#H13\">",
"     \"Cytomegalovirus infection in pregnancy\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2832634\">",
"    <span class=\"h4\">",
"     Chagas disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chagas disease is endemic to Latin America, thus the possibility of this infection should be considered in pregnant women who have lived in this region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Infected individuals are often unaware of their infection and the potential seriousness of the condition (eg,",
"    <span class=\"nowrap\">",
"     cardiovascular/digestive",
"    </span>",
"    complications, transmission to the fetus, hydrops fetalis). Prenatal screening is performed in some countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/59/14266?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Chagas heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23880?source=see_link&amp;anchor=H1618493691#H1618493691\">",
"     \"Epidemiology and control of Chagas disease\", section on 'Vertical transmission'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/34/551?source=see_link&amp;anchor=H541206333#H541206333\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Congenital Chagas disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Evaluation for inherited disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genetic history guides diagnostic screening and testing for heritable disorders. Some of these disorders are briefly discussed below. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/0/31751?source=see_link\">",
"     \"Basic principles of genetic counseling for the obstetrical provider\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892302\">",
"    <span class=\"h4\">",
"     Cystic fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information about cystic fibrosis screening should be available to all couples. Cystic fibrosis carrier screening especially should be offered to couples who are at increased risk because of Caucasian, European, or Ashkenazi Jewish ancestry. Cystic fibrosis counseling and carrier testing are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/62/22503?source=see_link\">",
"     \"Cystic fibrosis: Prenatal genetic screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892348\">",
"    <span class=\"h4\">",
"     Fragile X",
"    </span>",
"    &nbsp;&mdash;&nbsp;The population at risk includes, but is not limited to, individuals of either sex with intellectual disability, developmental delay, or autism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=see_link&amp;anchor=H15#H15\">",
"     \"Prenatal screening and diagnosis for fragile X syndrome\", section on 'Candidates for screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892309\">",
"    <span class=\"h4\">",
"     Hemoglobinopathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although risk assessment for hemoglobinopathy in the United States was previously primarily based upon ethnic origin, this approach is no longer reliable because of the increasingly diverse ethnic and geographic distribution of hemoglobinopathy genotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/56\">",
"     56",
"    </a>",
"    ]. Instead, a comprehensive personal and family medical history, with emphasis on history of anemia and other hematological disorders, is the preferred approach.",
"    <br/>",
"    <br/>",
"    A simple screening test that can be performed on all pregnant women as part of a baseline complete blood count is evaluation of red cell indices: an MCV less than 80 femtoliters (fL) in the absence of iron deficiency denotes patients at risk for alpha or beta thalassemia. A detailed description of patients and risk, indications for hemoglobin electrophoresis, and interpretation and management of test results can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=see_link\">",
"     \"Prenatal testing for the hemoglobinopathies and thalassemias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following description of hemoglobinopathies by ethnic origin is useful in the absence of significant ethnic diversity. In such settings, carrier screening for thalassemia and hemoglobinopathies should be offered to a woman if she",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    her partner are identified as belonging to an ethnic population whose members are at higher risk of being carriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Ideally, this screening is done pre-conceptionally or at the first prenatal visit:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Beta-thalassemia",
"      </strong>",
"      occurs with higher frequency in subcontinental ethnic groups except Northern Europeans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Alpha-thalassemia",
"      </strong>",
"      occurs with higher frequency in Chinese, Taiwanese, South-East Asian (Thai, Laotian, Cambodian, Vietnamese, Burmese, Malaysian, Singaporean, Indonesian, Philippino).",
"     </li>",
"     <li>",
"      The structural",
"      <strong>",
"       hemoglobin variants S and C",
"      </strong>",
"      (sickle cell disease) are most common in Africa including North Africans, African-Caribbeans, African-Americans, Black British and any other African ethnicity (eg, Central and South Americans of partly African ethnicity), Greeks, Southern Italians including Sicilians, Turks, Arabs, Indians [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Hemoglobin E",
"      </strong>",
"      is noted among Southeast Asians and may be the most common structural hemoglobin disorder in the world. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892415\">",
"    <span class=\"h4\">",
"     Eastern European (Ashkenazi) Jews and others",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are of Eastern European (Ashkenazi) Jewish descent or who have a relative with one of the genetic conditions prevalent in the Ashkenazi Jewish population should be offered carrier screening. One of these disorders, Tay-Sachs disease, also has a higher prevalence in individuals of",
"    <strong>",
"     Pennsylvania Dutch, Southern Louisiana Cajun, and Eastern Quebec French Canadian",
"    </strong>",
"    descent. The diseases for which these individuals are at risk and issues regarding screening are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/24/12681?source=see_link\">",
"     \"Prenatal screening for genetic disease in the Ashkenazi Jewish population\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892331\">",
"    <span class=\"h4\">",
"     Spinal muscular atrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic counseling, prenatal diagnosis, and carrier testing can be offered to women with a family history of spinal muscular atrophy (SMA or SMA-like disorders) in whom the genetic basis of the condition has been defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/59\">",
"     59",
"    </a>",
"    ]. However, there is no consensus regarding the utility of preconception and prenatal screening for SMA in those without a family history. The American College of Medical Genetics (ACMG) recommends offering carrier testing to all couples regardless of race or ethnicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. In contrast, ACOG states that such screening is not recommended in the general population at this time, but should be offered to those who first have genetic counseling that includes discussion of the sensitivity, specificity, and limitations of screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8344?source=see_link&amp;anchor=H5#H5\">",
"     \"Spinal muscular atrophy\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5892449\">",
"    <span class=\"h4\">",
"     Phenylketonuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be asked about this disorder, which is detected on newborn screening. If the patient does not volunteer the diagnosis because she is no longer on a restricted diet, asking her about dietary restrictions during childhood might reveal the diagnosis. Elevated serum phenylalanine concentration during early pregnancy in a mother with phenylketonuria or hyperphenylalaninemia can result in phenylalanine embryopathy, which can be prevented by dietary restriction of phenylalanine intake. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/58/35753?source=see_link\">",
"     \"Overview of phenylketonuria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H939359\">",
"    <span class=\"h3\">",
"     Lead level screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slight elevations of blood lead levels in pregnant women are of concern because of the potential for adverse effects on the mother and fetus (spontaneous abortion, gestational hypertension, low birthweight, impaired neurodevelopment). We agree with recommendations of major organizations that universal lead level screening in pregnancy is not indicated in the United States because the prevalence of blood lead levels over 5",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    in pregnant women is less than 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. Selective screening is indicated if the clinician has reason to suspect that the woman has any of the characteristics in the table (",
"    <a class=\"graphic graphic_table graphicRef86038 \" href=\"mobipreview.htm?9/9/9373\">",
"     table 8",
"    </a>",
"    ), which increase the likelihood of lead exposure and increased blood lead levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/62,64\">",
"     62,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the blood lead level is &lt;5",
"    <span class=\"nowrap\">",
"     mcg/dL,",
"    </span>",
"    no follow-up testing is needed. Otherwise, follow-up testing depends on the initial level (",
"    <a class=\"graphic graphic_table graphicRef81402 \" href=\"mobipreview.htm?28/27/29115\">",
"     table 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/62\">",
"     62",
"    </a>",
"    ]. At delivery, the pediatric provider should be informed of the mother&rsquo;s blood lead level. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=see_link&amp;anchor=H3#H3\">",
"     \"Childhood lead poisoning: Exposure and prevention\", section on 'Prenatal exposure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of pregnant women with elevated blood lead levels is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=see_link&amp;anchor=H1318049#H1318049\">",
"     \"Adult lead poisoning\", section on 'Pregnancy and breastfeeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other potentially useful tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Ultrasound examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials have shown that routine early ultrasound examination is beneficial in an unselected population because of better estimation of gestational age resulting in significantly reduced frequency of labor induction for postterm pregnancy and use of tocolysis for suspected preterm labor. These data are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=see_link\">",
"     \"Prenatal assessment of gestational age\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    First trimester ultrasound examination can lead to earlier detection of clinically unsuspected fetal malformations (including aneuploidies) and earlier detection of multiple pregnancy. This information has not been proven to improve overall fetal outcome, although studies have lacked power to assess for secondary outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43576?source=see_link\">",
"     \"Routine prenatal ultrasonography as a screening tool\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1276647\">",
"    <span class=\"h3\">",
"     Down syndrome screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Down syndrome is the most common chromosome abnormality among live born infants. All pregnant women should be offered Down syndrome screening. While such screening can be performed in the first or second trimester or both, first trimester screening test characteristics are better than those in the second trimester only. Screening and diagnostic tests for Down syndrome and other aneuploidies are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/27/22969?source=see_link\">",
"     \"Overview of prenatal screening and diagnosis of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PATIENT EDUCATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first prenatal visit is an appropriate time to discuss the patient's responsibilities and the expected course of pregnancy and delivery. This information can be provided by the physician, as well as by ancillary staff, and through written patient handouts. Some of the information should be repeated when the issues become more germane over the course of pregnancy.",
"   </p>",
"   <p>",
"    The patient's expectations should be oriented to the course of the average pregnancy. A more detailed discussion of the management plan should be communicated with women who are at risk for pregnancy complications because of a maternal disorder or prior adverse pregnancy outcome.",
"   </p>",
"   <p>",
"    The following list of topics represents potential areas for patient education. All of the topics may not be relevant for all women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Practice issues",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Number and frequency of prenatal visits",
"     </li>",
"     <li>",
"      Routine pregnancy monitoring (eg, maternal weight, blood pressure, uterine growth, fetal activity and heart rate, and possibly ultrasound examination)",
"     </li>",
"     <li>",
"      How to reach the provider after business hours, coverage arrangements, and the role of office personnel (eg, nurses, midwives)",
"     </li>",
"     <li>",
"      When to call the provider (eg, vaginal bleeding, fever, rupture of membranes, decreased fetal activity, frequent contractions). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/48/44807?source=see_link\">",
"       \"Prenatal care (after initial prenatal assessment)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Confidentiality issues (eg, information left on phone answering machines, use of electronic mail, and discussions with family members). There should be an explanation of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and how it affects the patient (information is available at",
"      <a class=\"external\" href=\"file://www.hhs.gov/ocr/hipaa/\">",
"       www.hhs.gov/ocr/hipaa/",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Seat belts and air bags",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women should continue wearing three-point seat belts during pregnancy. The lap belt is placed across the hips and below the uterus; the shoulder belt goes between the breasts and lateral to the uterus. Although there are case reports of maternal and fetal injuries resulting from seat belt use, the overall effect is that seat belts provide significantly more benefit than risk to the mother and fetus in the event of collision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is less evidence regarding the effects of air bags. The largest study was a retrospective cohort study that assessed the effect of air-bag availability and air-bag deployment on the risk of adverse pregnancy outcome in over 3000 pregnant, front-seat occupants in motor vehicle crashes in Washington State [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/67\">",
"     67",
"    </a>",
"    ]. Almost all of the women wore seat belts; two-thirds were in air bag equipped vehicles and one-third of the women were in vehicles without airbags. For the entire cohort, the authors did not find a statistically significant association between the presence of an air bag in the vehicle and risk of any adverse maternal or perinatal outcome in the event of a crash. When they compared only those crashes where an air bag deployed to those where it would have been likely to deploy if the vehicle was equipped with one, they found air bag deployment was associated with a trend toward increased preterm labor (RR 1.7, 95% CI 0.9-3.2), but not preterm birth (RR 0.8, 95% CI 0.3-1.9). The number of women with placental abruption or fetal death was too small to provide meaningful comparisons (abruption",
"    <span class=\"nowrap\">",
"     4/198",
"    </span>",
"    with airbag deployed versus",
"    <span class=\"nowrap\">",
"     10/622",
"    </span>",
"    without deployed air bag; fetal death",
"    <span class=\"nowrap\">",
"     2/198",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     2/622).",
"    </span>",
"   </p>",
"   <p>",
"    The American College of Obstetricians and Gynecologists (ACOG) recommends that pregnant occupants of motor vehicles wear lap and shoulder seatbelts and should not turn off air bags [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Vitamins, nutrition, and weight gain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A standard prenatal multivitamin with iron satisfies the daily requirements of most pregnant women. Well-nourished women may not need a multivitamin to satisfy these daily requirements, but in the absence of a careful evaluation by a nutritionist, it is prudent to recommend one. Folate supplements to prevent neural tube defects are recommended prior to conception and throughout the first trimester. There is also some evidence of a reduction in risk of some other congenital anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/69\">",
"     69",
"    </a>",
"    ], but more data are needed to confirm these findings as others have reported conflicting evidence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/70\">",
"     70",
"    </a>",
"    ]. In a systematic review of prenatal iron supplementation, supplementation reduced the frequency of anemia and iron deficiency at term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Overweight and obesity are common in pregnant women and are associated with several adverse pregnancy and non-pregnancy outcomes. Pregnancy is also a risk factor for excessive weight gain, beyond that needed for optimum pregnancy outcome. Prenatal care is an important opportunity for discussing these risks and counseling about diet and exercise to achieve an appropriate weight gain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19304?source=see_link\">",
"     \"Weight gain and loss in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/11/29882?source=see_link\">",
"     \"The impact of obesity on fertility and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of vitamins and minerals, nutrition, antigen avoidance diets, and",
"    <span class=\"nowrap\">",
"     foods/supplements",
"    </span>",
"    that should be consumed (eg, omega-3 fatty acids), limited (eg, some types of fish, caffeine), or avoided (eg, multivitamin or prenatal supplements containing more than 1500 mcg [5000 IU] of vitamin A]), are discussed in detail separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/44/28362?source=see_link\">",
"       \"Nutrition in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/31/33273?source=see_link\">",
"       \"Risks and benefits of fish consumption and fish oil supplements during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20119?source=see_link\">",
"       \"Primary prevention of allergic disease: Maternal avoidance diets in pregnancy and lactation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/35/20026?source=see_link\">",
"       \"The effects of caffeine on reproductive outcomes in women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Alcohol, cigarettes, and illicit drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal alcohol consumption, smoking, or use of illicit drugs can be harmful to the fetus. Ideally, pregnant women will completely stop using these substances. Patients should be strongly advised of the risks of this behavior and referred to cessation programs in their area. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41575?source=see_link\">",
"     \"Alcohol intake and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/12/6346?source=see_link\">",
"     \"Overview of illicit drug use in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Infection precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some infections are potentially harmful in pregnancy and interventions should be taken to minimize the risk of these infections. In general, pregnant women should avoid contact with people with febrile illnesses that could be contagious and should practice good hand hygiene.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Influenza &mdash; Influenza vaccination is recommended for women who are or will be pregnant during the influenza season, regardless of stage of pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32602?source=see_link\">",
"       \"Immunizations during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tetanus, diphtheria, pertussis &mdash; These immunizations should be up to date. If not up to date, Tdap is indicated during pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32602?source=see_link\">",
"       \"Immunizations during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxoplasmosis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=see_link&amp;anchor=H19#H19\">",
"       \"Toxoplasmosis and pregnancy\", section on 'Prevention'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cytomegalovirus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link&amp;anchor=H18#H18\">",
"       \"Cytomegalovirus infection in pregnancy\", section on 'Prevention'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Varicella (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33225?source=see_link\">",
"       \"Varicella-zoster virus infection in pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/26/37289?source=see_link\">",
"       \"Prevention of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Parvovirus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40408?source=see_link\">",
"       \"Parvovirus B19 infection during pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/1/31767?source=see_link\">",
"       \"Treatment and prevention of parvovirus B19 infection\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Infections associated with pets &mdash; Women who are pregnant or planning pregnancy should avoid contact with all rodents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/72\">",
"       72",
"      </a>",
"      ]. Precautions about handling pets and laboratory animals are discussed in topic reviews on each animal. See topic reviews on zoonotic infection, including: (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/42/31401?source=see_link\">",
"       \"Zoonoses from cats\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/24/29065?source=see_link\">",
"       \"Zoonoses from dogs\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/22/26986?source=see_link\">",
"       \"Zoonoses from pets other than dogs and cats\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Listeria and other foodborne infections (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/46/745?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment, prognosis, and prevention of Listeria monocytogenes infection\", section on 'Prevention of foodborne infection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/44/28362?source=see_link&amp;anchor=H7#H7\">",
"       \"Nutrition in pregnancy\", section on 'Avoidance of foodborne illnesses'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Work",
"    </span>",
"    &nbsp;&mdash;&nbsp;A woman with an uncomplicated pregnancy who is employed where there are no greater potential hazards than those encountered in routine daily life may continue to work without interruption until the onset of labor. However, workplace safety and the physical demands of the woman's job should be considered, especially in women at higher risk of preterm delivery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/37/20056?source=see_link\">",
"     \"Work and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthy women with uncomplicated pregnancies should continue to exercise during pregnancy. Issues regarding type, frequency, and duration of exercise, as well as risks of and contraindications to exercise, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/30/7657?source=see_link\">",
"     \"Recommendations for exercise during pregnancy and the postpartum period\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4568?source=see_link\">",
"     \"Anatomical and physiological changes of pregnancy and exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12840277\">",
"    <span class=\"h2\">",
"     Hot tubs and saunas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hot tubs and saunas probably should be avoided during the first trimester because maternal heat exposure has been associated with neural tube defects. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7386?source=see_link&amp;anchor=H29#H29\">",
"     \"Genetic and environmental causes of birth defects\", section on 'Fever/hyperthermia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Sexual activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Theoretically, sexual intercourse may stimulate labor due to physical stimulation of the lower uterine segment, endogenous release of oxytocin as a result of orgasm, direct action of prostaglandins in semen, or increased exposure to infectious agents. However, in the absence of pregnancy complications (eg, vaginal bleeding, ruptured membranes), there is insufficient evidence to recommend against sexual intercourse during pregnancy. Most studies have not shown an increased risk of preterm",
"    <span class=\"nowrap\">",
"     labor/delivery",
"    </span>",
"    or infectious complications (unless a sexually transmitted disease is acquired) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Birth defects and genetic issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of birth defects of medical, surgical, or cosmetic significance is 2 to 4 percent among liveborn infants and does not vary among ethnic groups. Both genetic and environmental factors play a role in pathogenesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinician should discuss the causes of congenital anomalies with the patient, assess the specific risk for her child, review options for and limitations of prenatal diagnosis, and decide whether additional testing and referral to a geneticist would be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medication use is common in pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/75\">",
"     75",
"    </a>",
"    ]. All patients should be encouraged to contact their provider with any concerns and before taking any drugs (prescription, over the counter, or herbal [alternative] remedies) that were not previously approved.",
"   </p>",
"   <p>",
"    Since 1975, the US Food and Drug Administration (FDA) has assigned pregnancy risk factors to all drugs available in the United States (",
"    <a class=\"graphic graphic_table graphicRef63892 \" href=\"mobipreview.htm?6/25/6556\">",
"     table 10",
"    </a>",
"    ). Information on the use of specific drugs in pregnancy, including the FDA risk category and pregnancy implications, is available in the UpToDate drug database, as well as in topics that review treatment of medical conditions in pregnant women. There are only a limited number of drugs that have been proven to be teratogenic in humans (",
"    <a class=\"graphic graphic_table graphicRef73369 \" href=\"mobipreview.htm?4/58/5024\">",
"     table 11",
"    </a>",
"    ). Conversely, there are few drugs that have definitely been proven to be safe. Therefore, it is prudent to minimize the number of medications taken, limit use of medication to situations where the benefit clearly outweighs the risk, choose medications with the best safety profile, and use them at the lowest dose and for the shortest duration that is effective.",
"   </p>",
"   <p>",
"    Women exposed to drugs of uncertain safety in the first trimester may be offered ultrasound examination at 18 to 20 weeks of gestation to screen for fetal anatomic abnormalities, with fetal echocardiography if congenital heart disease is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43576?source=see_link\">",
"     \"Routine prenatal ultrasonography as a screening tool\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4968?source=see_link\">",
"     \"Prenatal sonographic diagnosis of fetal cardiac anomalies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1702574\">",
"    <span class=\"h3\">",
"     Treatment of pain and fever",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H394093\">",
"    <span class=\"h4\">",
"     Acetaminophen",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    is a widely used drug for treatment of pain and fever, with no strong evidence in humans of increased risk of pregnancy loss, congenital anomalies, or neurodevelopmental delay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Epidemiologic studies have suggested a small, but statistically significant, association between maternal use of mild analgesics and cryptorchidism in offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/78-80\">",
"     78-80",
"    </a>",
"    ]. The increase in risk appeared to be related primarily to prolonged use (&gt;2 weeks) and use in early pregnancy. However, the reports were not consistent with respect to the type of mild analgesic (acetaminophen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ), the time in gestation of greatest risk, and the risk in different populations. Further study is needed, but, if possible, it seems reasonable to avoid prolonged use of acetaminophen in early pregnancy until more data are available.",
"   </p>",
"   <p>",
"    It is possible that reduction of fever with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    reduces the risk of some birth defects, but further study is needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/77\">",
"     77",
"    </a>",
"    ]. The extensive use of acetaminophen by pregnant women combined with the paucity of documented adverse effects has served to make this medication the pain reliever and antipyretic of choice during pregnancy when short-term drug therapy is indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H394100\">",
"    <span class=\"h4\">",
"     NSAIDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risks and benefits of using nonsteroidal antiinflammatory drugs (NSAIDs) for treatment of pain or fever depend on the dose, gestational age, and duration of therapy. These risks are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/53/35674?source=see_link&amp;anchor=H1279823#H1279823\">",
"     \"Inhibition of acute preterm labor\", section on 'Cyclooxygenase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H394107\">",
"    <span class=\"h4\">",
"     Opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little information on the effects of chronic (&ge;1 month) prescription narcotic use during pregnancy. Neonatal withdrawal syndrome is uncommon, but can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/82\">",
"     82",
"    </a>",
"    ]. A single population-based case-control study reported an increase (OR 1.8 to 2.7) in congenital heart disease, spina bifida, and gastroschisis with therapeutic use of narcotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/83\">",
"     83",
"    </a>",
"    ]. Most of the exposures were to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    and hydrocodone. Some limitations of the study were that exposure information was based on maternal recall about one year after delivery, information on drug dose and duration was not obtained, and many of the narcotics were part of a multi-component drug regimen. Further study is needed. In the meantime, it is reasonable to prescribe opioids for relief of moderate to severe pain at any stage of pregnancy.",
"   </p>",
"   <p>",
"    Issues related to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    and nonprescription opioids are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4570?source=see_link\">",
"     \"Methadone maintenance therapy during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/12/6346?source=see_link\">",
"     \"Overview of illicit drug use in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1702581\">",
"    <span class=\"h3\">",
"     Treatment of cold and allergy symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of over-the-counter and prescription drugs for treatment of respiratory infections and allergies in pregnancy is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36344?source=see_link\">",
"     \"Treatment of respiratory infections in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3914?source=see_link\">",
"     \"Recognition and management of allergic disease during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1702588\">",
"    <span class=\"h3\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics with a good safety profile in pregnant women include the cephalosporins, penicillins,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    (except the estolate),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    . Aminoglycosides are relatively safe, but carry a risk of fetal (and maternal) ototoxicity and nephrotoxicity. Although erythromycin and azithromycin have good safety profiles,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    , another macrolide, has produced adverse pregnancy outcome in animal studies at low-order multiples of human doses; human experience is very limited but has not suggested an increase in congenital anomalies in exposed pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/84-86\">",
"     84-86",
"    </a>",
"    ], but an increased risk of miscarriage has been reported, possibly related to the underlying maternal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/85,87\">",
"     85,87",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     Doxycycline",
"    </a>",
"    is avoided during pregnancy because other tetracyclines have been associated with transient suppression of bone growth and with staining of developing teeth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/88\">",
"     88",
"    </a>",
"    ], but available data do not show teratogenic effects from doxycycline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/89\">",
"     89",
"    </a>",
"    ]. Fluoroquinolones are generally avoided during pregnancy and lactation because they are toxic to developing cartilage in experimental animal studies. However, neither adverse effects on cartilage nor an increase in congenital malformations from use during human pregnancy has been documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/36/26182?source=see_link\">",
"     Trimethoprim",
"    </a>",
"    is generally avoided in the first trimester because it is a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    antagonist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/91-93\">",
"     91-93",
"    </a>",
"    ], has caused abnormal embryo development in experimental animals, and some case control studies have reported a possible association with a variety of birth defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/76\">",
"     76",
"    </a>",
"    ]. However, it is not a proven teratogen in humans. Additional evaluation of the safety of trimethoprim in human pregnancy is needed. The safest course is to avoid using trimethoprim in the first trimester if another antibiotic that is safe and effective is available. If exposure does occur, we advise patients of the baseline risk of birth defects in the population and the possibility of a low, but unproven increase in risk of birth defects after exposure to trimethoprim.",
"   </p>",
"   <p>",
"    A National Birth Defects Prevention (NBDP) Study reported statistically significant associations between a variety of birth defects and use of sulfonamides or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/94\">",
"     94",
"    </a>",
"    ]. In addition, a previous small case-control study reported a statistically significant association between nitrofurantoin use and cardiac defects (OR 1.7) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/95\">",
"     95",
"    </a>",
"    ]. These findings should be interpreted with caution because both studies were retrospective. In the NBDP study, multiple comparisons involving small numbers of affected exposed infants may have led by chance to the observed small increase in odds ratios. For each birth defect, only between 4 and 21 infants were exposed to one of the antibiotics and some patients in the study were exposed to more than one potential teratogen. For both studies, long periods between the exposure and patient interviews (six weeks to two years), recall bias, and inability to determine if the birth defects were related to the infection rather than the treatment further limit these findings. In contrast, a population-based cohort study from Norway found no significant association between filling a nitrofurantoin prescription in the first trimester and risk of congenital malformations (all, major, or cardiovascular) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/96\">",
"     96",
"    </a>",
"    ]. As discussed above, the safest course is to avoid using nitrofurantoin or sulfonamides in the first trimester if another antibiotic that is safe and effective is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sulfonamides compete with bilirubin for albumin binding sites and theoretically may increase the risk of kernicterus at low bilirubin levels. For this reason, these drugs are avoided near delivery if another antibiotic is available. However, a systematic review found no cases of kernicterus associated with maternal use of sulfonamides during pregnancy or lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/98\">",
"     98",
"    </a>",
"    ]. One study described an increased risk of kernicterus in preterm infants administered sulfisoxazole for antibiotic prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1702595\">",
"    <span class=\"h3\">",
"     Treatment of constipation and diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing dietary fiber and fluids or using bulk forming laxatives is the preferred treatment of constipation during pregnancy since these agents are not absorbed. For refractory cases, occasional use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/6/31847?source=see_link\">",
"     magnesium hydroxide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"     bisacodyl",
"    </a>",
"    is probably not harmful as magnesium salts have been widely used in pregnancy with a good safety profile and lactulose and bisacodyl, although not studied in human pregnancy, are minimally absorbed. Castor oil can stimulate uterine contractions and excessive use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    can interfere with absorption of fat soluble vitamins, so these agents are generally avoided. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link\">",
"     \"Management of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of patients with acute diarrhea initially involves general measures such as hydration and alteration of diet.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/53/16214?source=see_link\">",
"     Loperamide",
"    </a>",
"    was not teratogenic in animal studies, but human data are conflicting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/100\">",
"     100",
"    </a>",
"    ]. Antibiotic therapy is rarely needed since the illness is usually self-limited and most often viral in etiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=see_link\">",
"     \"Approach to the adult with acute diarrhea in developed countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1702610\">",
"    <span class=\"h3\">",
"     Treatment of nausea and vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nausea and vomiting may be pregnancy-related, or due to other causes. Supportive care is similar regardless of the etiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/15/41207?source=see_link\">",
"     \"Clinical features and evaluation of nausea and vomiting of pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/20/29002?source=see_link\">",
"     \"Treatment and outcome of nausea and vomiting of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5760400\">",
"    <span class=\"h3\">",
"     Treatment of gastrointestinal reflux",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy for gastrointestinal reflux disease (GERD) consists of lifestyle modification including elevation of the head of the bed, dietary modification, antacids (as needed), and use of H2 receptor antagonists or proton pump inhibitors, as needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/60/9160?source=see_link&amp;anchor=H8#H8\">",
"     \"Maternal gastrointestinal tract adaptation to pregnancy\", section on 'Gastroesophageal reflux disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=see_link\">",
"     \"Medical management of gastroesophageal reflux disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5760420\">",
"    <span class=\"h3\">",
"     Treatment of sleep disturbance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep during pregnancy, especially late pregnancy, is fragmented and characterized by increased waking after sleep onset, greater amounts of light sleep, and less deep sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/101-103\">",
"     101-103",
"    </a>",
"    ]. Some reasons for this include nocturia, nocturnal gastroesophageal reflux, anxiety, restless legs or leg cramps, low back pain, physical limitations in achieving a comfortable position, and, primarily in obese women, obstructive sleep apnea (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39561?source=see_link\">",
"     \"Obstructive sleep apnea in pregnancy\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the absence of treatment for a specific medical condition, such as GERD, suggestions for better sleep include maintaining a regular sleep schedule in a low stimuli environment; cutting down on the amount of liquids in the hours before bedtime; avoiding caffeine after noon; exercising regularly for at least 20 minutes at least a few hours before bedtime; placing pillows between the knees, under the abdomen and behind the back to take pressure off the lower back; putting a night light in the bathroom to avoid turning on a bright light, which tends to increase wakefulness; using relaxation techniques; and avoiding naps late in the day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We do not prescribe sleep medication for pregnant women. Sedating antihistamines (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/52/17221?source=see_link\">",
"     doxylamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/48/13064?source=see_link\">",
"     zolpidem",
"    </a>",
"    have been used for short-term treatment of sleeplessness in pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6593841\">",
"    <span class=\"h2\">",
"     Travel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women who travel need to consider several issues, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Their risk of pregnancy complications away from their usual source of medical care, as well as the availability of medical resources and their medical insurance coverage at their destination.",
"     </li>",
"     <li>",
"      The increased risk of venous thromboembolism during pregnancy and with prolonged immobility during the trip.",
"     </li>",
"     <li>",
"      The potentially increased risk of exposure to infectious diseases (eg, travelers&rsquo; diarrhea, malaria), as well as prophylaxis, prevention and treatment of these diseases.",
"     </li>",
"     <li>",
"      Issues related to air travel (eg, access to medical providers, lower oxygen environment, restricted movement).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These topics are discussed below and in separate topic reviews (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/48/8967?source=see_link\">",
"     \"Travel advice\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/13/20695?source=see_link\">",
"     \"Treatment and prevention of malaria in pregnancy\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Airline travel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most airlines allow women to fly up to 37 weeks of gestation, although individual policies may vary. Commercial airline travel is generally safe for women with uncomplicated pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/105-108\">",
"     105-108",
"    </a>",
"    ]. Fetal heart rate is not affected during flight if the mother and fetus are healthy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/106\">",
"     106",
"    </a>",
"    ]. Although observational studies have reported an increased risk of miscarriage in flight attendants (OR 1.62, 95% CI 1.29-2.04) and an increased risk of preterm birth among passengers (OR 1.44, 95% CI 1.07-1.93) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/109\">",
"     109",
"    </a>",
"    ], particularly women who fly for long durations and frequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/110\">",
"     110",
"    </a>",
"    ]. In contrast to passengers, flight attendants do not appear to have an increased risk of preterm birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/109\">",
"     109",
"    </a>",
"    ]. These findings could be due to failure to account for relevant differences between study subjects and controls.",
"   </p>",
"   <p>",
"    Maternal physiologic adaptations to high altitude include hemoconcentration, increased heart rate and blood pressure, and decreased aerobic capacity with reduction of partial oxygen pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/106,111\">",
"     106,111",
"    </a>",
"    ]. For these reasons and the lack of availability of emergency care, certain precautions should be taken during air travel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/107\">",
"     107",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women with complicated pregnancies that may be exacerbated by flight conditions or require emergency care should avoid air travel.",
"     </li>",
"     <li>",
"      All airline travelers should maintain hydration and periodically move their lower extremities to minimize stasis and reduce the risk of venous thrombosis; use of compression stockings and avoidance of restrictive clothing may also be helpful. Seat belts should be worn continuously to protect against injury from unexpected turbulence.",
"     </li>",
"     <li>",
"      Supplemental oxygen should be administered to pregnant women (eg, women with sickle cell disease, severe anemia [hemoglobin &lt;8",
"      <span class=\"nowrap\">",
"       g/dL],",
"      </span>",
"      or cyanotic heart disease) who must travel and may not tolerate the relatively hypoxic environment of high altitude flying, even in pressurized aircraft. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/10/28840?source=see_link\">",
"       \"Traveling with oxygen aboard commercial air carriers\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The amount of cosmic radiation received during airline travel is below the level at which there begins to be concern about possible harmful fetal effects (20 millisievert or 2 mrem) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/112\">",
"     112",
"    </a>",
"    ]. As an example, a woman on a round trip transpolar flight from New York to Tokyo would be exposed to approximately 15 mrem cosmic radiation; for a round trip transcontinental flight across the United States, the exposure would be 6 mrem. By comparison, the International Commission on Radiological Protection (ICRP) and the National Council on Radiation Protection (NCRP) recommended limit for maximum cumulative radiation exposure for a member of the general public over one year is 100 mrem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/113,114\">",
"     113,114",
"    </a>",
"    ]. Pilots, flight attendants, and frequent fliers might exceed this level, particularly if they fly during solar particle events, when radiation levels can increase significantly. They should be aware of their personal radiation exposure, which can be calculated using the Federal Aviation Administration Radiobiological Team web site (",
"    <a class=\"external\" href=\"file://jag.cami.jccbi.gov./cariprofile.asp\">",
"     jag.cami.jccbi.gov./cariprofile.asp",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A detailed discussion of radiation risks in pregnancy can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Travel to moderate and high altitudes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airplane passenger cabins are usually pressurized to an altitude of 5000 to 8000 feet (1524 to 2438 meters). The PO2 values at these altitudes are 132 and 118 mmHg, respectively (",
"    <a class=\"graphic graphic_table graphicRef63773 \" href=\"mobipreview.htm?9/36/9804\">",
"     table 12",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/111\">",
"     111",
"    </a>",
"    ]. Pregnant women may be exposed to altitudes in this range from other sources, such as visiting a mountain resort or traveling in a hot air balloon or noncommercial aircraft. There is scant literature about acute, short-term exposure of pregnant women to these moderate altitudes. One study evaluated seven women in the third trimester at sea level (180 feet) and then within two to four days of visiting a facility at 6000 feet (1829 m) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/111\">",
"     111",
"    </a>",
"    ]. Plasma glucose rose from 4.53 to 5.51",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    (81.6 to 99.2",
"    <span class=\"nowrap\">",
"     mg/dL);",
"    </span>",
"    maternal heart rate, oxygen consumption, ventilation, tidal volume, and plasma catecholamine and lactate levels did not change significantly, nor was there a change in fetal heart rate.",
"   </p>",
"   <p>",
"    These data and other reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/115,116\">",
"     115,116",
"    </a>",
"    ], although limited, are reassuring that women with uncomplicated pregnancies can tolerate acute exposure to moderate altitudes. Since an individual's altitude tolerance cannot be reliably determined at sea level, advice on travel to intermediate altitudes should err on the side of caution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/115,116\">",
"     115,116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High altitudes (over 8000 feet [2438 m]) are more likely to cause problems. In general, exposure of a pregnant woman to the hypoxia of high altitude results in acclimatization responses, which preserve the fetal oxygen supply. The fetus also can utilize some compensatory mechanisms during brief periods of hypoxia. However, these adaptive mechanisms may not be fully compensatory in complicated pregnancies, such as those with uteroplacental insufficiency, or at very high altitudes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/117\">",
"     117",
"    </a>",
"    ]. As an example, pregnancy in inhabitants of Cerro de Pasco, Peru (altitude 14,337 feet [4370 m]) is associated with 31 percent lower maternal cardiac output and 11 percent lower birthweight than observed in pregnant women residing at sea level (mean birth weight 2935 and 3290 grams, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A survey of obstetrical care providers in Colorado reported that preterm labor and bleeding complications of pregnancy were the most commonly encountered pregnancy complications among pregnant visitors to high altitudes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/119\">",
"     119",
"    </a>",
"    ]. Dehydration, engaging in strenuous exercise before acclimatization, and participation in activities with high risk of trauma were behaviors that could increase the risk of pregnancy complications. Some experts suggest that an altitude of 8000 feet should not be exceeded in the first few days of short-term exposure to high altitude [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/115\">",
"     115",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/297?source=see_link\">",
"     \"High altitude illness: Physiology, risk factors, and general prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Selected common environmental concerns",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Caffeine (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/35/20026?source=see_link\">",
"       \"The effects of caffeine on reproductive outcomes in women\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Methylmercury in fish (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/31/33273?source=see_link\">",
"       \"Risks and benefits of fish consumption and fish oil supplements during pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pesticides, plastics, and other potential toxins (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4746?source=see_link\">",
"       \"Occupational and environmental risks to reproduction in females\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hair treatments &mdash; There are no good studies on occasional use of hair products during pregnancy. Exposure to hair dyes or hair products results in very limited systemic absorption, unless scalp skin is compromised by disease (eg, burns). Therefore, these chemicals are unlikely to cause adverse fetal effects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/120,121\">",
"       120,121",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12838787\">",
"    <span class=\"h2\">",
"     Varicose veins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is a risk factor for varicose veins, which may become symptomatic anytime during the antepartum or postpartum period.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study involving 611 consecutively delivered women found that 22 percent reported varicose veins prior to that pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/122\">",
"       122",
"      </a>",
"      ]. The risk was increased with increasing age, parity and family history. Twenty-eight percent of the 474 women who had no history of varicosities developed them during that pregnancy.",
"     </li>",
"     <li>",
"      Another study evaluating the effectiveness of compression stockings during pregnancy noted that 50 percent of the 42 women enrolled developed emergent superficial varicose veins during the pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/123\">",
"       123",
"      </a>",
"      ]. Although compression stockings did not prevent varicose veins, more women in the treated group reported improvement in symptoms; thus, they can be useful for patient comfort.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluation and management are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34521?source=see_link\">",
"     \"Overview and management of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30681?source=see_link\">",
"     \"Vulvovaginal varicosities and pelvic congestion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4812727\">",
"    <span class=\"h1\">",
"     SPECIAL POPULATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4812811\">",
"    <span class=\"h2\">",
"     Adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/31/10744?source=see_link\">",
"     \"Pregnancy in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4812735\">",
"    <span class=\"h2\">",
"     Incarcerated women",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/39/632?source=see_link\">",
"     \"Prenatal care for incarcerated women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4812755\">",
"    <span class=\"h2\">",
"     Disabled women",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists (ACOG) provides resources for obstetricians serving women with disabilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/1/42010/abstract/124\">",
"     124",
"    </a>",
"    ]. General issues regarding care of adults with disabilities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/26/12713?source=see_link\">",
"     \"Primary care of the adult with intellectual disability (mental retardation)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/21/22873?source=see_link\">",
"     \"Disability assessment and determination in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4812839\">",
"    <span class=\"h2\">",
"     Advanced maternal age",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31865?source=see_link\">",
"     \"Effect of advanced age on fertility and pregnancy in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/48/35590?source=see_link\">",
"     \"Management of infertility and pregnancy in women of advanced age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12840141\">",
"    <span class=\"h1\">",
"     ONGOING PRENATAL CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal care after the initial prenatal visit is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/48/44807?source=see_link\">",
"     \"Prenatal care (after initial prenatal assessment)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/29/37331?source=see_link\">",
"       \"Patient information: Prenatal care (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/15/8434?source=see_link\">",
"       \"Patient information: Activity during pregnancy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/52/43843?source=see_link\">",
"       \"Patient information: Avoiding infections in pregnancy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/50/2851?source=see_link\">",
"       \"Patient information: Should I have a screening test for Down syndrome during pregnancy? (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/63/11248?source=see_link\">",
"       \"Patient information: Group B streptococcus and pregnancy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Studies have not established that prenatal care improves birth outcomes definitively, and it is not clear which components of prenatal care are most effective. However, all of these studies are flawed by multiple confounders. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Care provider'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In low risk pregnancies, there is good evidence that using midwives to provide prenatal care is cost-effective and does not adversely affect outcome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Care provider'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One goal of prenatal care is identification of women at increased risk of medical complications, pregnancy complications, or fetal abnormalities. This is achieved, in part, by taking a comprehensive social, medical, obstetrical, and family history; establishing an accurate estimated date of delivery; and appropriate laboratory testing. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is insufficient evidence on which to base recommendations on the optimal content of prenatal care. However, there is good evidence of benefit for performing the following tests on all pregnant women (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Laboratory tests'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Hematocrit/hemoglobin",
"      </span>",
"      and mean corpuscular volume",
"     </li>",
"     <li>",
"      Assessment for asymptomatic bacteriuria. We suggest urine culture.",
"     </li>",
"     <li>",
"      Rhesus type and red cell antibody screen",
"     </li>",
"     <li>",
"      Assessment for immunity to rubella and varicella",
"     </li>",
"     <li>",
"      Testing for syphilis, hepatitis B antigen, and chlamydia",
"     </li>",
"     <li>",
"      Opt-out approach to HIV testing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tests that are useful in selected women because of their increased risk of disease based on symptoms or epidemiologic risk factors include: (see",
"      <a class=\"local\" href=\"#H12\">",
"       'At-risk women'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Thyroid function tests",
"     </li>",
"     <li>",
"      Assessment for the following infections: N. gonorrhea, tuberculosis, toxoplasmosis, hepatitis C, bacterial vaginosis, trichomoniasis, herpes simplex virus, and Chagas disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend a supplement containing iron and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Routine supplementation reduces the risk of maternal anemia and neural tube defects in offspring. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Vitamins, nutrition, and weight gain'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/44/28362?source=see_link\">",
"       \"Nutrition in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Randomized trials have shown that routine early ultrasound examination is beneficial in an unselected population because of better estimation of gestational age resulting in significantly reduced frequency of labor induction for postterm pregnancy and use of tocolysis for suspected preterm labor. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Ultrasound examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All pregnant women should be offered Down syndrome screening. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/27/22969?source=see_link\">",
"       \"Overview of prenatal screening and diagnosis of Down syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patient education is an important component of prenatal care. It involves a number of subjects, including but not limited to practice issues, use of seat belts, use of medications, and avoidance of potentially harmful substances and infections. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Patient education'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Martin JA, Hamilton BE, Sutton PD, et al. Births: Final data for 2008. National vital statistics reports; vol 59 no 1. Hyattsville, MD: National Center for Health Statistics. 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/2\">",
"      Fiscella K. Does prenatal care improve birth outcomes? A critical review. Obstet Gynecol 1995; 85:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/3\">",
"      Klerman LV, Ramey SL, Goldenberg RL, et al. A randomized trial of augmented prenatal care for multiple-risk, Medicaid-eligible African American women. Am J Public Health 2001; 91:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/4\">",
"      Villar J, Farnot U, Barros F, et al. A randomized trial of psychosocial support during high-risk pregnancies. The Latin American Network for Perinatal and Reproductive Research. N Engl J Med 1992; 327:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/5\">",
"      Villar J, Ba'aqeel H, Piaggio G, et al. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet 2001; 357:1551.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. www.acog.org (Accessed on May 01, 2012).",
"    </li>",
"    <li>",
"     The Management of Uncomplicated Pregnancy Working Group. DoD/VA Clincial Practice Guideline for the Management of Uncomplicated Pregnancy. Washington, DC: Department of Defense and Veterans Administration, 2002.",
"    </li>",
"    <li>",
"     Kirkham C, Harris S, Grzybowski S. Evidence-based prenatal care www.aafp.org.",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence (see Antenatal Care: Routine Care for the Healthy Pregnant Woman). www.nice.org.uk. (Accessed on April 19, 2012).",
"    </li>",
"    <li>",
"     Society of Obstetricians and Gynaecologists of Canada. Clinical Practice Guidelines. Obstetrics. www.sogc.org (Accessed on May 01, 2012).",
"    </li>",
"    <li>",
"     WHO Reproductive Health Library. Pregnancy and Childbirth. file://apps.who.int/rhl/pregnancy_childbirth/en/ (Accessed on May 01, 2012).",
"    </li>",
"    <li>",
"     Sakala, C, Corry, MP. Evidence-based maternity care: what is it and what can it achieve. October 2008. available at www.milbank.org/ (accessed February 11, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/13\">",
"      Khan-Neelofur D, G&uuml;lmezoglu M, Villar J. Who should provide routine antenatal care for low-risk women, and how often? A systematic review of randomised controlled trials. WHO Antenatal Care Trial Research Group. Paediatr Perinat Epidemiol 1998; 12 Suppl 2:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/14\">",
"      Hatem M, Sandall J, Devane D, et al. Midwife-led versus other models of care for childbearing women. Cochrane Database Syst Rev 2008; :CD004667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/15\">",
"      Whitworth M, Quenby S, Cockerill RO, Dowswell T. Specialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomes. Cochrane Database Syst Rev 2011; :CD006760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/16\">",
"      Wilson A, Gallos ID, Plana N, et al. Effectiveness of strategies incorporating training and support of traditional birth attendants on perinatal and maternal mortality: meta-analysis. BMJ 2011; 343:d7102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/17\">",
"      American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 313, September 2005. The importance of preconception care in the continuum of women's health care. Obstet Gynecol 2005; 106:665.",
"     </a>",
"    </li>",
"    <li>",
"     Flitcraft, A, Hadley, S, et al. Diagnostic and treatment guidelines on domestic violence. American Medical Association, Chicago 1992.",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Psychosocial risk factors: perinatal screening and intervention. Educational bulletin No. 255. ACOG, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/20\">",
"      Shah PS, Shah J, Knowledge Synthesis Group on Determinants of Preterm/LBW Births. Maternal exposure to domestic violence and pregnancy and birth outcomes: a systematic review and meta-analyses. J Womens Health (Larchmt) 2010; 19:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/21\">",
"      Kiely M, El-Mohandes AA, El-Khorazaty MN, et al. An integrated intervention to reduce intimate partner violence in pregnancy: a randomized controlled trial. Obstet Gynecol 2010; 115:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/22\">",
"      American College of Obstetricians and Gynecologists Committee on Health Care for Undeserved Women. ACOG Committee Opinion No. 343: psychosocial risk factors: perinatal screening and intervention. Obstet Gynecol 2006; 108:469.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 2012; 7th ed. Elk Grove Village, Illinois: AAP; Washington, DC: ACOG.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/24\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol 2008; 112:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/25\">",
"      Marin M, G&uuml;ris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/26\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/27\">",
"      U.S. Preventive Services Task Force. Screening for hepatitis B virus infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009; 150:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/28\">",
"      Lin K, Vickery J. Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009; 150:874.",
"     </a>",
"    </li>",
"    <li>",
"     www.library.nhs.uk/screening/ViewResource.aspx?resID=32072 (Accessed April 27, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/30\">",
"      Cook RL, Hutchison SL, &Oslash;stergaard L, et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142:914.",
"     </a>",
"    </li>",
"    <li>",
"     Canadian Agency for Drugs and Technologies in Health. Urine Based Testing for Gonorrhea and Chlamydia: A Review of Diagnostic Accuracy, Cost-Effectiveness, and Compliance. November 2009. file://www.cadth.ca/media/pdf/L0124_Urine_Based_Testing_for_Gonorrhea_and_Chlamydia_final.pdf (Accessed on April 01, 2011).",
"    </li>",
"    <li>",
"     Expert Consultation Meeting Summary Report January 13���15, 2009. Atlanta, GA. Laboratory Diagnostic Testing for Chlamydia trachomatis and Neisseria gonorrhoeae. file://www.aphl.org/aphlprograms/infectious/std/Documents/CTGCLabGuidelinesMeetingReport.pdf (Accessed on April 01, 2011).",
"    </li>",
"    <li>",
"     National chlamydia coalition. Developments in STD Screening: Chlamydia Testing. 2010. file://www.prevent.org/data/files/ncc/research%20brief%201%20std%20testing.pdf (Accessed on April 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/34\">",
"      Roberts SW, Sheffield JS, McIntire DD, Alexander JM. Urine screening for Chlamydia trachomatis during pregnancy. Obstet Gynecol 2011; 117:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/35\">",
"      American College of Obstetrics and Gynecology Committee on Obstetric Practice. ACOG Committee Opinion No. 418: Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2008; 112:739.",
"     </a>",
"    </li>",
"    <li>",
"     SOGC Clinical Practice Guideline. HIV screening in pregnancy. file://www.jogc.com/abstracts/full/200612_SOGCClinicalPracticeGuidelines_1.pdf (Accessed on April 23, 2012).",
"    </li>",
"    <li>",
"     Royal College of Obstetricains and Gynaecologists. HIV in pregnancy, Management (Green-top 39) file://www.rcog.org.uk/womens-health/clinical-guidance/management-hiv-pregnancy-green-top-39 (Accessed on April 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/38\">",
"      Walmsley S. Opt in or opt out: what is optimal for prenatal screening for HIV infection? CMAJ 2003; 168:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/39\">",
"      Breese P, Burman W, Shlay J, Guinn D. The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancy. Obstet Gynecol 2004; 104:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/40\">",
"      Hogge JS, Hogge WA. Preconception genetic counseling. Clin Obstet Gynecol 1996; 39:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/41\">",
"      Committee on Patient Safety and Quality Improvement, Committee on Professional Liability. ACOG Committee Opinion No. 381: Subclinical hypothyroidism in pregnancy. Obstet Gynecol 2007; 110:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/42\">",
"      Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/43\">",
"      Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/44\">",
"      Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007; 92:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/45\">",
"      Horacek J, Spitalnikova S, Dlabalova B, et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010; 163:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/46\">",
"      Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011; 96:E1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/47\">",
"      Brent GA. Diagnosing thyroid dysfunction in pregnant women: Is case finding enough? J Clin Endocrinol Metab 2007; 92:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/48\">",
"      Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/49\">",
"      Brent GA. The debate over thyroid-function screening in pregnancy. N Engl J Med 2012; 366:562.",
"     </a>",
"    </li>",
"    <li>",
"     www.ahrq.gov/clinic/cps3dix.htm. (Accessed May 22, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/51\">",
"      Coonrod DV, Jack BW, Stubblefield PG, et al. The clinical content of preconception care: infectious diseases in preconception care. Am J Obstet Gynecol 2008; 199:S296.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/mmwr/preview/mmwrhtml/mms5703a2.htm (Accessed May 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/53\">",
"      Verani JR, Montgomery SP, Schulkin J, et al. Survey of obstetrician-gynecologists in the United States about Chagas disease. Am J Trop Med Hyg 2010; 83:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/54\">",
"      Buekens P, Almendares O, Carlier Y, et al. Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Matern Child Health J 2008; 12:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/55\">",
"      Ramos JM, Milla A, S&aacute;nchez V, et al. [Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women]. Enferm Infecc Microbiol Clin 2009; 27:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/56\">",
"      ACOG Committee on Obstetrics. ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet Gynecol 2007; 109:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/57\">",
"      Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 2010; 149:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/58\">",
"      Langlois S, Ford JC, Chitayat D, et al. Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can 2008; 30:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/59\">",
"      ACOG Committee on Genetics. ACOG committee opinion No. 432: spinal muscular atrophy. Obstet Gynecol 2009; 113:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/60\">",
"      Prior TW, Professional Practice and Guidelines Committee. Carrier screening for spinal muscular atrophy. Genet Med 2008; 10:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/61\">",
"      Prior TW. Spinal muscular atrophy: a time for screening. Curr Opin Pediatr 2010; 22:696.",
"     </a>",
"    </li>",
"    <li>",
"     Ettinger, AS, Gurthrie Wengrovitz, A (Eds). Guidelines for the identification and management of lead exposure in pregnant and lactating women. National Center for Environmental Health/Agency for Toxic Substances and Disease Registry; Centers for Disease Control and Prevention, Atlanta, GA, 2010  available at file://www.cdc.gov/nceh/lead/publications/LeadandPregnancy2010.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/63\">",
"      Rischitelli G, Nygren P, Bougatsos C. Screening for elevated lead levels in childhood and pregnancy: Update of a 1996 United States Preventive Services Task Force review. U.S. Preventive Services Task Force Evidence Syntheses.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/64\">",
"      Committee on Obstetric Practice. Committee opinion no. 533: lead screening during pregnancy and lactation. Obstet Gynecol 2012; 120:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/65\">",
"      Klinich KD, Flannagan CA, Rupp JD, et al. Fetal outcome in motor-vehicle crashes: effects of crash characteristics and maternal restraint. Am J Obstet Gynecol 2008; 198:450.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/66\">",
"      Motozawa Y, Hitosugi M, Abe T, Tokudome S. Effects of seat belts worn by pregnant drivers during low-impact collisions. Am J Obstet Gynecol 2010; 203:62.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/67\">",
"      Schiff MA, Mack CD, Kaufman RP, et al. The effect of air bags on pregnancy outcomes in Washington State: 2002-2005. Obstet Gynecol 2010; 115:85.",
"     </a>",
"    </li>",
"    <li>",
"     The American College of Obstetricians and Gynecologists. Car safety for you and your baby. file://www.acog.org/publications/patient_education/bp018.cfm (Accessed on December 10, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/69\">",
"      Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006; 28:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/70\">",
"      De-Regil LM, Fern&aacute;ndez-Gaxiola AC, Dowswell T, Pe&ntilde;a-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; :CD007950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/71\">",
"      Pe&ntilde;a-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; 12:CD004736.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/mmwr/preview/mmwrhtml/mm54d812a1.htm. (Accessed August 29, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/73\">",
"      Read JS, Klebanoff MA. Sexual intercourse during pregnancy and preterm delivery: effects of vaginal microorganisms. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1993; 168:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/74\">",
"      Sayle AE, Savitz DA, Thorp JM Jr, et al. Sexual activity during late pregnancy and risk of preterm delivery. Obstet Gynecol 2001; 97:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/75\">",
"      Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005; 193:771.",
"     </a>",
"    </li>",
"    <li>",
"     www.Reprotox.org. (Accessed July 1, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/77\">",
"      Feldkamp ML, Meyer RE, Krikov S, Botto LD. Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 2010; 115:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/78\">",
"      Kristensen DM, Hass U, Lesn&eacute; L, et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011; 26:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/79\">",
"      Snijder CA, Kortenkamp A, Steegers EA, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 2012; 27:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/80\">",
"      Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010; 21:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/81\">",
"      Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician 2003; 67:2517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/82\">",
"      Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011; 204:259.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/83\">",
"      Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314.e1.",
"     </a>",
"    </li>",
"    <li>",
"     www.reprotox.org (Accessed on September 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/85\">",
"      Einarson A, Phillips E, Mawji F, et al. A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 1998; 15:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/86\">",
"      Lin KJ, Mitchell AA, Yau WP, et al. Safety of macrolides during pregnancy. Am J Obstet Gynecol 2013; 208:221.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/87\">",
"      Andersen JT, Petersen M, Jimenez-Solem E, et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS One 2013; 8:e53327.",
"     </a>",
"    </li>",
"    <li>",
"     www.reprotox.com. (Accessed November 19, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/89\">",
"      Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009; 23:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/90\">",
"      Bar-Oz B, Moretti ME, Boskovic R, et al. The safety of quinolones--a meta-analysis of pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2009; 143:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/91\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/92\">",
"      Newman RD, Parise M, Nahlen B. Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 2001; 344:934; author reply 934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/93\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/94\">",
"      Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009; 163:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/95\">",
"      K&auml;ll&eacute;n BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003; 17:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/96\">",
"      Nordeng H, Lupattelli A, Rom&oslash;ren M, Koren G. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 2013; 121:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/97\">",
"      American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol 2011; 117:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/98\">",
"      Forna F, McConnell M, Kitabire FN, et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006; 8:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/99\">",
"      ANDERSEN DH, BLANC WA, CROZIER DN, SILVERMAN WA. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18:614.",
"     </a>",
"    </li>",
"    <li>",
"     Loperamide www.reprotox.org (Accessed on April 26, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/101\">",
"      Wilson DL, Barnes M, Ellett L, et al. Decreased sleep efficiency, increased wake after sleep onset and increased cortical arousals in late pregnancy. Aust N Z J Obstet Gynaecol 2011; 51:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/102\">",
"      Hertz G, Fast A, Feinsilver SH, et al. Sleep in normal late pregnancy. Sleep 1992; 15:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/103\">",
"      Okun ML, Kiewra K, Luther JF, et al. Sleep disturbances in depressed and nondepressed pregnant women. Depress Anxiety 2011; 28:676.",
"     </a>",
"    </li>",
"    <li>",
"     Pregnancy and sleep file://www.sleepfoundation.org/article/sleep-topics/pregnancy-and-sleep (Accessed on October 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/105\">",
"      Daniell WE, Vaughan TL, Millies BA. Pregnancy outcomes among female flight attendants. Aviat Space Environ Med 1990; 61:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/106\">",
"      Huch R, Baumann H, Fallenstein F, et al. Physiologic changes in pregnant women and their fetuses during jet air travel. Am J Obstet Gynecol 1986; 154:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/107\">",
"      ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 443: Air travel during pregnancy. Obstet Gynecol 2009; 114:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/108\">",
"      Freeman M, Ghidini A, Spong CY, et al. Does air travel affect pregnancy outcome? Arch Gynecol Obstet 2004; 269:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/109\">",
"      Magann EF, Chauhan SP, Dahlke JD, et al. Air travel and pregnancy outcomes: a review of pregnancy regulations and outcomes for passengers, flight attendants, and aviators. Obstet Gynecol Surv 2010; 65:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/110\">",
"      Chibber R, Al-Sibai MH, Qahtani N. Adverse outcome of pregnancy following air travel: a myth or a concern? Aust N Z J Obstet Gynaecol 2006; 46:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/111\">",
"      Artal R, Fortunato V, Welton A, et al. A comparison of cardiopulmonary adaptations to exercise in pregnancy at sea level and altitude. Am J Obstet Gynecol 1995; 172:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/112\">",
"      Barish RJ. In-flight radiation exposure during pregnancy. Obstet Gynecol 2004; 103:1326.",
"     </a>",
"    </li>",
"    <li>",
"     National Council on Radiation Protection and Measurements. Limitation of exposure to ionizing radiation. NCRP Report 116. Bethesda (MD): NCRP; 1993.",
"    </li>",
"    <li>",
"     International Commission on Radiological Protection. 1990 Recommendations of the ICRP. ICRP Publication 60. In: Annals of the ICRP 21 (1&ndash;3). New York (NY): Pergammon Press; 1991. p. 42, 46.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/115\">",
"      Huch R. Physical activity at altitude in pregnancy. Semin Perinatol 1996; 20:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/116\">",
"      Baumann H, Huch R. [Altitude exposure and staying at high altitude in pregnancy: effects on the mother and fetus]. Zentralbl Gynakol 1986; 108:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/117\">",
"      Parer JT. Effects of hypoxia on the mother and fetus with emphasis on maternal air transport. Am J Obstet Gynecol 1982; 142:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/118\">",
"      Kametas NA, McAuliffe F, Krampl E, et al. Maternal cardiac function during pregnancy at high altitude. BJOG 2004; 111:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/119\">",
"      Niermeyer S. The pregnant altitude visitor. Adv Exp Med Biol 1999; 474:65.",
"     </a>",
"    </li>",
"    <li>",
"     Chua-Gocheco, A, Bozzo, P, Einarson, A. Safety of hair products during pregnancy. October 2008. Available at www.motherisk.org/prof/updatesDetail.jsp?content_id=890 (accessed January 5, 2010).",
"    </li>",
"    <li>",
"     Organization of Teratology Information Specialists. Hair Treatments and Pregnancy. Available at www.OTISpregnancy.org. (Accessed January 5, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/122\">",
"      Dindelli M, Parazzini F, Basellini A, et al. Risk factors for varicose disease before and during pregnancy. Angiology 1993; 44:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/1/42010/abstract/123\">",
"      Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly 2001; 131:659.",
"     </a>",
"    </li>",
"    <li>",
"     Interactive site for clinicians serving women with disabilities file://www.acog.org/About_ACOG/ACOG_Departments/Women_with_Disabilities/Interactive_site_for_clinicians_serving_women_with_disabilities (Accessed on April 20, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 446 Version 60.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-F7344C3B4D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42010=[""].join("\n");
var outline_f41_1_42010=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H44\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12840240\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CARE PROVIDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GROUP PRENATAL CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Estimated date of delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LABORATORY TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Routine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1272361\">",
"      - Rhesus type and antibody screen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1272450\">",
"      - Hematocrit or hemoglobin and mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1272458\">",
"      - Cervical cytology cancer screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1272465\">",
"      - Rubella immunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276165\">",
"      - Varicella immunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H109279416\">",
"      - Urine protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276173\">",
"      - Urine culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276310\">",
"      - Syphilis testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276336\">",
"      - Hepatitis B antigen testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276364\">",
"      - Chlamydia testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276464\">",
"      - Human immunodeficiency virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      At-risk women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276972\">",
"      - Thyroid function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H362934781\">",
"      - Type 2 diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Testing for infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832578\">",
"      N. gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832586\">",
"      Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832594\">",
"      Toxoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832602\">",
"      Hepatitis C antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832610\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832618\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832626\">",
"      Herpes simplex virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12839588\">",
"      CMV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2832634\">",
"      Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Evaluation for inherited disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892302\">",
"      Cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892348\">",
"      Fragile X",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892309\">",
"      Hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892415\">",
"      Eastern European (Ashkenazi) Jews and others",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892331\">",
"      Spinal muscular atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5892449\">",
"      Phenylketonuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H939359\">",
"      - Lead level screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other potentially useful tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Ultrasound examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1276647\">",
"      - Down syndrome screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PATIENT EDUCATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Practice issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Seat belts and air bags",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Vitamins, nutrition, and weight gain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Alcohol, cigarettes, and illicit drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Infection precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Work",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12840277\">",
"      Hot tubs and saunas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Sexual activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Birth defects and genetic issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1702574\">",
"      - Treatment of pain and fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H394093\">",
"      Acetaminophen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H394100\">",
"      NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H394107\">",
"      Opioids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1702581\">",
"      - Treatment of cold and allergy symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1702588\">",
"      - Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1702595\">",
"      - Treatment of constipation and diarrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1702610\">",
"      - Treatment of nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5760400\">",
"      - Treatment of gastrointestinal reflux",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5760420\">",
"      - Treatment of sleep disturbance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6593841\">",
"      Travel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Airline travel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Travel to moderate and high altitudes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Selected common environmental concerns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12838787\">",
"      Varicose veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4812727\">",
"      SPECIAL POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4812811\">",
"      Adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4812735\">",
"      Incarcerated women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4812755\">",
"      Disabled women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4812839\">",
"      Advanced maternal age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12840141\">",
"      ONGOING PRENATAL CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/446\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/446|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/56/12171\" title=\"table 1\">",
"      Initial prenatal social and demographic assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/27/38331\" title=\"table 2\">",
"      Past obstetrical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/30/34285\" title=\"table 3\">",
"      Medical history in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/39/2683\" title=\"table 4\">",
"      Menstrual history in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/50/3883\" title=\"table 5\">",
"      Current pregnancy history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/2/4139\" title=\"table 6\">",
"      Timing of first ultrasound appearance of pregnancy landmarks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/55/36732\" title=\"table 7\">",
"      Who should be tested LTBI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/9/9373\" title=\"table 8\">",
"      Risk factors for lead exposure in pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/27/29115\" title=\"table 9\">",
"      Frequency of maternal blood lead follow-up testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/25/6556\" title=\"table 10\">",
"      FDA pregnancy categories",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/58/5024\" title=\"table 11\">",
"      Selected agents with potential adverse fetal effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/36/9804\" title=\"table 12\">",
"      Physical effects of altitude",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=related_link\">",
"      Adult lead poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41575?source=related_link\">",
"      Alcohol intake and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4568?source=related_link\">",
"      Anatomical and physiological changes of pregnancy and exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/0/31751?source=related_link\">",
"      Basic principles of genetic counseling for the obstetrical provider",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6826?source=related_link\">",
"      Cervical cancer in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=related_link\">",
"      Cervical intraepithelial neoplasia: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/34/551?source=related_link\">",
"      Chagas disease: Natural history and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=related_link\">",
"      Childhood lead poisoning: Exposure and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/15/41207?source=related_link\">",
"      Clinical features and evaluation of nausea and vomiting of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/59/14266?source=related_link\">",
"      Clinical manifestations and diagnosis of Chagas heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/62/22503?source=related_link\">",
"      Cystic fibrosis: Prenatal genetic screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=related_link\">",
"      Cytomegalovirus infection in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/21/22873?source=related_link\">",
"      Disability assessment and determination in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31865?source=related_link\">",
"      Effect of advanced age on fertility and pregnancy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23880?source=related_link\">",
"      Epidemiology and control of Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/31/4602?source=related_link\">",
"      Epidemiology, transmission, and prevention of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/33001?source=related_link\">",
"      Genital herpes simplex virus infection and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43062?source=related_link\">",
"      Group B streptococcal infection in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11030?source=related_link\">",
"      Group prenatal care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21703?source=related_link\">",
"      Hematologic changes in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/297?source=related_link\">",
"      High altitude illness: Physiology, risk factors, and general prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32602?source=related_link\">",
"      Immunizations during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/53/35674?source=related_link\">",
"      Inhibition of acute preterm labor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6393?source=related_link\">",
"      Intimate partner violence: Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/41/5784?source=related_link\">",
"      Intimate partner violence: Epidemiology and health consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/54/14183?source=related_link\">",
"      Intimate partner violence: Intervention and patient management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=related_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/48/35590?source=related_link\">",
"      Management of infertility and pregnancy in women of advanced age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/21/5464?source=related_link\">",
"      Management of pregnancy complicated by Rhesus (Rh) alloimmunization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/60/9160?source=related_link\">",
"      Maternal gastrointestinal tract adaptation to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4570?source=related_link\">",
"      Methadone maintenance therapy during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/57/39833?source=related_link\">",
"      Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/44/28362?source=related_link\">",
"      Nutrition in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39561?source=related_link\">",
"      Obstructive sleep apnea in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4746?source=related_link\">",
"      Occupational and environmental risks to reproduction in females",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34521?source=related_link\">",
"      Overview and management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32982?source=related_link\">",
"      Overview of Rhesus (Rh) alloimmunization in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/12/6346?source=related_link\">",
"      Overview of illicit drug use in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16921?source=related_link\">",
"      Overview of malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/58/35753?source=related_link\">",
"      Overview of phenylketonuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/27/22969?source=related_link\">",
"      Overview of prenatal screening and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/51/16186?source=related_link\">",
"      Overview of thyroid disease in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40408?source=related_link\">",
"      Parvovirus B19 infection during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/15/8434?source=related_link\">",
"      Patient information: Activity during pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/52/43843?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/63/11248?source=related_link\">",
"      Patient information: Group B streptococcus and pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/29/37331?source=related_link\">",
"      Patient information: Prenatal care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/50/2851?source=related_link\">",
"      Patient information: Should I have a screening test for Down syndrome during pregnancy? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=related_link\">",
"      Preconception evaluation and counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/31/10744?source=related_link\">",
"      Pregnancy in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=related_link\">",
"      Prenatal assessment of gestational age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/48/44807?source=related_link\">",
"      Prenatal care (after initial prenatal assessment)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/39/632?source=related_link\">",
"      Prenatal care for incarcerated women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=related_link\">",
"      Prenatal screening and diagnosis for fragile X syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/24/12681?source=related_link\">",
"      Prenatal screening for genetic disease in the Ashkenazi Jewish population",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4968?source=related_link\">",
"      Prenatal sonographic diagnosis of fetal cardiac anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=related_link\">",
"      Prenatal testing for the hemoglobinopathies and thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/44/40648?source=related_link\">",
"      Prevention of Rh(D) alloimmunization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/26/37289?source=related_link\">",
"      Prevention of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/26/12713?source=related_link\">",
"      Primary care of the adult with intellectual disability (mental retardation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20119?source=related_link\">",
"      Primary prevention of allergic disease: Maternal avoidance diets in pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3914?source=related_link\">",
"      Recognition and management of allergic disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/30/7657?source=related_link\">",
"      Recommendations for exercise during pregnancy and the postpartum period",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/31/33273?source=related_link\">",
"      Risks and benefits of fish consumption and fish oil supplements during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43576?source=related_link\">",
"      Routine prenatal ultrasonography as a screening tool",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6087?source=related_link\">",
"      Rubella in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9210?source=related_link\">",
"      Screening and diagnosis of diabetes mellitus during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=related_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/27/3513?source=related_link\">",
"      Significance of minor red blood cell antibodies during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8344?source=related_link\">",
"      Spinal muscular atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=related_link\">",
"      Syphilis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/11/7353?source=related_link\">",
"      Tetanus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/35/20026?source=related_link\">",
"      The effects of caffeine on reproductive outcomes in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/11/29882?source=related_link\">",
"      The impact of obesity on fertility and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=related_link\">",
"      Toxoplasmosis and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/48/8967?source=related_link\">",
"      Travel advice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/10/28840?source=related_link\">",
"      Traveling with oxygen aboard commercial air carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/20/29002?source=related_link\">",
"      Treatment and outcome of nausea and vomiting of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/13/20695?source=related_link\">",
"      Treatment and prevention of malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/1/31767?source=related_link\">",
"      Treatment and prevention of parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=related_link\">",
"      Treatment and prognosis of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36344?source=related_link\">",
"      Treatment of respiratory infections in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/46/745?source=related_link\">",
"      Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=related_link\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/26/29096?source=related_link\">",
"      Tuberculosis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=related_link\">",
"      Urinary tract infections and asymptomatic bacteriuria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/59/38842?source=related_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/44/25290?source=related_link\">",
"      Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33225?source=related_link\">",
"      Varicella-zoster virus infection in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30681?source=related_link\">",
"      Vulvovaginal varicosities and pelvic congestion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19304?source=related_link\">",
"      Weight gain and loss in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/37/20056?source=related_link\">",
"      Work and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/42/31401?source=related_link\">",
"      Zoonoses from cats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/24/29065?source=related_link\">",
"      Zoonoses from dogs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/22/26986?source=related_link\">",
"      Zoonoses from pets other than dogs and cats",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_1_42011="Presports exam counseling";
var content_f41_1_42011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anticipatory guidance for preparticipation examination for children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       A medical history and physical examination can identify undiagnosed or incompletely rehabilitated injury or define underlying conditions that require treatment or may exclude a child from certain activities or sports.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Discuss injurious practices such as use of anabolic steroids, ergogenic aids, and dangerous methods of weight loss and weight gain.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Discuss with parents characteristics of physical, cognitive, and social preparation, as well as proper training.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Assure that children and parents have reasonable expectations of a training program.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Identify significant musculoskeletal abnormalities or weaknesses that may require additional training to reach the desired level of fitness and ability without sustaining injury. Anatomical malalignments that commonly occur in growing children may be justification for temporary limitations on sports participation and training. Any deficits in strength and flexibility of major muscle groups and range of motion, stability, and symmetry of major joints ought to be corrected before participating in vigorous sports training. Likewise, any abnormalities related to previous injuries ought to be corrected prior to sport-specific training.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Review nutritional factors that may affect growth and development, as well as performance. A diet that provides adequate calories and a proper balance of nutrients is critical because nutritional needs are increased by growth, as well as training. Dietary practices that compromise physical development, growth, or performance should be discouraged.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inquire about a child's physical activity habits. Encourage youth to participate in a variety of physical activities and training methods rather than \"specializing\" in one sport or one training method. Specialization can hinder the development of the whole individual.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42011=[""].join("\n");
var outline_f41_1_42011=null;
var title_f41_1_42012="Transplant fungal prophylaxis";
var content_f41_1_42012=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71877&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71877&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested approach to antifungal prophylaxis for organ transplant recipients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Transplant organ",
"      </td>",
"      <td class=\"subtitle1\">",
"       Targeted pathogen*",
"      </td>",
"      <td class=\"subtitle1\">",
"       High risk characteristics",
"      </td>",
"      <td class=\"subtitle1\">",
"       Agent&bull;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Duration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver",
"      </td>",
"      <td>",
"       Aspergillus",
"      </td>",
"      <td>",
"       Poor allograft function; fulminant hepatic failure pretransplantation; reexploration or retransplantation; hemodialysis; isolation of Aspergillus from any site",
"      </td>",
"      <td>",
"       Lipid AmB&Delta;",
"      </td>",
"      <td>",
"       1 to 4 weeks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver",
"      </td>",
"      <td>",
"       Candida",
"      </td>",
"      <td>",
"       Repeated operation; higher intraoperative transfusion requirements; longer operation time; renal failure; ICU stay",
"      </td>",
"      <td>",
"       <p>",
"        Fluconazole",
"       </p>",
"       <p>",
"        Alternatives: echinocandin or lipid-AmB&Delta;",
"       </p>",
"      </td>",
"      <td>",
"       1 to 4 weeks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lung",
"      </td>",
"      <td>",
"       Aspergillus",
"      </td>",
"      <td>",
"       Airway specimen cultures positive for Aspergillus, particularly for patients with rejection or poor graft function; increased immunosuppression; CMV&loz; infection; obliterative bronchiolitis",
"      </td>",
"      <td>",
"       <p>",
"        Itraconazole or voriconazole&sect; or lipid-AmB&Delta; (full dose intravenous) &plusmn; nebulized AmB",
"       </p>",
"       <p>",
"        (CMV prophylaxis&yen;)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Depends on CT findings and clearance of sputum cultures, appearance of tracheal anastomosis.",
"       </p>",
"       <p>",
"        1 to 6 months",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pancreas",
"      </td>",
"      <td>",
"       Candida",
"      </td>",
"      <td>",
"       <p>",
"        All procedures",
"       </p>",
"       <p>",
"        (Risk increased with enteric drainage, anastamotic leak, pancreas transplantation after kidney transplantation, pancreatitis)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Fluconazole",
"       </p>",
"       <p>",
"        Alternatives: echinocandin or lipid-AmB&Delta;",
"       </p>",
"       <p>",
"        (CMV prophylaxis&yen;)",
"       </p>",
"      </td>",
"      <td>",
"       4 weeks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bowel",
"      </td>",
"      <td>",
"       Candida",
"      </td>",
"      <td>",
"       <p>",
"        All procedures",
"       </p>",
"       <p>",
"        (Risk increased with peritonitis or leaks, reexploration, renal failure, ischemia, CMV infection, parenteral nutrition)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Fluconazole",
"       </p>",
"       <p>",
"        May use echinocandin or lipid-AmB&Delta; as alternatives.",
"       </p>",
"       <p>",
"        (CMV prophylaxis&yen;)",
"       </p>",
"      </td>",
"      <td>",
"       2 to 4 weeks",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Adjusted for prevalence at center",
"     <br>",
"      &bull; An echinocandin (eg, caspofungin) might be considered as an alternative to fluconazole for prophylaxis against Candida and voriconazole as an alternative to lipid AmB; however, hepatotoxicity and drug interactions may limit their use",
"      <br>",
"       &Delta; A lipid formulation of amphotericin B is preferred over amphotericin B deoxycholate in order to reduce administration-associated side effects and nephrotoxicity",
"       <br>",
"        &loz; Cytomegalovirus",
"        <br>",
"         &sect; Adjust doses of calcineurin inhibitors and monitor levels carefully when initiating or discontinuing azole antifungal",
"         <br>",
"          &yen; CMV prophylaxis is recommended during treatment of invasive fungal infections",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42012=[""].join("\n");
var outline_f41_1_42012=null;
var title_f41_1_42013="Activation criteria for rapid response systems";
var content_f41_1_42013=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of published activation criteria for rapid response systems",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Bellomo calling criteria",
"            <sup>",
"             [1]",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            If one of these is present:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Staff member is worried about the patient",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in heart rate to &lt;40 or &gt;130 beats/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in systolic blood pressure to &lt;90 mmHg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in respiratory rate &lt;8 or &gt;30 breaths/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in pulse oximetry saturation to &lt;90 percent despite oxygen administration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in conscious state",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute change in urine output to &lt;50 mL in 4 hours",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            MERIT calling criteria",
"            <sup>",
"             [2]",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Airway:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            If threatened",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Breathing:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            All respiratory arrests",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Respiratory rate &lt;5 breaths/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Respiratory rate &gt;36 breaths/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Circulation:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            All cardiac arrests",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pulse rate &lt;40 beats/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pulse rate &gt;140 beats/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Systolic blood pressure &lt;90 mmHg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Neurology:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sudden fall in level of consciousness (fall in Glasgow coma scale of &gt;2 points)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Repeated or extended seizures",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Other:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Any patient you are seriously worried about that does not fit the above criteria",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Pittsburgh calling criteria",
"            <sup>",
"             [3]",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Respiratory:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rate &lt;8 or &gt;36 breaths/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            New onset difficult breathing",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            New pulse oximeter reading less than 85 percent for more than 5 minutes (unless patient known to have chronic hypoxemia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Heart rate:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            &lt;40 or &gt;140 with symptoms or any rate &gt;160 beats/min",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Blood pressure:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            &lt;80 or &gt;200 systolic or 110 mmHg diastolic with symptoms",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Acute neurological change:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute loss of consciousness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            New onset lethargy or Narcan use without immediate response",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Seizure (outside of seizure monitoring unit)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sudden loss of movement (or weakness) of face, arm, or leg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Other:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Chest pain unresponsive to nitroglycerine or doctor unavailable",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Color change (of patient or extremity): pale, dusky, gray, or blue",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Unexplained agitation for more than 10 minutes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Suicide attempt",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Uncontrolled bleeding",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Bellomo R, et al. Prospective controlled trial of effect of medical emergency team on postoperative morbidity and mortality rates. Critical care 2004; 32:916.",
"       </li>",
"       <li>",
"        Hillman K, et al. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet 2005; 365:2091.",
"       </li>",
"       <li>",
"        DeVita MA, et al. Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Quality &amp; safety in health care 2004; 13:251.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42013=[""].join("\n");
var outline_f41_1_42013=null;
var title_f41_1_42014="Trichomonas vaginalis";
var content_f41_1_42014=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Trichomonas vaginalis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power microscopy revealing Trichomonas vaginalis with easily identified flagella.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jack D. Sobel, MD and William E. Secor.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42014=[""].join("\n");
var outline_f41_1_42014=null;
var title_f41_1_42015="Approach to patients with PBC or PSC and features of AIH";
var content_f41_1_42015=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Approach to patients with primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC) and features of autoimmune hepatitis (AIH)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 498px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Essentially based on the recommendations in the EASL guidelines.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      There are no established definitions of the required degree of elevation of serum transaminases or IgG levels. ALT at least 5x, ULN and IgG at least 2x ULN, as previously suggested as criteria for AIH, may serve as guidelines.",
"      <br>",
"       &Delta; Immunosuppressive treatment is not evidence-based. It can be suggested that initial treatment is given according to guidelines for AIH.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        The AASLD guidelines recommend against UDCA in patients with PSC, whereas the EASL guidelines acknowledge that UDCA is widely used in PSC, although the long-term efficacy remains unproven.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Boberg KM, Chapman RW, Hirschfield GM. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54:374. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_1_42015=[""].join("\n");
var outline_f41_1_42015=null;
